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Abstract 
Introduction: There is a dearth of literature on third-wave Cognitive Behavioural 
Therapies (CBT) for Functional Neurological Disorder (FND). These approaches adopt a 
transdiagnostic approach to support people to change their relationship with their psychological 
experiences (Hayes, 2004). This thesis examines the existing literature regarding these 
approaches and explores the impact of a Clinical Health Psychology Service two-phase 
psychological intervention for FND. This consists of assessment and formulation sessions 
(Phase 1) and an innovative seven-week Acceptance and Commitment Therapy (ACT) group 
(Phase 2). 
Aims: A scoping review explores the extent and nature of the literature on third-wave 
CBT for FND and determines whether there is good quality evidence available regarding its 
effectiveness. Preliminary factors for intervention feasibility, acceptability and effectiveness are 
explored within the review. The empirical study aims to evaluate the impact and experiences of 
participants receiving the two-phase psychological intervention for FND. 
Methods: A broad scoping review of third-wave CBT for FND was carried out on the 
bibliographic databases PsychINFO, EMBASE and MEDLINE, which were searched from the 
earliest listing up to June 2020. Key information is charted and explores factors related to 
intervention feasibility, acceptability and effectiveness. For the two-phase psychological 
intervention, pre and post standardised outcome measures are explored for three participants 
who attended assessment and formulation and three participants who attended the ACT group 
and participated in a Single Case Experimental Design (SCED). Seven participants completed a 
semi-structured Change Interview (Elliott, 1999; Elliott et al., 2001) regarding their experiences 
of the intervention and perceived changes, explored through thematic analysis (Braun & Clarke, 
2006). 
Results: The scoping review found a small number of low-quality studies have applied 
third-wave CBT in different formats across several FND presentations. All lacked information 
on feasibility and acceptability. There was promise for third-wave CBT effectiveness with 
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improvements found for QoL, distress and psychological flexibility measures for some. The 
study found that changes in standardised outcome measures following each phase of the two-
phase psychological intervention were complicated with a mixture of improvement, lack of 
change and, in some cases, worsening on standardised measures. In contrast, participants' 
interview accounts described the intervention positively and detailed important therapeutic 
changes attributable to the intervention.  
Conclusion: Third-wave CBT is not well established for FND. While some patients 
benefit from these approaches, it is unclear what factors influence effectiveness. Higher quality 
intervention studies are required and could be developed through feasibility studies and 
qualitative research on different patient's perceptions and experiences of psychological 
intervention. The results from the two-phase psychological intervention for FND highlight the 
challenges of providing psychological intervention for a complex and heterogeneous clinical 
population.  
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1 Introduction 
1.1 Research overview 
Functional Neurological Disorder (FND), also known as conversion disorder, 
describes neurological symptoms, such as limb weakness, seizures and visual 
disturbances, which, while not feigned, are inconsistent with known disease pathologies 
or structural or pathophysiological changes in the nervous system (American 
Psychiatric Association, 2013). FND results in chronic and severe symptoms associated 
with high health and social care costs (Adjei & Coebergh, 2014; Stone et al., 2010). The 
literature on effective treatments is scarce, with emerging evidence supporting the use 
of psychological therapies and physical rehabilitation (Baslet et al., 2020; Mayor et al., 
2010; Nielsen et al., 2017; Sattel et al., 2012). 
This thesis evaluates the impact of third-wave CBT for people with FND. Third-
wave CBT adopts a transdiagnostic approach to support people to change their 
relationship with their psychological experiences (Hayes, 2004). Special attention will 
be paid to the impact and experiences of a two-phase psychological intervention FND 
treatment pathway within the Clinical Health Psychology Service at Mid Yorkshire 
Hospitals NHS Trust. In Phase 1, patients with FND are offered an assessment and 
formulation with a Clinical Psychologist, which can last up to six sessions. Suitable 
patients are then offered a seven-session Acceptance and Commitment Therapy (ACT) 
group in Phase 2. 
A multi-methods design is adopted. First, a scoping review of the extent and 
nature of third-wave CBT for FND is presented. The quality of evidence available 
regarding the effectiveness of third-wave CBT for people with FND is explored, 
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alongside preliminary evidence of factors related to intervention feasibility, 
acceptability and effectiveness. Next, the impact of a two-phase psychological 
intervention for FND is evaluated, focusing on exploring therapeutic change. This 
evaluation is achieved through looking at pre and post-standardised outcome measures 
across each phase and by a Single Case Experimental Design (SCED) for the 
participants who attend the ACT group. In addition, a Change Interview (Elliott, 1999; 
Elliott et al., 2001) explores each participant's experiences of the intervention, perceived 
changes and how they make sense of this change.  
1.2 The research process 
Initially, this work focused on a SCED exploring the changes that patients with 
FND experienced across a seven-week ACT group, offered as part of clinical care. The 
first group ran between September and November 2019, and data for three participants 
was collected. Unfortunately, due to the exceptional circumstances caused by the 
pandemic, the second ACT group was abruptly stopped in March 2020, with data 
collection less than halfway through. The first group participants were enthusiastic and 
dedicated a significant amount of their time to complete daily surveys and a Change 
Interview on their experiences of the group. Subsequently, it was considered essential to 
present this data to the best of the author's ability. 
Due to the uncertainty caused by the pandemic, it was necessary to adapt some of 
the research objectives. It was decided to keep the initial exploration of ACT for FND 
and to perform an additional systematic review of the literature focused on this topic. 
Since the literature on ACT interventions for FND was small, this review was expanded 
to explore all third-wave CBT for FND. In the current thesis, due to the small and 
diverse nature of the studies covered, this review is presented as a scoping review. 
- 3 - 
Data collection from the FND pathway was amended to include Change 
Interviews with the four participants recruited from the suspended ACT group. Rather 
than focusing on their ACT group experiences, these interviews explored their 
experiences of assessment and formulation sessions (Phase 1). This approach has 
provided a broader account of participants' experiences of change across the two-phase 
psychological intervention and is complimented by pre and post-standardised outcome 
measures for each phase.  
1.3 Overview of FND 
FND covers a diverse range of symptoms. The most common symptoms are 
sensory (such as numbness or visual impairment), seizures, and motor symptoms (such 
as limb weakness, tremor, dystonia or gait disorders)(Carson et al., 2012). Motor 
Functional Neurological Disorders (mFND) covers several presentations, including 
weakness, gait disorders and tremor (Ricciardi & Edwards, 2014). Several terms are 
used to describe seizures, such as dissociative seizures/dissociative nonepileptic attack, 
Non-Epileptic or Psychogenic Seizures (abbreviated to NES or PNES), Functional Non-
Epileptic Attacks Disorder (FNEAD) and Non-Epileptic Attack Disorder (NEAD)(Cope 
et al., 2017). Throughout this work, seizures will be referred to as NEAD. FND 
symptoms can begin suddenly and progress quickly, disappear with distraction and 
increase with attention or fatigue (Espay et al., 2018). The frequency and persistence of 
symptoms range from a single acute episode to a more chronic presentation (Stone et 
al., 2011). 
FND frequently co-exists with somatoform/psychosomatic disorder, also known 
as Somatoform Symptom Disorder (SSD), which refers to physical bodily symptoms in 
response to psychological distress (Kozlowska, 2013; Stone et al., 2004). Comorbidity 
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of above 50% has been reported (Şar et al., 2004). Furthermore, FND is commonly 
associated with experiences of medically unexplained symptoms (MUS). Dixit et al. 
(2013) found the comorbidity to be as high as 82%. 
The prevalence of FND is currently unknown. Establishing a population 
prevalence is difficult due to changes in its terminology, diagnostic criteria and the need 
for neurological examination before diagnosis (Binzer et al., 1997). Black and 
Andreasen (2014) estimate that 20-25% of patients admitted to neurology wards have 
FND symptoms, with an 18-month follow-up showing an inaccurate diagnosis in only 
0.4 cases (Stone et al., 2009). A large study of neurology outpatients in Scotland 
estimated that around 5000 cases of FND were diagnosed per year and that functional 
symptoms were the second most common disorder after a headache (Stone, 2010). 
1.3.1 The challenges of managing FND 
FND is as disabling and distressing as other neurological disorders, such as 
multiple sclerosis and epilepsy (Stone, 2010). It is associated with as much or more 
disability, distress and unemployment as other neurological disorders presented to 
neurologists. The long-term prognosis for FND, while variable, is often poor (Carson et 
al., 2012). FND is also associated with frequent hospital admissions, lengths of stay and 
high costs (Adjei & Coebergh, 2014; Bermingham et al., 2010). Bermingham et al. 
(2010) estimated the health care costs in the United Kingdom (UK) of patients with 
FND to be £3 billion in 2008-2009. This cost accounted for 10% of the total NHS 
expenditure for the working-age population during that time. They also estimated that 
the cost of sickness absence and decreased quality of life of people experiencing FND 
amounted to over £14 billion. An audit of nineteen patients diagnosed with FND in a 
UK hospital between 2009-2012 found that these individuals had on average five ward 
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admissions, six Accident and Emergency admissions, and twenty-four days of hospital 
stay (Adjei & Coebergh, 2014). 
Qualitative studies on patients' experiences of FND and MUS highlights several 
difficult experiences associated with the diagnosis (Gerskowitch et al., 2015; Nielsen et 
al., 2019). Frequent misdiagnosis, stigma, dysfunctional medical encounters and 
inadequate treatments can lead to patients feeling misunderstood (Canna & Seligman, 
2020). These experiences are often associated with conflicts with Health Care 
Professionals (HCP) and feeling abandoned by the health care system (Ahern et al., 
2009; Nielsen et al., 2019). Nettleton et al. (2005) used the term 'medical orphans' to 
describe patients' experiences of FND. Acceptance of diagnosis is associated with 
higher chances of recovery. However, acceptance can be dependent on how the illness 
is viewed. Literature highlights the need for an integrated biopsychosocial explanatory 
model to help patients make sense of their illness experience and the importance of 
careful communication of the diagnosis as a first step in the treatment (Espay, 2018). 
1.4 Making sense of FND 
The aetiology of FND remains far from being fully understood. One of the earliest 
accounts dates back to the 19th Century when Jean-Martin Charcot proposed that 
'functional lesions' to the nervous system gave rise to 'hysteria' (Bogousslavsky, 2011). 
Researchers have identified various psychological and psychiatric factors common in 
people with FND, which are purported to support different theories of FND. This 
section describes the following theories: 
• early models; 
• psychodynamic models of FND; 
• cognitive behavioural and somatisation theories; 
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• integrative models; 
• psychobiological approaches. 
1.4.1 Early models 
Classical models of FND attributed symptoms to psychological stressors, 
particularly historical traumas. Janet's (1889) dissociation theory of hysteria posits that 
symptoms result from exposure to stressful events that cause psychological 
fragmentation or dissociation. Thus, a person's ability to synthesise mental content 
breaks down when faced with stress, resulting in disturbances of a person's voluntary 
control and heightened suggestibility and fragmentation (i.e. dissociation) of 
psychological systems. Within this framework, somatic flashbacks reflect the activation 
of triggered memory fragments. The person has limited awareness that they are reliving 
a previous experience, as memory fragments remain separated from consciousness 
because of the anxiety associated with recalling them. Associations between FND and 
increased suggestibility, attentional dysfunction and trauma have been purported to 
provide evidence for this dissociation theory (Brown, 2016). 
1.4.2 Psychodynamic models of FND 
In contrast to Janet, Freud surmised that trauma could lead to the forcible 
repression of feelings and memories into the subconscious, with the person entirely 
unaware of their existence. Within this framework, psychological trauma can lead to 
physical excitation, which, without an outlet, can be converted into a physical 
complaint. Thus, symptoms are seen as a defence that helps a person survive traumatic 
experiences and cope with overwhelming emotions (Bowman, 2006; Goldstein & 
Mellers, 2006). Both Freud and Breuer postulated that once the trigger (past traumas) 
for the symptoms re-entered the realm of conscious recollection, catharsis can be found. 
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The terms dissociation and conversion are still widely used. Links with early trauma 
and FND have been alleged to support this psychodynamic approach to FND (Ludwig 
et al., 2018; Myers et al., 2019). However, it is recognised that many people with FND 
do not report experiencing early trauma or adversity (Reuber, 2018). 
FND is associated with more disruptions in emotion processing than controls and 
alexithymia, which refers to difficulties recognising or acknowledging affect (Novakova 
et al., 2015; Urbanek et al., 2014). Emotion processing difficulties correlate with more 
severe FND symptoms, psychological distress and poorer illness understanding. In 
FND, emotion processing difficulties are characterised by excessive avoidance and 
suppressing emotions (Novakova et al., 2015; Roberts & Reuber, 2014). Early and 
accumulating emotional stress can substantially impact emotion processing (Steffen et 
al., 2015), posited to ensue when emotional disturbances are not absorbed. This process 
can result in a broad range of signs that include intrusive or obsessive thoughts, 
irritability, fatigue, and insomnia (Rachman, 1980). These signs of emotional 
processing disruption are linked to interactions between predisposing, precipitating, and 
perpetuating factors that lead to the onset and maintenance of FND symptoms (Carson 
et al., 2012). 
1.4.3 Cognitive behavioural and somatisation models 
Cognitive-behavioural models of MUS (Deary et al., 2007) propose that distorted 
illness beliefs (such as thinking something is catastrophically physically wrong) inform 
unhelpful illness behaviours (such as avoidance), which in turn, maintains symptoms. 
Similarly, a somatisation model of MUS assumes FND symptoms reflect psychological 
distress (Lipowski, 1988).  This model provides a broader perspective by 
acknowledging the importance of biological, psychological and social variables, which 
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are also identified in cognitive behavioural models. Figure 1 illustrates the key factors 
implicit within cognitive behavioural and somatisation models of MUS and FND. 
Figure 1 
 
Factors involved in the creation and maintenance of medically unexplained symptoms 
taken from Chalder and Willis (2019) 
 
There are several predisposing factors for FND, such as temperamental 
characteristics, genetic factors and early experiences such as trauma (Myers et al., 
2019). Early trauma experiences appear associated with increased symptom severity, 
comorbid mental health difficulties and MUS (Selkirk et al., 2008). A subgroup of FND 
patients appears to experience insecure and fearful attachments and increased 
psychological and emotional regulation difficulties (Jalilianhasanpour et al., 2019; 
Levita et al., 2020). Researchers have found two distinct profiles evident in NEAD 
patients. The first group is associated with conforming and overly controlled behaviour. 
The second group is characterised by more significant emotional dysregulation, a 
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history of using psychiatric services and a significantly poorer prognosis (Brown & 
Reuber, 2016a). 
Several precipitating factors have been associated with FND, including a higher 
frequency of childhood and adulthood stressors and current or recent illness or injury 
(Deary et al., 2007; Ludwig et al., 2018; Nicholson et al., 2016). Additionally, higher 
employment in caregiving positions has been found in mFND patients, where it is 
hypothesised that observing unwell others can create the modelling of neurological 
symptoms (O'Connell et al., 2020). Potential perpetuating factors for FND patients 
include sensitisation processes; attributions, beliefs and responses to illness; and 
attention, cognitive and emotional processes (Deary et al., 2007). 
Until recently, the somatosensory amplification model of functional symptoms 
(Barsky & Wyshak, 1990) formed the central basis of functional symptoms' cognitive-
behavioural models. This model hypothesises that stress-related physical arousal and 
attention to physical symptoms lead to the misattribution of normal physical sensations 
to disease. Over time, with increased attention on physical symptoms, tolerance 
decreases and arousal increases, further exacerbating physical symptoms (Nakao & 
Barsky, 2007). However, the model does not explain why subjective and measured 
stress levels can be lower in those with functional symptoms (Tak et al., 2011). This is 
accounted for by the predictive coding framework of functional symptoms (Van den 
Bergh et al., 2017). Here symptoms are a set of perceptions guided by experience and 
based on the brain's interpretation of information from the body. Preconscious cognitive 
representations of a symptom are activated when specific triggers are present, such as 
physiological stress (Van den Bergh et al., 2017). Thus, the predictive coding 
framework of functional symptoms explains symptoms that occur in the absence of 
subjective stress and highlights the importance of context on the individual's 
interpretations of symptoms. 
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The models of FND discussed so far are all limited by the assumption that FND 
symptoms are a product of psychological distress. This is a premise not well established 
empirically. Moreover, these models fail to explain how physical symptoms can exist in 
the absence of visible physiological changes, such as those observed in NEAD. 
Attempts to account for these shortfalls have been made by integrating various models 
into a single coherent model explained next. 
1.4.4 Integrative conceptual model of FND 
At the heart of the Integrative Conceptual Model (ICM) of FND, there is an 
awareness of the different components of consciousness, such as attention, perception 
and memory, that guide the preconscious interpretation of the world (Brown, 2006). 
Dissociation is a disruption in conscious awareness, where there is an unaccounted loss 
of contact with surroundings (American Psychiatric Association, 2013). There are two 
types of dissociative phenomena: detachment and compartmentalisation (Brown, 2016). 
Detachment is an altered state of consciousness characterised by a sense of separation 
from aspects of everyday experiences. In contrast, compartmentalisation is a shortfall in 
controlling processes or actions, but in which the disrupted functions continue to 
operate (Holmes et al., 2005). FND is fundamentally compartmentalisation (Brown, 
2016). 
Two mechanisms underlie compartmentalisation in FND (Brown, 2016). The first 
is a monitoring problem, where symptoms arise due to a person triggering a behaviour 
or processes they are unaware of. Consequently, the person experiences the symptom as 
an involuntary experience of control dissociated from their experience. The second 
mechanism is a loss of executive control over lower-level systems. Low-level 
processing is automatically triggered by cues in the environment, without direct input 
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from the executive system. Thus, symptoms are experienced as involuntary because 
they bypass the systems responsible for initiating intentional action. 
The ICM describes how information in memory shapes the automatic predictions 
or hypotheses we make about the input of data from our senses, which plays a critical 
role in our experiences and actions. Sensory information is combined with the most 
current hypothesis to produce a working representation of the environment, which 
corresponds to conscious awareness. This process enables the interpretation of events 
quickly by drawing on prior experiences. Typically, sensation and experiences match 
preconscious predictions about the world and are accurate. However, if a hypothesis in 
memory is disproportionately active due to strong expectation or motivation, this 'rogue 
representation' can be inappropriately selected as the most likely interpretation of 
sensory input and distort awareness to create FND symptoms. Researchers have found 
several disruptions to subjective experience in FND patients. These disruptions include 
implicit attentional biases (Pick et al., 2019), perceptual-cognitive inferences (Edwards 
et al., 2012), and mnemonic contributions to metacognition (Bègue et al., 2018). 
Brown and Reuber (2016b) propose that NEAD results from the automatic 
activation of a dynamic mental representation termed 'seizure scaffold' that contains 
cognitive-emotional-behavioural action programs developed through experience (such 
as observing seizures in others, experiencing trauma, previous loss of consciousness or 
illness) (See Figure 2).  
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Figure 2 
 
Factors involved in the development of symptom chronicity from the ICM (taken from 
Brown, 2006) 
 
These action programmes interact with behavioural response tendencies (such as 
hard-wired fear-escape responses), triggered in response to internal or external cues 
(such as trauma memories, autonomic arousal, conditioned stimuli). This integrative 
model explains why some factors, such as psychiatric difficulties and early adversity, 
may be present in some people diagnosed with FND but not others. Edwards et al. 
(2012) describe a predictive coding account of mFND, which suggests that symptoms 
arise from disturbances in basic neurocognitive processes of sensory feedback during 
movement and attention to movement, which a person is unaware of. As with other 
models, these processes can become represented in high-level cognitive processing, 
such as illness beliefs and vice-versa. This account emphasises the role of neuro-
rehabilitation and physiotherapy treatment for mFND. Given that FND symptoms arise 
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due to disruptions in the body's equilibrium, psychobiological approaches are explored 
next. 
1.4.5 Psychobiological approaches 
A physiological approach to FND considers the body's role, which is a complex 
entity of interrelated systems that can be disrupted when faced with internal or external 
stress. Integral to how our body responds to stress is the autonomic nervous system. 
This system controls the functions that are not voluntary but often reflect our emotional 
state (such as heart rate, pupil and blood vessel dilation, sweat glands, and bowel and 
bladder movement). The autonomic nervous system is subdivided into the sympathetic 
nerves (that determine how to react when faced with a threat) and the parasympathetic 
nerves (that exert unconscious control over organs when relaxed). In the face of sudden 
stress, the sympathetic nerves act quickly but transiently until the threat passes. 
However, under chronic stress, the sympathetic nervous system might be activated for 
prolonged periods at a low level, while the parasympathetic system is suppressed 
(Kozlowska, 2013). This process disrupts the equilibrium between the body's 
interrelated systems (i.e. homeostasis). It can create harmful brain and bodily wear and 
tear (McEwen, 2004) that can result in a range of somatic, behavioural and cognitive 
symptoms that predispose us to illness (Kozlowska, 2013). 
The body also responds to stress through the action of the Hypothalamic-Pituitary-
Adrenal (HPA) axis, which integrates neurological and endocrine systems. The 
hypothalamus can secrete hormones, some of which bind to the pituitary gland. Cortisol 
plays a vital role in the metabolic, cardiovascular, immune, and behavioural responses 
to stress and regulates the HPA axis response's magnitude. Rising levels of cortisol 
further reduce the adrenocorticotropic hormone and cortisol release via the 
hypothalamus and pituitary gland. This negative feedback loop is essential to prevent an 
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overactive response of the body's various systems to stress. The failure of the negative 
feedback loop when stress is chronic, and the failure of the adequate response of the 
HPA axis in the face of stress, is implicated in psychosomatic illness (Keynejad et al., 
2019; Kozlowska, 2013). Indeed, there is a strong association between stress and the 
onset or exacerbation of various physical and mental health difficulties via early life 
traumas and later life events preceding symptom onset (Keynejad et al., 2019). 
Keynejad et al. (2019) proposed a stress-diathesis model of FND, where biological 
susceptibility interacts with early-life adversity. A combination of risk and protective 
factors influences a person's cumulative susceptibility to FND. These factors relate to 
neurophysiology (such as interoception, motor planning/initiation), endocrine (such as 
HPA response), and psychological (such as hypervigilance) functions. They propose 
that greater biological susceptibility can lead to FND resulting from less severe and 
more recent stress. In comparison, FND precipitated by more severe stress is associated 
with lower biological vulnerability. The model highlights that FND is maintained by 
psychological responses. Recent research which has focused on the neurobiology of 
FND is now explored. 
A range of psychobiological changes have been observed in people with FND, 
such as reduced activation in the sensory parts of the brain (Baek et al., 2017; Maurer et 
al., 2016), increased connectivity between the amygdala and the supplementary motor 
area of the frontal lobe (Espay, Maloney, et al., 2018), and heightened amygdala 
reactivity when shown affectively valenced stimuli (Aybek et al., 2015; Hassa et al., 
2017; Morris et al., 2017; Szaflarski et al., 2018). However, difficulties arise when 
considering what these observed neurobiological changes in people with FND mean. 
Some have interpreted the lack of structural differences in the brain to connectivity 
issues between different areas of the brain (Carson et al., 2016). 
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Bègue et al. (2019) reviewed 29 papers on structural neuroimaging in FND and 
SSD patients. They found that some FND and SSD populations exhibit overlapping 
structural brain alterations. Similarly, Roelofs et al. (2019) explored neuroimaging in 
mFND and noted studies have started to find subtle structural brain changes in people 
with FND. They highlight emerging neurobiological theories implicating dysfunctional 
emotional processing, self-image and sense of agency in people with FND. Bègue et al. 
(2019) specifically reviewed the role of stress-related neuroplasticity in the development 
of FND. They highlighted how traumatic experiences have enduring neurobiological 
effects. In non-clinical populations, childhood maltreatment was associated with 
automatic, biased negative emotional processing and aberrant amygdala activations that 
were also present in people with FND. 
Pick et al. (2019) reviewed 27 experimental studies of emotional processing using 
behavioural, psychophysiological and neuroimaging measures in conjunction with 
affective processing tasks. FND was associated with heightened preconscious ('bottom-
up') processing of emotionally significant stimuli and increased affective arousal, 
alongside disrupted 'top-down' regulation and interoception of bodily responses. 
Emotional processing was associated with hyperactivation of limbic and motor systems 
and increased interaction of these neurocircuits. These differences could result from a 
range of biological and psychological risk factors associated with FND. Taken together, 
the latest neurobiological research highlights that the brains of people with FND are 
behaving differently to control participants. However, the meaning behind this remains 
unclear. 
1.4.6 Summary 
As presented, there are several ways that researchers have made sense of FND. 
Some have adopted a purely psychological understanding. For example, early models 
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and psychodynamic approaches highlight the role of early adversity and trauma and 
formulate that FND symptoms result from psychological distress that is either 
dissociated from awareness or unconsciously suppressed. Cognitive behavioural and 
somatisation approaches highlight the role of thoughts and behaviours in maintaining 
FND symptoms and identify a range of predisposing and precipitating factors 
contributing to the condition. However, these approaches are primarily evidenced by 
exploring specific psychiatric and psychological characteristics in people with FND, 
where methodological shortcomings mire research. Shortcomings include small sample 
sizes, a lack of conceptual consistency, inappropriate control groups (e.g. epilepsy 
control groups), and samples with a female bias (Brown & Reuber, 2016a) 
The latest psychobiological research into FND provides insights into brain activity 
changes, functional connectivity and brain structure and the role of cognitive processes 
such as self-representation and agency and emotional processing (Pick et al., 2019). 
However, these ideas need to be treated with caution, given the speculative 
interpretation of neuroimaging (Logothetis et al., 2001). Most studies involve small 
numbers, with results between studies variable and not always reproducible (Bègue et 
al., 2019). 
Current formulations of FND incorporate the spectrum of predisposing 
vulnerabilities, acute precipitants, and perpetuating factors that have been associated 
with FND (Bègue et al., 2019; Brown & Reuber, 2016b). This integrative theoretical 
understanding has implications in how FND is treated by indicating several areas that 
may be amenable to psychological intervention. For example, the ICM (Brown, 2016) 
highlights the importance of case formulation in choosing interventions that target 
factors contributing to the mental representations underlying symptoms. The model also 
suggests that only targeting cognitions may not be useful for all individuals with FND, 
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but rather other factors such as distress tolerance, emotion regulation, and interpersonal 
functioning should also be considered.  
The heterogeneous nature of FND highlights a role for psychological approaches 
that consider cognitions (CBT) and approaches that take into account the individual's 
needs, defence, conflicts and relationship difficulties (e.g. psychodynamic therapy). 
Literature also highlights potential advantages in third-wave CBT approaches that move 
away from looking at the content of thoughts and draw instead upon acceptance and 
mindfulness approaches that support the improvement of transdiagnostic processes, 
such as emotional processing, acceptance, and psychological flexibility. The predictive 
coding framework of functional symptoms indicates that developing greater present 
awareness skills may also be beneficial. For example, attentional disengagement, top-
down processing bias, and somatosensory distortions suggest that the ability for greater 
present awareness (i.e. mindfulness) would perhaps prove beneficial. The next section 
provides a brief overview of the main psychological interventions used for people with 
FND, based on psychodynamic and cognitive behavioural approaches. 
1.5 Psychological interventions for FND 
Due to limited randomised controlled trial evidence, there are currently no official 
treatment guidelines for FND. Clinical practices for FND include patient education 
(Carson et al., 2011), physical interventions (Hall‐Patch et al., 2010), such as 
occupational therapy (Gardiner et al., 2018) and physical therapy and rehabilitation 
strategies (Nielsen et al., 2017), as well as psychological interventions (Goldstein et al., 
2010; LaFrance et al., 2014; Sharpe et al., 2011). Psychological interventions are 
traditionally considered the treatment of choice for FND. These interventions typically 
draw upon psychodynamic therapy or Cognitive Behavioural Therapy (CBT). Carlson 
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and Perry (2017) conducted a meta-analysis of psychological studies for NEAD. The 
authors found a 50% reduction in NEAD frequency by at least 50% in 83% of 
participants, with 47% of people being seizure-free post-therapy. They found no 
particular therapy to be more effective than others, highlighting that various approaches 
may have value. 
1.5.1 A psychodynamic approach 
Psychodynamic interventions for FND draw upon the dissociative and 
psychodynamic theoretical understanding of FND (Breuer & Freud, 2009). These 
formulations posit that FND results from the person suppressing trauma or interpersonal 
conflicts in early life, which is then converted into FND symptoms. Kompoliti et al. 
(2014) drew upon this theoretical framework to explore psychotherapy for fifteen 
individuals with FND who were randomly selected to receive immediate or delayed 
psychodynamic treatment. The intervention involved making individuals aware of their 
unconscious phenomena and elucidating underlying conflicts. No significant 
improvement in mood or symptoms could be directly related to the intervention. 
In contrast, Sattel et al. (2012) found that a brief course of Psychodynamic-
Interpersonal Therapy (PIT) was effective in a Randomised Control Trial (RCT) of 
individuals experiencing 'Multisomatoform Disorder' including at least one FND 
symptom. Further studies have explored Brief Augmented Interpersonal Therapy 
(BAPIT), which contains somatic trauma therapy elements, explicitly adapted to 
address FND (Howlett & Reuber, 2009; Sattel et al., 2012). Drawing upon 
psychodynamic theory, BAPIT addresses childhood trauma or neglect common within 
the FND population (Reuber et al., 2007). BAPIT has been associated with significant 
improvements in psychological distress, mental health, physical health, and healthcare 
utilisation in patients with FND (Reuber et al., 2007). In individuals with NEAD, 
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BAPIT is also associated with sustained improvements in seizure control and healthcare 
utilisation (Mayor et al., 2010). 
1.5.2 A cognitive behavioural approach 
Later theories of FND have drawn from cognitive behavioural and related 
somatisation models of FND. CBT involves interrupting current patterns of thoughts 
and behaviour by identifying negative thoughts and illness beliefs and engaging in 
avoided activities to reduce any anxiety associated with them. Coping strategies such as 
relaxation exercises and distraction techniques are also developed as part of these 
interventions. Such CBT approaches have been trialled with the most common FND 
presentations, including NEAD (Goldstein & Mellers, 2016; LaFrance et al., 2014), 
mFND (Dallocchio et al., 2016) and functional dizziness (Schmid et al., 2018).  
Several studies have suggested that CBT has positive effects on patients with 
FND. Goldstein et al. (2020) compared a CBT intervention to standard medical care to 
treat NEAD (both groups n = 60). They found superior seizure reduction in the CBT 
group post-intervention and a tendency to experience fewer seizures at three-month 
follow-up. LaFrance et al. (2014) studied nine individuals with NEAD randomised to 
CBT informed psychotherapy treatment for sixteen weeks and found a 51.4% seizure 
reduction and significant improvements in depression, anxiety and Quality of Life 
(QoL) compared to controls. 
Goldstein et al. (2020) carried out one of the most extensive multicentre 
Randomised Controlled Trials (RCT) to date. They recruited 368 patients with NEAD 
from twenty-seven neurology and epilepsy services across the UK. Patients were 
randomly allocated standardised medical care or standardised medical care plus CBT. 
The authors found no statistically significant advantage of CBT compared with standard 
care alone to reduce monthly seizures. However, they did find improvements in several 
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clinically relevant secondary outcomes following CBT, including health-related QoL, 
symptom inference, distress and somatic symptoms, which remained at 12-month 
follow-up. 
O'Connell et al. (2020) examined CBT's effectiveness for mFND in a 
neuropsychiatric outpatient centre in the UK by exploring routine data collection from 
98 patients with mFND between 2006 and 2016. Only a small subset of patients had pre 
and post-CBT scores related to symptoms, distress and QoL. However, significant 
improvements were found across scores. The authors found that the only predictor of 
symptom improvement was the acceptance of a psychological explanation of symptoms 
before treatment. A recent systematic review and meta-analysis by Revell (2019) 
explored CBT as an intervention for a wide range of FND symptoms. Based on nine 
high-quality studies, they found CBT significantly improved daily functioning 
outcomes, FND symptoms and depression and anxiety when compared to control 
groups. 
1.5.3 Third-wave CBT 
CBT was the most popular psychological approach in the late 1980s and 1990s. 
However, critiques highlighted insufficiencies in the ability of the approach to 
adequately address the needs of disenfranchised or hard to treat clinical populations, as 
well as inadequate consideration of mechanisms of change through which symptoms 
improved (Linehan, 1993; Safran et al., 1988; Wierzbicki & Pekarik, 1993). These 
concerns spurred the development of diverse therapeutic approaches that included 
processes such as mindfulness, acceptance, cognitive defusion, emotions, meta-
cognition, dialectics, contextual analysis, valued action and behavioural activation (Kahl 
et al., 2012). These approaches are distinct from primarily behavioural (first-wave) and 
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cognitive (second wave) approaches and were subsequently termed 'third-wave' (Hayes, 
2004). 
Unlike its predecessors, third-wave CBT approaches are based on contextual 
concepts focused more on the person's relationship to thoughts and emotion than their 
content (Hayes, 2004). This shift from emphasising specific cognitive techniques aimed 
at distracting from unpleasant experiences or symptoms may be particularly beneficial 
for patients with FND. Villatte et al. (2015) argue that cognitive approaches focused on 
cognitive techniques and avoidance may paradoxically increase an individual's 
experiences via increasing vigilance (e.g. initiating or maintaining distraction) and 
through outcome monitoring (e.g. by evaluating the success or failure of control 
attempts). This process, in turn, causes insensitivity to other vital parts of their 
experience. In contrast, third-wave CBT focuses on developing meta-cognitive skills 
that support patients in observing their thoughts as mental events without becoming 
'hooked' in their content. Being able to defuse from thinking leaves room for people to 
consider what is important to them and contributes to adaptive behaviour that decreases 
symptomatology. 
Third-wave CBT approaches include ACT, Dialectical Behaviour Therapy (DBT), 
Mindfulness‐Based Therapy (MBT), Meta Cognitive Therapy (MCT) and Compassion‐
Focused Therapy (CFT), among others (Hayes, 2004; Hayes, Villatte, et al., 2011). 
DBT was initially developed for patients diagnosed with Borderline Personality 
Disorder (BPD) and assumes shortfalls of emotion regulation skills (Linehan, 1993). As 
a result, DBT teaches an extensive range of skills in mindfulness, distress tolerance, 
emotion regulation and interpersonal effectiveness (Mckay et al., 2007). Similarly, 
MBT uses psychoeducation and encourages patients to practise mindfulness meditation 
(Ludwig & Kabat-Zinn, 2008). The main aim is to develop metacognitive awareness, 
where an individual can experience cognitions and emotions as mental events that pass 
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through the mind, which may or may not be related to external reality (Segal et al., 
2002). 
MCT was developed from traditional cognitive therapy and focuses on 
metacognition, which is an aspect of cognition that controls mental processes and 
thinking (Wells, 2011). This approach theorises that at the core of anxiety and 
depression is a cognitive attentional syndrome, which consists of repetitive cognitive 
processes such as worrying, rumination, flawed threat monitoring, cognitive and 
behavioural coping. MCT targets metacognition changes by teaching detached 
mindfulness, using attention training techniques to develop cognitive flexibility skills, 
and guiding cognitive and behavioural experiments to change metacognition. Finally, 
CFT encourages patients to care for their wellbeing, become sensitive to their own 
needs and distress, and extend warmth and understanding towards themselves (Gilbert, 
2009).  
1.5.4 Acceptance and Commitment Therapy  
ACT is a transdiagnostic approach designed to increase psychological flexibility, 
or the ability to behave consistently with one's values even in the face of unwanted 
thoughts, feelings, and bodily sensations (Hayes et al., 2006). In contrast, psychological 
inflexibility is characterised by experiential avoidance, cognitive fusion, self-as-content, 
lack of contact with the present moment, lack of values, and a lack of commitment to 
action. The ACT model conceptualises that many psychological and behavioural 
problems occur as a result of experiential avoidance or an unwillingness to experience 
unwanted internal events (such as thoughts, emotions, memories, and body sensations) 
and attempts to reduce the form, frequency, or situational sensitivity of these events 
(Hayes et al., 2006). 
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There is some evidence for ACT improving outcomes in chronic pain (Hann & 
McCracken, 2014) and growing evidence for ACT improving mental health conditions 
(A-tjak et al., 2015) and chronic diseases (Graham et al., 2016). However, this evidence 
is inconsistent, and studies are characterised by small samples and low-quality methods 
(A-tjak et al., 2015; Williams et al., 2020). Thus, indicating the need for higher quality 
research for ACT and these different clinical groups.  
Recent research using single-case study designs has shown decreases in FND 
symptoms and distress (Graham et al., 2018; Graham et al., 2017), suggesting that an 
ACT approach may have value for individuals experiencing FND. Unlike other 
approaches which focus on FND symptoms to control or eliminate them, and related 
emotions and cognitions, ACT focuses on helping individuals move towards meaningful 
activities. Thus, an individual with FND may not experience symptom change, but 
therapy may still be effective (Graham et al., 2016). 
Intervention according to the ACT model typically consists of three components 
that increase psychological flexibility: i) awareness and non-judgmental acceptance of 
all experiences, both negative and positive; ii) identification of valued life directions 
and iii) appropriate action toward goals that support those values (Hayes et al., 2011b). 
This process is facilitated through targeting specific aspects of psychological 
inflexibility such as acceptance (i.e. willingness to experience aversive emotions and 
other internal experiences without avoidance), cognitive defusion (i.e. relating to 
thoughts as just thoughts), present moment awareness (flexible attention to current 
experiences), and values (i.e. clarifying personally meaningful qualities of action) 
(Hayes et al., 2011).  
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1.6 Research aims 
This work evaluates the impact of third-wave CBT for people with FND using a 
multi-methods design. First, a scoping review explores the extent and nature of third-
wave CBT for FND and the quality of evidence regarding its efficacy and effectiveness. 
Moreover, preliminary evidence of factors related to intervention feasibility, 
acceptability and effectiveness are explored. The review uses established transparent 
and systematic methods to collate, summarise, and report findings (Arksey & O'Malley, 
2005; Peters et al., 2020). Next, the impact of a Clinical Health Psychology Service 
two-phase psychological intervention for FND is explored, focusing on exploring what 
therapeutic change is experienced by participants. Specific hypotheses are made 
concerning changes in pre and post-standardised outcome measures following each 
intervention phase. A SCED facilitates a more detailed exploration of changes across 
the ACT group intervention.  Finally, a Change Interview captures the participant's 
experiences of the intervention, perceived therapeutic changes and how they made sense 
of these changes. 
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2 A scoping review of third-wave CBT for FND 
2.1 Rationale 
Third-wave CBT aims to change the individual's relationship to their 
psychological experiences and, consequently, adopt a transdiagnostic approach that 
transcends diagnostic categories (Hayes, 2004). Transdiagnostic processes such as 
difficulties with emotion regulation are essential skills addressed in third-wave CBT. 
This approach aims to reduce unhelpful and avoidant coping and encourage adaptive 
emotion regulation skills such as reappraisal, self-soothing and mindfulness (Shields et 
al., 2016). The broad focus on psychological experience and transdiagnostic processes 
means that third-wave CBT comprises a heterogeneous group of different therapeutic 
approaches. These include ACT (Hayes, Strosahl, et al., 2011), DBT (Linehan, 1993), 
MBT (Ludwig & Kabat-Zinn, 2008), and MCT (Wells, 2011).  Connecting these 
approaches is a focus on strategies such as; mindfulness, acceptance, cognitive defusion, 
dialectics, contextual analysis, valued action and behavioural activation (Kahl et al., 
2012). 
Each of these third-wave CBT approaches has a growing evidence-base for 
various clinical populations. There is some evidence, albeit low quality, supporting 
ACT for improving outcomes in chronic pain (Hann & McCracken, 2014), mental 
health conditions (A-tjak et al., 2015), and chronic diseases (Graham et al., 2016). DBT 
has been shown to lead to decreases in suicidal behaviour and depression and improved 
anger control and healthcare utilisation for patients with a diagnosis of BPD (McMain et 
al., 2009; Neacsiu et al., 2012; Soler et al., 2009) and to impact intrapsychic and 
personality factors (Bedics et al., 2012). While MBT has shown changes in 
metacognitions for individuals with Obsessive-Compulsive Disorder (OCD), improved 
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outcomes for patients with generalised anxiety disorders and high remission rates in 
treatment-resistant depression (Solem et al., 2009; van der Heiden et al., 2012; Wells et 
al., 2012). MCT has also shown reduced relapse rates and outcomes in depression 
(Kuyken et al., 2008), alcohol and drug use (Witkiewitz & Bowen, 2010). 
Although there is a growing interest in third-wave CBT, little is known about 
third-wave CBT for FND. A preliminary search for existing scoping reviews and 
systematic reviews on the third-wave CBT for FND was carried out in June 2020 on the 
following bibliographic databases: PsycINFO, EMBASE MEDLINE. It revealed that no 
reviews had explored the relationship between third-wave CBT and FND, and only a 
small number of diverse studies have explored third-wave CBT for FND. From this 
preliminary search of the literature, it was established that a scoping review would allow 
the author to examine the extent and nature of studies on third-wave CBT for FND. A 
scoping review helps determine the value of undertaking a full systematic review, 
summarises and disseminates research findings and identifies gaps in the existing 
literature (Arksey & O'Malley, 2005). The review determines the quality of available 
evidence to enable practice recommendations to be made in the context of the evidence 
quality. The review also charts any preliminary evidence of factors related to 
intervention feasibility, acceptability and effectiveness and efficacy. 
2.2 Method 
The present study consulted the Joanne Briggs Institute manual for scoping 
reviews (Peters et al., 2020) and adopts the five-stage framework of Arksey and 
O'Malley (2005), which involves (1) identifying the research question, (2) identifying 
relevant studies, (3) study selection, (4) charting the data, and (5) collating, 
summarising, and reporting the results.  
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2.2.1 Identifying the research questions 
The current review explores the extent and nature of studies on third-wave CBT 
for FND and determines whether there is good quality evidence regarding their efficacy 
or effectiveness to facilitate practice recommendations. The extent and nature of third-
wave CBT interventions for FND are explored by describing the research designs, 
participant demographics, research interventions, and outcome measures.  The literature 
is then critically appraised using standardised tools to identify potential sources of bias 
and research gaps to contextualise practice recommendations. Finally, establishing 
whether any preliminary factors relate to feasibility, acceptability, and effectiveness or 
efficacy of these approaches may help understand current trends and gaps in knowledge 
and identification of areas that may benefit from further exploration.  
Feasibility is a concept that encapsulates ideas about whether it is possible to do 
something and refers to the state or degrees of the intervention being easily or 
conveniently delivered (Sekhon et al., 2017). Acceptability is a multi-faceted construct 
that refers to the perceived appropriateness, fairness, reasonableness, and intrusiveness 
of intervention for addressing a specific concern (Kazdin, 1981; Nastasi & Truscott, 
2000; Reimers et al., 1992). In a healthcare intervention, acceptability reflects the extent 
to which people who are delivering or receiving a healthcare intervention consider it to 
be appropriate, based on anticipated or experiential cognitive and emotional responses 
to the intervention (Sekhon et al., 2017). Finally, efficacy explores whether an 
intervention produces the expected result under ideal circumstances; effectiveness 
measures the degree of beneficial effect under 'real world' settings (Godwin et al., 
2003).  
Feasibility and acceptability are assessed by participant uptake, drop-out, non-
response and deterioration rates in intervention studies, the practicality of the 
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intervention (e.g. duration, clinician involvement and expertise and adaptability of 
intervention across different contexts), and by qualitative descriptions of intervention 
experiences and satisfaction (Gadke et al., 2021). Effectiveness and efficacy will be 
measured by analysing the impact of the intervention on outcome measures. In 
summary, the review considers the following research questions: 
1. What third-wave CBT interventions for individuals with FND have been 
reported? 
2. What is the quality of the evidence for CBT third-wave therapies for FND? 
3. Is there any preliminary evidence of factors related to intervention feasibility, 
acceptability and efficacy or effectiveness? 
2.2.2 Identifying relevant studies 
The search terms were developed and categorised based on two dimensions related 
to the review aims. One dimension was related to third-wave CBT (i.e. the intervention 
examined), while the other dimension related to FND (i.e. the clinical population). 
Initial scans of the literature were carried out to find keywords for each dimension. 
Once a preliminary list of words was collected, experts in the area were asked for their 
opinion and to identify any missed keywords related to the review aims. Examples of 
third-wave CBT approaches searched for included MBT, ACT and DBT. Examples of 
FND search terms included psychogenic, conversion disorder and nonepileptic seizure 
disorder (see Table 1). 
Full details of the search strategy, including MeSH terms, are provided in 
Appendix A. The Boolean OR operator separated each search term, and each dimension 
was separated by the Boolean AND operator, outlined in Table 1. The following 
bibliographic databases were searched from the earliest available listing up to June 
2020: PsycINFO, EMBASE, and MEDLINE, to identify potentially relevant 
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documents. The abstract, title and keyword fields were searched in all databases to 
capture relevant studies. Due to limitations in resources, only English Language studies 
were included. The search strategy was drafted by an experienced librarian and further 
refined through discussion in supervision. The final search results were exported into 
EndNote, and duplicates were removed. The electronic database search was 
supplemented by carrying out a backwards and forwards citation search. 
Eligibility criteria were developed to focus the scope of the review. Literature 
related to third-wave CBT interventions, delivered either by a trained clinician or 
supervised by a trained clinician. Self-help interventions were included if they were 
guided by weekly input from a clinician. If identified studies involved participants 
receiving additional treatment alongside a third-wave CBT intervention, they were 
included but highlighted as such. Literature could relate to intervention outcome studies 
or qualitative accounts of third-wave CBT interventions. Literature also had to relate to 
participants diagnosed with and experiencing FND. Studies with subgroups of patients 
who met the criteria for FND were included if separate data on FND participants could 
be extracted. There was no age specification placed on participants. 
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Table 1 
 
Key Search terms 
 
2.2.3 Study selection 
Based on the PRISMA (Preferred Reporting Items for Systematic Reviews and 
Meta-Analysis) statement (Moher et al., 2009), articles were evaluated on whether they 
met the eligibility criteria by following three screening steps; title, abstract, and full text 
(see Figure 3). The last database search was conducted in June 2020; 1127 articles were 
identified, from which 510 duplicates were removed. All potentially relevant articles 
went through a two-step screening process. The first step was to exclude irrelevant 
articles by screening titles and abstracts. The second step was to filter out unrelated 
articles by screening full texts. Any studies where it was unclear whether inclusion 
criteria were met were discussed with the supervisory team. 
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Figure 3 
 
Flow diagram of study identification and inclusion 
 
 
Note. PRISMA reporting standards (Moher et al., 2009) 
 
2.2.4 Data charting and collation 
The lead author extracted data from all studies which met eligibility criteria. Data 
were extracted onto standard forms (Appendix B). Extracted information included the 
author, year of publication, description of the intervention, study design, data collected, 
participant characteristics, evidence of feasibility and acceptability and main findings. 
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summarised descriptively and structured according to the review questions (Khalil et al., 
2016). For example, information related to the intervention, such as the rationale for the 
third-wave CBT approach, intervention description, duration and facilitators and 
treatment fidelity and deviations, were charted and collated. This intervention 
information then informed exploration of preliminary factors related to intervention 
feasibility, acceptability, efficacy, and effectiveness.  
2.2.5 Critical appraisal 
This review explores the characteristics and methodological quality of third-wave 
interventions for patients with FND to identify potential sources of bias and understand 
research gaps to contextualise practice recommendations. Given the broad range of 
study designs extracted, a range of quality appraisal tools was initially considered. After 
piloting several tools, the Mixed Methods Appraisal Tool (MMAT, 2008) was chosen 
as it provided an overarching quality appraisal tool covering the diverse range of studies 
captured. It enables the appraisal of five study categories; qualitative research, 
randomised controlled trials, non-randomised studies, quantitative descriptive studies, 
and mixed methods studies. However, due to the design of studies identified, only the 
'quantitative descriptive studies' category was used. This category consists of five 
different quality criteria, which are rated as either '0' (Yes), '1' (No) or '2' (cannot tell).  
Notably, two of the quality items on the MMAT – 'is the sample representative?' 
and 'is there a risk of non-response bias?' – did not apply to the single-case designs 
included in this review. Non-response bias occurs when people who participate in a 
research study are inherently different from those who do not participate, which 
negatively impacts a sample's representativeness and skews outcomes (Hong et al., 
2018). The single-case studies cannot be rated to these items due to the focus on one 
participant, and the items were subsequently marked as 'non-applicable'. 
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The MMAT allows for the use of additional quality appraisal tools to capture 
study designs not explicitly covered (Hong et al., 2018). Thus, for the single-case 
studies and case series, Morley's (2017) single-case appraisal guidelines were also used. 
These guidelines provide a minimum requirement for considering the quality of single-
case research using six different criteria designed to provide a descriptive account of 
studies. In the current study, a three-point rating was used to supplement the descriptive 
account. The six items were rated as either '0' (Yes), '1' (No) or '2' (Partial). This 
numerical rating was adopted from the RoBiNT (Risk of Bias in N-of-1 Trials) 
developed for SCED (Tate et al., 2008), which enabled an overall quality rating.  
In addressing the research question 'What is the quality of evidence for third-wave 
therapies?' (See section 2.3.2), overlapping categories from the MMAT and Morley's 
(2017) guidelines are integrated under the same subheadings when providing 
descriptive detail to avoid repetition. 
Inter-rater reliability. Inter-rater reliability can be defined as "the extent to 
which independent coders evaluate a characteristic of a message or artefact and reach 
the same conclusions" (Lombard et al., 2002, p. 589). Measuring this is important to 
establish a reliable estimation of study quality, with a low agreement between raters 
indicative of weakness in the critical appraisal process (Kolbe & Burnett, 1991). 
Consequently, each study was appraised by an independent rater, enabling inter-rater 
reliability to be calculated using Fleiss's kappa statistic, which considers the chance 
agreement between two or more raters (Fleiss, 1971). Both coders individually rated 
each of the studies against the quality criteria for the MMAT and, where appropriate, 
Morley's (2017) single-case appraisal guidelines (see Appendix C). Results were then 
compared, and disagreements were discussed between coders.  
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2.3 Summarising and reporting findings 
Following the fifth stage of Arksey and O'Malley's (2005) framework for scoping 
reviews, the next sections summarise, report on, and discuss findings from the identified 
articles. The review explores the extent and nature of third-wave CBT for FND and 
determines whether there is good quality evidence regarding their efficacy and 
effectiveness by now presenting the findings for each of the research questions.  
 
2.3.1 What third-wave CBT interventions for individuals with FND have been 
reported? 
The search strategy yielded 1126 articles; 616 of these were duplicates. After 
screening and eligibility checks, eight articles detailing different third-wave CBT 
interventions for FND met eligibility criteria (see Figure 3). All articles outlined 
intervention studies; no qualitative articles were found. Table 2 summarises the data 
extraction table detailing key information from the studies included in the review. Here, 
the characteristic sources of evidence are described in relation to research design, 
research demographics and the research intervention to explore the scope and nature of 
third-wave CBT for FND.  
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Table 2 
 
































N = 6  
FND type: NEAD 
Age range: not 
reported 
Mean age: 45.3 
yrs (SD = 15.86) 
Gender: 5 




flexibility, and QoL 
All measures were 











Psychological flexibility improved 
for all; reliable and clinically 
significant change for 
psychological flexibility, QoL and 
psychological health for 4 
participants post-intervention, with 
QoL improvement remaining at 
follow-ups. Reductions in NEAD 
frequency for 4 participants, with 3 
maintaining this at follow-up. 
2. Baslet, 
Dworetzky, 














N = 6  
FND type: NEAD 
Age range: 18 – 
59 yrs 
Mean age: 39.7 
yrs 
Gender: 6 females 
NEAD frequency, 
depression and 
psychological health.  
All measures collected 
just at; 
T1: Start of treatment 




Average QoL improved from 2.59 
(SD = 0.73) at baseline, to 2.4 (SD 
= 0.76) mid-intervention, and 2.14 
(SD = 0.77) post-intervention. All 
reported a decline in weekly 
NEAD frequency from baseline 
(median of 5.5 weekly events, 
mean of 18 weekly events) by the 
sixth session (median of 0.75 
weekly events, mean of 2.25 
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weekly events). The mean 
difference between pre (baseline) 
and post-treatment (12th session) 
was -14.98 weekly NEAD events. 
Three participants had remission of 
episodes based on weekly NEAD 
frequency at session 12. 
3. Baslet, 




















N = 26 
FND type: NEAD 
Age range: not 
reported 
Mean age: 46.4 
yrs 
Gender: 23 
females, 3 males 
NEAD frequency, 
intensity and duration, 
psychological health, 
QoL, somatisation and 
dissociation. 
All measures collected 
just at; 
T0: Baseline 
T1: Start of treatment 
T2: Treatment midpoint 
(S6) 




NEAD frequency decreased by 
0.12 episodes per week 
(95%, CI = 0.2 – 0.04) for every 
successive session (p = 0.002).  
Thirteen patients reported no 
NEAD at the final session from the 
previous session and six described 
sustained cessation during the last 
four weeks of treatment. At last 
session median NEAD intensity 
significantly reduced to 3.74 (SD = 
2.65) (p = 0.012). From post-
diagnosis appointment (T0) to last 
session, Qol improved (p = 0.002). 
4. Baslet & 
















N = 1 
FND type: mixed 
FND 
Age: 31 yrs 
Gender: female 
 
Qualitative changes in 
FND symptoms. 
FND symptoms reported as not 
present by the end of treatment and 












N = 19 
FND type: NEAD 
Sessional NEAD 
frequency collected.  
A reduction of at least 50% from 
the baseline weekly seizure rate 
occurred in 9/17 (53%) completers. 




















Age range: not 
reported 
Mean age: 44.5 
yrs 
Gender: 18 
females, 1 male 
Six participants had complete 
cessation of seizure activity during 
the study. Using all available data 
from 19 participants over two 
years, mixed-effects regression 
model estimates indicated that 
from baseline to session 20.5 
(average treatment time), the 
average seizure rate decreased by 
66% (event rate ratio 50.34; 95%, 
CI = 50.19, 62). Statistically 
significant drop in average seizure 
frequency from 13.8 to 4.7 events 























N = 8 
FND type: mixed 
Age range: 18-65 
yrs 









flexibility, and mood. 
All measures collected 
just at;  
T1: Start of treatment 
T2: Post-intervention 
Five participants showed reliable 
improvements in symptom 
interference to a large magnitude 
(d = 1.02), 4 showed reliable 
improvements in mood to a large 
magnitude (d = 1.70). There was 
variation in psychological 
flexibility where improvement was 





















N = 1 






flexibility, and mood. 
All measures were 
collected just at;  
T1: Start of treatment 
T2: Post-intervention 
Participant experienced a reliable 
and clinically significant 
improvement in symptom 
interference (RCI = 6.07), mood 
(RCI = 5.91; CSC = 10.84) and 
psychological flexibility (RCI = 
- 38 - 
6.22; CSC = 22.76). FND 
symptoms almost entirely ceased. 


















N = 1 
Age: 30yrs 
Gender: female 
FND type: mFND 
Depression, PTSD, and 
alcohol intake 
All measures were 
collected just at; 
T1: Start of treatment 
T2: Mid-intervention 
T3: Post-intervention 
Reliable and clinically significant 
improvement in PTSD (pre = 63; 
post = 51) and a reliable 
improvement in mood (pre = 26, 
post = 13). RCI not provided. In 
the final session participant using a 
walker and not in a wheelchair. 
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Characteristics of sources of evidence 
Research design. Eight studies met the criteria for this review. As summarised in 
Table 2, these studies used diverse designs, clinical populations and measures. Three 
studies were single-case studies, three were case series, one used a naturalistic design, 
and another used a non-controlled trial design.  
Participant demographics. The vast majority of participants across the studies 
were female, which appeared not to be intentional but somewhat representative of the 
female preponderance in FND (Asadi-Pooya et al., 2013; O'Connell et al., 2020). Ages 
ranged from 18 to 65 years. Sample sizes varied from single-case studies (Baslet & Hill, 
2011; Graham et al., 2017; Rancourt & Darkes, 2018), up to a sample of 26 patients 
(Baslet et al., 2020), with full details of these different characteristics summarised in 
Table 2. 
Four studies focused exclusively on NEAD participants (Barrett-Naylor et al., 
2018; Baslet et al., 2015; Baslet et al., 2020; Bullock et al., 2015). Two single case 
studies reported on participants with mFND (Graham et al., 2017; Rancourt & Darkes, 
2018). A further two studies reported participants with mixed FND presentations 
(Baslet & Hill, 2011; Graham et al., 2018). Mixed FND presentations included; arm 
tremor, leg weakness/ paralysis, propriospinal myoclonus, paraesthesia, visual 
disturbance, and syncope. 
Several studies described participants having a range of comorbid psychiatric 
diagnoses and physical health difficulties. Baslet et al. (2020) provided a detailed 
account of participants’ clinical characteristics; 88.5% (n = 23) of their sample reported 
current or past anxiety disorders, 80.8% (n = 21) depressive disorder, and 53.8% (n = 
14) reported Post Traumatic Stress Disorder (PTSD); with a total of 23 of their 
participants (88.5%) reporting past psychiatric treatment. In comparison, some studies 
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did not provide details on broader participant characteristics (Barrett-Naylor et al., 
2018; Graham et al., 2017).  
Other studies provided only brief details on participants' demographics. For 
example, Baslet et al. (2015) described one patient with NEAD also had epileptic 
seizures, while Bullock et al. (2015) reported that two patients with NEAD also had 
epilepsy. Graham et al. (2017) noted that their participant 'Claire' had no comorbid 
diagnosis. Rancourt et al. (2019) explained that 'Jane' met the criteria for the Diagnostic 
and Statistical Manual of Mental Disorders (DSM-IV) diagnosis of PTSD and major 
depressive disorder. Finally, Baslet and Hill's (2011) study of 'Annie' reported that she 
had a diagnosis of recurrent major depressive disorder, generalised anxiety disorder, and 
PTSD. 
Research interventions. A range of third-wave CBT approaches was adopted, with 
sessions spanning from 3 to 26 sessions and delivered in varying formats – group 
sessions, individual sessions and guided self-help. Full details of the interventions are 
summarised in Table 3. Three studies focused on ACT interventions (Barrett-Naylor et 
al., 2018; Graham et al., 2018; Graham et al., 2017). Three studies used MBT (Baslet et 
al., 2015; Baslet et al., 2020; Baslet & Hill, 2011) and two used DBT-informed 
interventions (Bullock et al., 2015; Rancourt & Darkes, 2018). 
 



















Experiential avoidance of 
internal states, limited 
awareness, automatic 
(versus purposeful) 
behaviour, and heightened 
arousal implicated in 
NEAD addressed by ACT 
through psychological 
flexibility. Self-help 
hypothesised to be helpful, 
given psychological 
intervention, and face-to-
face therapies can be 
experienced as aversive 
and precipitate seizure 
occurrence. 
Six session ACT self-help 
intervention with weekly 30-
minute phone calls to support 
material. The intervention was 
based on chapters from the 
book 'Get out of your head and 
into your life' (Hayes, 2005) 
and covered acceptance, 
cognitive defusion, self as 
content, mindfulness, values 
and committed action. 
Six weekly 30 -




No treatment deviations or treatment 
fidelity measures reported. 





Oser, 2015.  
MBT corresponds well 
with NEAD, as the 
approach targets 
underlying psychological 
vulnerabilities, such as 
Individual face-to-face MBT 
programme. Four modules; (1) 
psychoeducation and goal 
setting, (2) stress management 
training, (3) mindfulness 
Four modules 
delivered over 12-
hour sessions.  
 
Timing for completion of each of the four 
core models was flexible. The frequency 
of sessions was flexible depending on 
patient availability. A weekly to biweekly 
frequency of sessions encouraged but not 
- 42 - 
 
poor recognition and 
acceptance of emotional 
states.  
training, and (4) emotion 




always possible. No treatment fidelity 
measures specified.  







MBT corresponds well 
with NEAD, as the 
approach targets 
underlying psychological 
vulnerabilities, such as 
poor recognition, 
acceptance and 
management of emotional 
states. 
 
Individual face-to-face MBT 
programme. Five modules; (1) 
understanding your disease and 
treatment, (2) stress and 
management strategies, (3) 
mindfulness, (4) emotion 
management, and (5) 







Attendance of weekly supervision. 
Manual checklists, notes and discussions 
determined compliance with elements of 
the programme.  
Thirteen participants required at least one 
additional session (seven participants had 
one additional session, five participants 
had two additional sessions, and one 
participant had three additional sessions).  
The average time between sessions 10.15 
days (SD = 2.23). 
The intervention adopted a manualised 
approach. 
4. Baslet & 
Hill, 2011. 
Increased avoidance and 
difficulties in emotion 
expression involve a 
disruption in the 
integrative capacity that 
may underlie FND. 
Mindfulness focused on 
acceptance redirects 
attention and behaviour 
choices toward high-value 
roles. 
Group based MBT programme 
and individual follow-up 
sessions, covering; (1) lifestyle 
development associated with 
better management of stress 
(e.g. supportive relationships, 
interpersonal effectiveness, 
personal responsibility), (2) 
mindfulness practice and 
discussion, (3) 
uncontrollability of thoughts, 









No treatment deviations or treatment 
fidelity measures reported.  
The intervention adopted a manualised 
approach for group sessions and an 
individualised formulation for one-to-one 
sessions.  
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and controllability of actions, 
and (4/5) historical links to 






characteristics of patients 
with FND similar to BPD, 
FND patients show a 
deficit in implicit to 
explicit processing of 
emotions. Subsequently, a 
DBT approach targeting 
emotional dysregulation 
may be useful for patients 
with FND. 
DBT-Skills Training was 
psycho-educational and 
included; (1) distress tolerance, 
(2) emotion regulation, and (3) 
interpersonal effectiveness. 
Each module was preceded by 
one week of mindfulness 
training. Groups adhered to 
Marsha Linehan's ‘Skills 





Group held weekly 
for 90-minutes in 
three consecutive 
repeating modules 
lasting 8–10 weeks 
each. 
 
They were led by 
an intensively 
trained DBT 
therapist and two 
trainee level co-
leaders. 
Groups were videotaped and reviewed for 
adherence criteria by an outside DBT 
certified consultant. Process and content 
supervision occurred during weekly hour 
debriefings with consultant and co-
leaders. 




Kemp, 2018.  
ACT does not have prior 
assumptions on the causes 
of FND and emphasises 
patient’s lived experiences 
of the disorder makes ACT  
applicable for the 
psychological 
heterogeneity within FND.  
ACT intervention 
compromised assessment, 
formulation and treatment 
strategies. 







trained in ACT. 
The number of sessions could be 
extended based on need. No treatment 
fidelity measures reported.  
The intervention used adopted an 






Kemp, 2017.  
ACT via a process of 
psychological flexibility 
supports behaviours 
consistent with a person's 
As described above in Graham, 
O'Hara, and Kemp, 2018. 
Six sessions of 
ACT. 
 
No treatment deviations or treatment 
fidelity measures reported. 
The intervention used adopted an 
individualised formulation approach. 
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overarching values even in 
challenging, uncertain or 
immutable contexts and 
may have benefits in the 
context of FND. 
A clinical 
psychologist 
trained in ACT. 
8. Rancourt 
& Darkes, 
2018.   
FND conceptualised as a 
maladaptive coping 
response to pervasive 
emotion dysregulation that 
occurs in response to a 
stressor. Note that 
affective stress and 
impaired emotional 
processing are implicated 
in the development of 
FND and BPD. Thus, DBT 
is useful as it targets the 
underlying mechanism of 
emotion dysregulation 
through relevant skills.  
 
The intervention focused on 
increasing distress tolerance, 
emotional regulation, and 
interpersonal effectiveness 
skills. Distress tolerance skills 
included self-soothe activities, 
tolerating negative emotions, 
pros and cons, and radical 
acceptance. Emotion regulation 
skills included identifying and 
labelling emotions, opposite 
action, distress tolerance and 
problem-solving. Interpersonal 
effectiveness skills included 
assertiveness, effective 









No treatment deviations or treatment 
fidelity measures reported. 
The intervention used adopted an 
individualised formulation approach. 
Notes. BPD = Borderline Personality Disorder
- 45 - 
 
Outcome measures. All but one study (Baslet & Hill, 2011) used quantitative 
measures. Appendix D provides an overview and references for these outcome 
measures. Quantitative data was collected using pre-established and well-validated 
measures of a broad range of self-reported variables. Measures included; mood, 
psychological health, functioning and psychological flexibility, QoL, symptom 
interference and PTSD (see Table 2). Four studies also included idiographic measures 
of NEAD frequency, duration and intensity (Barrett-Naylor et al., 2018; Baslet et al., 
2015; Baslet et al., 2020; Bullock et al., 2015). No idiographic measures of other FND 
symptoms were used. 
Measures of FND symptoms. Improvement in FND symptoms was reported in five 
studies by measuring NEAD frequency or through qualitative reports of changes in 
symptoms (see Table 2). In all these studies, NEAD symptoms were reported through 
weekly self-reported idiographic measures of NEAD frequency. This included NEAD 
experiences, NEAD frequency diaries and logs (Barrett-Naylor et al., 2018; Baslet et al., 
2015; Baslet et al., 2020; Bullock et al., 2015). Both daily and weekly measures of 
NEAD frequency were used (Table 2). In addition to weekly NEAD frequency, Baslet 
et al. (2020) measured weekly seizure duration and intensity using a 10-point Likert 
scale.  
The single-case studies reported symptom improvement through qualitative 
descriptions of participants' self-reported experiences of symptom reductions (Graham 
et al., 2017; Rancourt & Darkes, 2018) or at one-month follow-up (Baslet & Hill, 2011). 
Graham et al. (2018, 2017) did not directly measure symptom change and instead 
reported changes in symptom interference by using the Work and Social Adjustment 
Scale (WSAS; Mundt et al., 2002). The WSAS is a 5-item self-report measure. The 
measure asks a person how their difficulties interfere with their ability to function 
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across work, home management, social leisure activities, private leisure activities, and 
close relationships, using a severity rating from 0 to 8. 
Measures of distress. Six studies collected standardised and well-validated 
outcome measures related to distress (Table 2). Two studies exploring NEAD also 
collected Quality of Life (QoL) measures (Baslet et al., 2020; Barrett-Naylor et al., 
2018), using the Quality of Life in Epilepsy-10 (QOLIE-10; Cramer et al., 1996). The 
QOLIE is a 10-item Likert-type scale measuring a range of health concepts related to 
epilepsy, such as emotional wellbeing, seizure worry, cognitive and social functioning. 
Baslet et al. (2020) also explored changes in a range of secondary outcome measures 
(mood, anxiety, dissociation, somatisation and QoL). 
Baslet et al. (2015; 2020) and Barrett-Naylor et al. (2018) used the Depression 
Anxiety and Stress Scale-21 (DASS, Lovibond & Lovibond, 1995). The DASS is a 42- 
item self-report questionnaire that measures depression (DASS-D), anxiety (DASS-A), 
and stress (DASS-S) levels over the preceding week. Barrett-Naylor et al. (2018) only 
used the DASS-A subscale, alongside the Beck Depression Inventory-II (BDI-II; Beck 
et al., 1996). The BDI-II is a 21-item self-report scale that measures depressive 
symptoms over the preceding two weeks, developed to assess the DSM-IV diagnostic 
criteria for depressive symptoms. Graham et al. (2017; 2018) used the Clinical 
Outcomes in Routine Evaluation-10 (CORE-10, Barkham et al., 2013), a 10‐item 
measure of mood and distress. Rancourt and Darkes (2018) used the Patient Health 
Questionnaire-9 (PHQ-9: Kroenke et al., 2001), a 9-item measure of depression. These 
measures ask the respondent to report on the frequency that they have experienced 
symptoms of depression based on the DSM-IV diagnostic criteria. Rancourt and Darke 
also measured PTSD through the PTSD Checklist-Civilian Version (PCL-C; Blanchard 
et al., 1996), using a 17-item Likert item measure that corresponds to PTSD symptoms 
based on the DSM-IV diagnostic criteria. 
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Measures of psychological flexibility. Three studies of ACT interventions 
measured psychological flexibility as an outcome (see Table 2) using two different 
outcome measures – the Acceptance and Action Questionnaire-II (AAQ-II; Bond et al., 
2011) and the Comprehensive assessment of Acceptance and Commitment Therapy 
processes (compACT; Francis et al., 2016). The AAQ-II was developed to measure 
psychological flexibility as conceptualised within the ACT model (see Section 1.5.5 An 
ACT approach). The measure consists of items rated from 1 (‘never true’) to 7 (‘always 
true’). The AAQ-II has been criticised for its lack of validity, which is discussed further 
below in ‘Appropriate measurements and sufficient timepoints’ – Section 2.3.2. 
Subsequently, the Comprehensive assessment of Acceptance and Commitment Therapy 
processes (compACT; Francis et al., 2016) was developed to measure psychological 
flexibility. The compACT is a 23-item measure consisting of three subscales capturing 
the dyadic processes, which are ‘openness to experience’, ‘valued action’ and 
‘behavioural awareness’. 
2.3.2 What is the quality of evidence for third-wave CBT for FND? 
Studies were appraised according to the MMAT (2008) quantitative descriptive 
appraisal tool and, where appropriate, Morley's (2017) quality appraisal guidelines for 
single-case studies and case series; each article's final quality ratings are summarised in 
Table 4. Inter-rater agreement on quality was high: Fleiss’s kappa statistic was found to 
be at 0.76, indicating an “excellent” agreement across final ratings (see Appendix C). 
The only disagreement between raters related to the Mixed Methods Appraisal Tool 
(MMAT) item 3 – ‘are the measurements appropriate?’. Here two articles were rated as 
‘No’ by the author, but ‘Yes’ by the independent rater, which is explained in more detail 
in ‘Appropriate measurements and sufficient timepoints’ below. The primary purpose of 
the critical appraisal process was to provide a descriptive exploration of studies’ quality. 






Note. S1 – Barrett-Naylor et al. (2018), S2 – Baslet et al. (2015), S3 – Baslet et al. (2020), S4 – Baslet & Hill (2011), S5 – Bullock et al. (2015), S6 
– Graham et al. (2018), S7 – Graham et al. (2017), S8 – Rancourt & Darkes (2018). Colour coding key: N = no/ not present, Y = yes/ present, P = 
partially present, C = cannot tell, N/A = Not applicable  
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Each area of the quality appraisal will now be addressed in the order presented in 
Table 4. 
Sampling strategy and representation. The sampling strategies varied from 
targeted recruitment in a social media site to routine clinical practice to convenience 
sampling (see Table 2). While some studies recruited through convenience sampling 
and single locations, all strategies appeared relevant to the studies’ aims. Barrett-Naylor 
et al. (2018) was the only study not to recruit from a clinical population but rather a 
community sample. 
Several studies used convenience sampling that may have led to the over or under-
representation of patients with specific characteristics (e.g. greater motivation, female 
preponderance) (Baslet et al., 2015; 2020; Barrett-Naylor et al., 2018; Bullock et al., 
2015). These factors limit the studies’ sample representativeness to broader FND 
populations and generalisability to males. Furthermore, across studies, small sample 
sizes reduced reliability through potentially increased variability and bias. However, the 
studies did not claim that their samples were more general than the subcategories they 
recruited from. 
Appropriate measurements and sufficient timepoints. The quality of measurement 
varied across all studies (see Table 4). All single-case studies and case series, other than 
Baslet and Hill (2011), provided a clear definition and specification of the variables 
measured that was appropriate to the study's aims. Baslet and Hill (2011) provided only 
qualitative descriptions of change. None of the studies discussed whether their 
standardised measures had previously been used in FND populations. Some studies’ 
measures had limited generalisability to a wider FND population. For example, 
Rancourt and Darkes (2018) used measurement based on the client’s individualised 
formulation, which included alcohol intake and trauma symptomatology, which were 
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not measured in other studies. Only Barrett-Naylor et al. (2018) and Graham et al. 
(2017, 2018) described the standardised outcome measures' validity and reliability.  
Measurement issues were identified in Graham et al.’s (2017; 2018) studies due to 
measuring psychological flexibility using the Acceptance and Action Questionnaire-II 
(AAQ-11; Bond et al., 2011). The AAQ-II has been criticised for its lack of face 
validity. It is esoteric and hard to understand, particularly for those not socialised to the 
ACT model (Tyndall et al., 2019). This measure may have introduced a measurement 
error that confounded results. Due to the use of this contentious measure, the two 
Graham studies were marked as ‘No’ on the MMAT item three – ‘are the measurements 
appropriate?’ by the author, which was kept as the final rating. However, these items 
were marked as ‘present’ by the independent rater as it was felt that the measure was 
consistent with the studies’ aims. Additionally, studies collecting participants’ NEAD 
experiences, NEAD frequency diaries and logs, relied upon participants' accurate self-
reports. These measures were not standardised and were used differently across studies. 
Studies’ data collection points varied, as summarised in Table 2. The highest 
quality-rated data points were those that collected weekly measures. They enabled 
greater ability to determine a causal relationship between the intervention and observed 
changes (Barrett-Naylor et al., 2018; Baslet et al., 2015; 2020; Bullock et al., 2015). 
However, Barrett-Naylor et al. (2018) was the only study that collected weekly 
timepoint measurements that supported inferences about the relationship between 
change and the intervention to be drawn. This was due to their interpretation of findings 
being on an individual level. Furthermore, this was the only study to collect follow-up 
measures to investigate whether changes were sustained. 
Baslet et al. (2020) tracked changes in NEAD frequency at assessment and at all 
subsequent sessions, alongside collecting secondary psychological measures at four 
different time points. They were the only study to utilise a baseline measure, which 
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allowed the baseline to be compared to later measurements to judge effectiveness. 
Baslet et al. (2015) and Rancourt and Darkes (2018) collected pre, mid and post-
intervention measures. In comparison, Graham et al. (2017; 2018) provided lower-
quality time points by using only pre and post-intervention measures. This pre and post-
design offered the least control of confounding variables. Still, it enabled reliable and 
clinically significant change calculations. All single-case studies and case series using 
quantitative measures used timepoints appropriate to their data analysis.  
Risk of non-response bias. In the six studies that recruited more than one 
participant, it was hard to evaluate the risk of non-response bias due to the lack of 
reporting on the differences between responders and non-responders and drop-out rates. 
Studies provided limited information on participants who experienced deteriorations or 
no change following post-intervention. Baslet et al. (2020) did not give any details of 
participants experiencing deterioration or no change. Bullock et al. (2015) found that 
three participants reported worsening symptoms during the last week of intervention but 
provided no account for this. Baslet et al. (2015) reported that the two participants who 
experienced the least improvement had distinct characteristics, with a history of 
alcoholism and recurrent depression that was not present in others. This mirrored 
Graham et al.’s (2018) case series, where authors reported that participants who 
experienced the least change had comorbid mental health issues and more severe FND 
symptoms. 
Baslet et al. (2020) was the only study to examine participants' drop-out rates. Out 
of 144 participants initially recruited, 103 dropped out. The authors noted that non-
completers tended to be younger and from ethnic minority groups. Bullock et al.'s 
(2015) report on drop-out rates was limited. Out of the 21 participants who enrolled, 19 
completed at least one module of the four-module programme. Further details were not 
provided. Drop-out was low for Barrett-Naylor et al. (2018), who described only one 
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participant not completing their intervention. In comparison, Graham et al. (2018) and 
Baslet et al. (2015) did not report drop-out rates. The lack of reporting on drop-out rates 
makes it impossible to explore sample bias that could lower the intervention's 
generalisability.  
Statistical analysis. Statistical analysis included calculation of reliable and 
clinically significant change, median regression, and mixed-effect model analysis. 
Overall statistical analyses were all described in sufficient detail, and all appeared 
appropriate for answering the research questions. The highest quality statistical analysis 
was Baslet et al.'s (2020), with the largest sample and comprehensive collection of 
outcome measures across timepoints. These factors increased validity and enabled more 
sophisticated data analysis using group statistics. Barrett-Naylor et al.'s (2018) SCED 
had a good analysis compared to other studies. Here, visual analysis of key-dependent 
variables across the intervention enabled participants to serve as their control to track 
changes. This was carried out alongside exploring reliable and clinically significant 
change of standardised measures pre and post-intervention. 
A lower quality statistical analysis was found in Bullock et al.'s (2015) study due 
to their use of group-level statistics. They used data collected across a two-year time 
point, which did not account for the varying length of time participants participated in 
the group, thus, significantly limiting their findings. Single-case studies and case series 
collecting quantitative data, provided well-presented graphs or tables that gave a greater 
understanding of the results. Except for Baslet and Hill’s (2011) descriptive study, all 
case studies and case series reported data; however, none explicitly stated who had 
conducted the analysis. 
 The rationale for the design. All single-case studies and case series provided 
specification of the experimental design, except for Baslet and Hill (2011), who offered 
a solely descriptive account of change. This descriptive account was less 
- 53 - 
 
methodologically robust and did not enable any conclusions about the intervention's 
effectiveness. Only one of the studies provided an explicit rationale for their design – 
Barrett-Naylor et al. (2018), whose SCED enabled participants to serve as their control. 
None of the study designs took into account confounding variables, such as concurrent 
treatment, which lowered all the studies' ability to conclude intervention effectiveness.   
Information related to the intervention. The single-case studies and case series 
provide varying levels of detail about the intervention used, outlining the intervention 
and the number of treatment sessions (see Table 3). Six studies detailed who had 
conducted the intervention (Baslet et al., 2011, 2020; Barrett Naylor et al., 2018; 
Graham et al., 2018, 2017; Rancourt & Darkes, 2018). Baslet and Hill (2011) provided 
a detailed description of their intervention but did not provide information on the group 
sessions' duration. Graham et al.’s (2018) case series explored treatment integrity by 
excluding potential participants who had not received the full treatment protocol. 
Rancourt and Darkes (2018) assessed treatment integrity by videotaping sessions.  
Summary of critical appraisal. Applying the MMAT and Morley’s (2017) 
quality assessment guidelines enabled a descriptive exploration of literature that, on 
balance, indicates that Baslet et al.’s (2020) study provides the highest quality evidence 
for third-wave CBT effectiveness. This is due to the study’s comparatively large sample 
size, time-specific and manualised intervention, numerous time-points (including a 
baseline measure), valid measurements and high-quality data analysis, albeit in a mostly 
female sample with high drop-out rates. 
The next highest quality studies are Barrett-Naylor et al.'s (2018) study on six 
volunteers and Bullock et al.'s (2015) study of nineteen participants recruited in a 
clinical setting. Both adopted a manualised approach and focused on NEAD outcomes. 
However, Barrett-Naylor et al. (2018) had the added strength of collecting secondary 
outcomes at clearly specified time points across their short intervention that enabled 
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tracking of change. In contrast, Bullock et al.’s (2015) statistical analysis of NEAD 
frequency over two years reduced the level of information that could be drawn from 
their results. However, their larger clinical sample offers higher ecological validity and 
subsequent generalisability to broader FND populations than Barret-Naylor et al.’s 
(2018) small sample recruited on a social media website.  
Graham et al. (2018) and Baslet et al. (2015) offer lower quality data. Neither 
benefit from numerous data points or a larger sample. Graham et al. (2018) measured 
pre and post-intervention change. However, Baslet et al. (2015) tracked change across 
three time-points, although unlike Graham et al. (2018), who measured several 
variables, they only provide NEAD count. Graham et al. (2017) and Rancourt and 
Darkes (2018) also offer relatively low-quality evidence in their single-case studies. 
Rancourt and Darkes (2018) provided an in-depth description of their 26-session 
intervention and collected outcome measures over three time points. However, their 
outcome measures are perhaps less generalisable to the broader FND population, in 
contrast to those used by Graham et al. (2017). Finally, the lowest quality study was 
Baslet and Hill’s (2011). Here, the authors provide an in-depth account of their 
intervention but used no quantitative measures, leading to results being open to research 
bias. 
Overall, the quality assessment process indicates that the literature for third-wave 
CBT for FND is low quality and mired by methodological difficulties. The process of 
applying MMAT and Morley’s quality criteria highlights the diversity of the studies 
identified within this scoping review. It will be drawn upon to contextualise findings in 
the next sections. 
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2.3.3 Is there any preliminary evidence of factors related to intervention 
feasibility, acceptability and efficacy or effectiveness? 
Factors related to intervention feasibility and acceptability. Data charting 
identified three themes relating to the feasibility and acceptability of the third-wave 
CBT interventions: replicability versus individualisation; clinical versus community 
samples and; willingness and barriers. 
Replicability versus individualisation. The first factor related to intervention 
replicability versus individualisation. The interventions studied ranged on a scale from 
replicable (manualised) to individualised (formulation driven) approaches. Five studies 
used a manualised intervention with varying adaptation levels to FND participants 
(Barrett-Naylor et al., 2018; Baslet et al., 2015; 2020; Baslet & Hill, 2011; Bullock et 
al., 2015). Baslet et al. (2015, 2020) tailored their MBT programme to participants’ 
NEAD diagnosis. They included a focused session on understanding FND symptoms. 
These studies appeared to have evolved from Baslet and Hill’s (2011) case study, which 
reported a four-session manualised MBT group-based intervention within an inpatient 
setting.  
Barrett-Naylor et al.’s (2018) ACT self-help material was not adapted for 
participants and was taken directly from a book. Here, participants read the material at 
home, with minimal input. Similarly, Bullock et al.'s (2015) lower quality study did not 
specify any adaptions in their manualised DBT programme held on a rolling basis. 
However, their group-based intervention exposed participants to others experiencing 
NEAD.  
Three studies described interventions driven by individualised formulation 
(Graham et al., 2017, 2018; Rancourt & Darkes, 2018). Although there are differences 
in the interventions' lengths, the two ACT interventions were between six to eight 
sessions, which contrasted with the DBT case study lasting twenty-six sessions. 
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However, this could be weighed within the context of the participants’ severe FND 
presentation, comorbid mental health difficulties and costs of repeated utilisation of 
inappropriate health care services. 
The studies with comparatively higher quality used time specified manualised 
methods, running between 6-12 sessions. Manualised approaches offer higher feasibility 
than individualised approaches, and the lack of difference in outcomes between 
manualised and individualised approaches suggests that they are effective. A 
manualised approach is more straightforward to replicate across settings and requires 
less clinical expertise (Nezu & Nezu, 2008).  
Clinical versus community sample. A second preliminary factor related to 
acceptability and feasibility was differences between a clinical versus community 
sample. There were differences in the samples used within the studies (see Table 2)—
seven studies recruited from clinical populations. In contrast, Barrett-Naylor et al. 
(2018) used a community sample rather than a clinical sample. It is unclear how 
representative and subsequently acceptable their volunteer sample is to a broader FND 
population. 
Willingness and barriers. The final preliminary factor related to willingness and 
barriers to engagement. Two studies identified potential barriers to engagement related 
to participant characteristics or experiences. In the highest quality study, Baslet et al. 
(2020) provided a detailed analysis and breakdown of their twenty-four non-completers 
demographics, as well as broader drop-out rates during recruitment. Those that did not 
complete the intervention were younger, tended to belong to ethnic minorities, and had 
fewer years of education. The most commonly cited reason for dropping out was due to 
difficulties accessing the sessions. The only other study to describe drop-out 
characteristics was Bullock et al. (2015). They noted that two participants dropped out 
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at the start of the group because they felt ‘different’ from the other group members, 
which they did not expand on. 
Several authors described barriers to engagement regarding the necessity of 
accepting a psychological explanation of FND. Graham et al. (2017, 2018) and Barrett-
Naylor et al. (2018) hypothesised that ACT’s focus on the individual’s values (rather 
than their FND symptoms), rather than FND,  might enable engagement through a focus 
on lived experiences within an uncertain context. For example, in Graham et al.’s 
(2017) single-case study of ‘Claire’, the intervention was shaped around her values and 
explored the outcome and function of her behaviours concerning these values.  
In contrast to the ACT studies, Rancourt and Darkes (2018) DBT approach shared 
an explicit formulation that FND symptoms are a coping strategy for psychological 
distress. The authors hypothesised that supporting participants to interpret problematic 
behaviours as learnt responses decrease judgment and stigmatisation and provide 
individuals with the opportunity to feel validated and supported. They evidenced this 
process in their detailed case study of ‘Jane’, who did not believe her paralysis was 
psychologically driven at the start of the intervention. She slowly shifted her perspective 
to be more open to a psychological understanding throughout the intervention. The only 
other study using a DBT approach provided limited evidence of patient acceptability 
(Bullock et al., 2015). Here, the authors suggested participant willingness was evident 
through completion rates, ease of recruitment, implementation, and positive exit 
intervention responses but provided minimal detail of these factors.  
Barrett-Naylor et al. (2018) were the only study to collect evidence of participants’ 
experiences of engagement in their intervention through the use of a Change Interview. 
This semi-structured interview explores participants' experiences of the intervention, 
any changes they experienced, and what they attributed to these changes. The interview 
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results presented lacked detail but indicated that participants found the intervention 
acceptable, accessible, and led to meaningful changes. 
There was a recognition of the potential barriers to ascribing psychological 
explanations for FND symptoms reported by the authors within all the studies, which 
was addressed differently, dependent on the intervention's theoretical orientation. 
Across studies, there was a lack of direct qualitative accounts of the participants’ 
intervention experiences. Indeed, Barret-Naylor et al. (2018) was the only study to give 
participants a voice, albeit limited.  
Factors related to intervention efficacy and effectiveness. None of the studies 
had sufficient quality to evidence efficacy; subsequently, only effectiveness will be 
explored. Perhaps due to the studies' diverse nature, no specific intervention factors 
appear to be related to intervention effectiveness. Three categories became apparent 
when charting the study effectiveness data, which related to study outcomes. These 
categories were: FND symptom change; QoL and distress changes; and psychological 
flexibility change. Each factor is presented below.  
FND symptom change. A reported reduction in FND symptoms or FND 
interference was associated with intervention effectiveness (see Table 2). Baslet et al. 
(2020) found that median NEAD frequency decreased for every subsequent session. 
Furthermore, 52% of participants (n = 13) reported no NEAD occurrences at the last 
session. These findings suggest promise for the 12-session MBT programme’s 
effectiveness. Bullock et al.’s (2015) naturalistic study explored the impact of their 
rolling DBT group intervention by participants keeping a weekly NEAD frequency 
diary. Using group statistics across the data collected over two years, over half of the 
participants (n = 9) experienced decreased NEAD frequency of at least 50%. However, 
the group intervention most effectively reduced NEAD frequency when offered in 
conjunction with a DBT orientated individual psychotherapy. Their data was aggregated 
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from participants who attended different group programme parts for varying lengths 
over two years. These factors limited the evidence of the intervention’s effectiveness.   
Baslet et al. (2015) and Barrett-Naylor et al. (2018) also found a decline in weekly 
NEAD frequency. Barrett-Naylor et al. (2018) found that this reduction remained for 
four out of six participants at a one-month follow-up. Their SCED enabled participants 
to serve as their control. However, the study’s small and selective sample makes 
conclusions on the intervention’s effectiveness limited. All case studies described 
qualitative improvements in mFND, with Baslet and Hill (2011) also describing 
improvements in NEAD. These qualitative accounts came from the researcher’s 
observation rather than through any formal measurement. Graham et al.’s (2018, 2017) 
ACT interventions found some participants experienced reliable symptom interference 
reductions (five out of eight in the case series). 
All studies found either reduced NEAD frequency, improved FND symptoms and 
reductions in FND symptom interference for some participants. Positive outcomes 
occurred in the context of the low quality of research and varying third-wave CBT 
approaches duration and delivery across studies. There is a lack of objective measures 
of these changes in the single-case studies, leading to conclusions being open to 
significant research bias. The use of group statistics in small and underpowered 
samples, alongside lack of control group, baseline and follow-up measures and existing 
concurrent therapy, makes any inferences on the effectiveness of third-wave CBT in 
reducing FND symptoms tentative. 
QoL and distress changes. A second preliminary factor related to intervention 
effectiveness was QoL and distress improvements. The highest quality study by Baslet 
et al. (2020) found the only measure to reach statistically significant improvement was 
QoL (measured by QOLIE-10; Cramer et al., 1996). Similarly, Barrett-Naylor et al.’s 
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(2018) found that four participants also experienced reliable and clinically significant 
improvement on this measure of QoL, which remained at follow-up periods.  
Distress was measured across six studies and revealed a mixed picture with 
improvements found for some participants. Baslet et al. (2020) found no changes in 
distress measures. While Baslet et al.’s (2015) results suggested a slight improvement. 
However, the authors explained that psychopharmacological changes happened during 
the intervention to address depression, anxiety, and insomnia. They were the only 
authors to acknowledge the potential impact medication may have had on confounding 
results.  
Barrett-Naylor et al. (2018) found that four participants experienced reliable and 
clinically significant improvements in distress, which remained at one-month follow-up 
for two participants. Graham et al.’s (2018) lower quality case series also collected pre 
and post-outcome data on distress and found a large improvement in mood. 
Furthermore, two lower quality single-case studies found reliable and clinically 
significant improvements in standardised distress measures (Graham et al., 2017; 
Rancourt & Darke, 2018). 
The two most robust studies reported reliable and clinically significant improved 
QoL outcomes for some participants with NEAD (Barrett-Naylor et al., 2018; Baslet et 
al., 2020). Barrett-Naylor et al. (2018) found four out of six participants experienced 
reductions in NEAD episodes. Baslet et al. (2020) found half of the participants (n = 13) 
reported NEAD cessation in the final session, with a NEAD frequency decrease of 0.12 
episodes per week.  
The interventions diverged significantly in intervention length, content and 
delivery. The findings for post-intervention improvements in distress outcomes were 
inconsistent. Four low-quality studies explored distress using ACT, guided self-help 
ACT and DBT. Again, studies had varying durations, but all found post-intervention 
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improvements in distress outcomes for some participants. In the higher-quality study by 
Barrett-Naylor et al. (2018), distress outcomes were also improved. However, the 
highest quality study by Baslet et al. (2020) found no improvements in distress 
outcomes. It is unclear whether the observed post-intervention improvements in QoL 
and distress outcomes result from placebo or non-therapeutic factors, regression to the 
mean or a range of other potentially confounding variables, such as participant history. 
Psychological flexibility change. A further preliminary factor linked to 
effectiveness was psychological flexibility improvements. The three ACT studies that 
were of varying quality found improved psychological flexibility for the majority of 
participants. In the most robust of these studies, Barrett-Naylor et al. (2018) found an 
improving upward weekly trend in psychological flexibility measured by the compACT 
throughout the intervention and at follow-up. The development of psychological 
flexibility was found to be a cumulative process. However, Barrett-Naylor et al. (2018) 
found one participant who reported improvements in psychological flexibility using the 
compACT also experienced deteriorations in the AAQ-II. The authors reasoned that the 
worsening of the AAQ-II was a likely artefact of the measure’s lower face and 
discrimination validity.  
Graham et al.’s (2017) case study of ‘Clare’ showed reliable and clinically 
significant improvement post-intervention on the AAQ-II. Graham et al.’s (2018) case 
series found improvements of a medium magnitude in psychological flexibility using 
the AAQ-II, with reliable improvement evident in four participants. However, they 
found a deterioration in psychological flexibility for two participants. Unlike those who 
experienced improvements, these participants showed no improvement in symptom 
interference or mood measures. They were also described as ‘distinct’ from other 
participants, as they reported ‘extremely severe’ functional impairment. 
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Overall, ACT interventions studies found some participants reported improved 
psychological flexibility associated with reduced distress, FND symptoms and 
interference and improved QoL. However, the studies are methodologically limited. 
They have small samples and a lack of control, baseline measures, and potential 
instrumentation issues (i.e. AAQ-II), making it impossible to draw any causal 
relationship from the intervention. 
Summary of findings. This review examined the extent and nature of studies on 
third-wave CBT for FND and explored preliminary factors related to intervention 
feasibility, acceptability and effectiveness. The review identified eight low-quality 
intervention studies using varying quantitative designs. Studies used DBT, MBT and 
ACT interventions delivered to people experiencing various FND presentations, 
although mainly NEAD. Effectiveness was most commonly assessed through NEAD 
frequency and standardised QoL and psychological flexibility measures. The majority 
of these studies were carried out as part of routine clinical practice, offering high 
ecological validity. However, the quality was impaired by small and highly selective 
samples that were predominantly female, case series lacking multiple baselines, a lack 
of follow-up measures, and a reliance on self-report measures.  
There is currently limited evidence of the feasibility and acceptability of third-
wave CBT. The literature indicated that there might be particular feasibility in adopting 
manualised third-wave CBT that can be replicated across clinical contexts by facilitators 
with varying skills mixes (Nezu & Nezu, 2008). All but one study reported from a 
clinical sample, suggesting feasibility within this setting. Only one study provided 
detailed information on non-completers, who tended to be younger, from an ethnic 
background, and have fewer years of education. The two reasons for participant drop-
out related to difficulty accessing sessions or feeling ‘different’ from other group 
members. Authors identified that ascribing a psychological explanation for FND could 
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be a barrier to psychological treatment, which was addressed differently, depending 
upon the intervention’s theoretical orientations. Across studies, there was a lack of 
direct qualitative accounts of the participants’ intervention experiences. 
No specific intervention factors related to intervention effectiveness. Intervention 
effectiveness was indicated by improvements in FND symptoms and symptom 
interference, with the most robust evidence for reducing NEAD frequency. Some 
improvements were also found for standardised QoL, distress and psychological 
flexibility measures, with the lowest improvement rates in distress. However, the low-
quality evidence makes it impossible to know whether changes were due to the 
intervention or other confounding factors.  
2.4 Discussion 
This review explored the extent and nature, and quality of evidence regarding 
third-wave CBT effectiveness for people with FND. Eight diverse intervention studies 
were found, and no qualitative research. Overall, the quality assessment process 
indicated that the literature for third-wave CBT for FND is low quality and mired by 
methodological difficulties. 
Charting of the interventions’ feasibility and acceptability involved exploring 
uptake, drop-out, non-responder rates, and participant experience and satisfaction. Here 
the evidence was limited. Only Baslet et al. (2020) described characteristics of non-
completers being younger, from ethnic backgrounds, and with fewer years of education, 
consistent with the broader literature on adherence to mental health interventions 
(Olfson et al., 2009). Most studies did not report on uptake, drop-out and non-responder 
rates, and participant experience and satisfaction, making it impossible to compare these 
variables between studies. Notably, the lack of reporting on non-responders and 
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deterioration rates is a common problem in general psychotherapy literature (Radcliffe 
et al., 2018). In the few studies that provided details on non-responses or worsening, 
participants were described as having more severe FND symptoms of a longer duration 
and comorbid mental health difficulties. This finding corresponds with research 
exploring predictive factors of poor outcomes for people with FND, which includes a 
longer time with the diagnosis (Asadi-Pooya et al., 2019), having a previous psychiatric 
diagnosis (McKenzie et al., 2010) and other evidence of psychopathology (Reuber et al., 
2004).  
 No differences were found in acceptability between using an individualised 
formulation driven approach or a time-specific manualised approach. However, when 
considering feasibility, there may be advantages to adopting a manualised approach. For 
example, manualised approaches can permit treatments to be easily replicated, which 
underlines evidence-based practice (a guiding principle for healthcare in the NHS) 
(Nezu & Nezu, 2008). A manualised approach can also facilitate staff training and play 
an important role in providing support and structure to less experienced practitioners 
(Wilson, 1998). Furthermore, manualised approaches can enhance treatment integrity 
and offer a minimum quality assurance. For example, a meta-analysis of psychotherapy 
outcomes found that the use of treatment manuals reduced variability in treatment 
outcome across therapists, particularly with inexperienced therapists (Crits-Cristoph et 
al., 1991). However, the acceptability of manualised treatments has been questioned, 
highlighting that they can be perceived as prescriptive and rigid (Addis & Krasnow, 
2000). Flexibility can be increased using a modular approach or by specifying the 
session format but allowing the session content to be guided by the patient's current 
problems (Henin et al., 2001).  
 This review found several authors had identified factors related to either 
willingness or barriers to engaging in third-wave CBT. For example, ACT studies 
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described the advantage of not requiring direct discussion of FND but instead focusing 
on what is personally meaningful for the patient and being guided by their goals and 
values. Thus, addressing the barriers to engagement imposed by psychological 
explanations of FND, where patients can feel that their symptoms are not being taken 
seriously (Carson et al., 2012). A focus on personally meaningful goals was also 
identified to increase willingness to engage in individualised DBT. Barrett-Naylor et al. 
(2018) also purported that their self-help format offered increased acceptability for 
some, as the approach can be used alone, in a safe and familiar setting, at one's own 
pace, and without the need for a broader acceptance or discussion of the diagnosis with 
others. However, here acceptability was surmised by the author's opinions and not the 
experiences of the participants. Strikingly across the intervention studies, there was a 
lack of participants' qualitative experiences of the intervention, how they made sense of 
the intervention and how it impacted them. 
By charting the studies’ effectiveness, improvements were found in FND 
symptoms and symptom interference with the most robust evidence for reducing NEAD 
frequency. Additional standardised QoL, distress, and psychological flexibility 
measures also revealed improvements, although inconsistently. No specific intervention 
factors were found to relate to intervention effectiveness. Overall, the low-quality 
evidence makes it impossible to know whether the observed improvements were due to 
the intervention, non-specific therapy factors, regression to the mean, placebo effects, or 
other confounding factors. 
 These outcome findings echo those of systematic reviews on third-wave CBT 
approaches for different clinical populations. For example, Graham et al.'s (2016) 
systematic review of eighteen ACT intervention studies for long-term health conditions 
found a pattern of improved QoL and distress (both in six studies), but due to the low 
quality of research, could not make any firm conclusions regarding the effectiveness of 
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ACT. Similarly, Robinson et al.'s (2019) systematic review of nineteen studies of third-
wave CBT for long-term neurological conditions found promise in this approach 
addressing emotional difficulties associated with neurological conditions. However, this 
was also amidst a range of methodological issues paralleling those found within the 
current review.  
Billones et al.’s (2020) systematic review on Mindfulness-Based Interventions 
(MBI) for medically unexplained conditions identified twenty-four studies of 
comparatively higher quality, with nineteen RCTs and five case-controlled clinical 
studies. The authors found MBI had a middle to large effect sizes on symptom severity 
(d = 0.82), pain intensity (d = 0.70), depression (d = 0.62) and anxiety (d = 0.67). 
Unlike the current review, due to using studies with more robust methods, they were 
able to identify four intervention components critical for effectiveness. These factors 
were; psycho-education to understand symptoms better, the practice of awareness, the 
non-judgmental observance of experience in the moment, and compassion for oneself. 
2.4.1 Strengths and limitations 
Several limitations are implicit in this review due to the search strategy. Non-
English language papers were excluded due to resource constraints, which may have led 
to a language bias and relevant literature not being included. This review also specified 
a third-wave CBT intervention and FND population as part of the electronic database 
search strategy. As a result of this restrictive search strategy, potential sources of 
information may have been missed, particularly when considering feasibility and 
acceptability. A broader search strategy could have explored either FND or third-wave 
CBT and concepts of feasibility and acceptability, alongside searching broader sources, 
such as Google search using key phrases and hand searches of websites and forums. 
This search may have provided more contextual information about the intervention 
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procedures, outcome measures, and techniques (Arian et al., 2010; Shanyinde et al., 
2011) and information on individuals with FND experiences and attitudes towards third-
wave CBT interventions. More details on experience and context could have been 
incorporated into intervention study findings to give an in-depth and balanced view of 
the value of third-wave CBT for people with FND (Sekhon et al., 2017). 
 The lack of qualitative literature on third-wave CBT and FND may have been an 
artefact of the restricted search terms and sources, which led to this review's focus 
solely on intervention outcomes (i.e. does this work?), not the intervention process (i.e. 
can this work? how does this work?), which is addressed by feasibility research 
(Orsmond & Cohn, 2015). Additionally, the search terms may have limited details on 
participants’ self-reported satisfaction with the intervention. However, Carter (2008) 
note that intervention acceptability requires a wider focus than just the participants, as 
acceptability is distributed among the system, interventionists, and participants. 
Subsequently, each of these subsystems needs to be explored when evaluating 
intervention acceptability. A search strategy that enabled the capturing of clinicians' 
views or NHS contexts (e.g. neurology departments or FND services) might have also 
provided a more rounded exploration of acceptability.  
 Due to the scoping review's focus upon intervention studies, two appraisal tools 
were used to provide a more in-depth exploration of study quality. The decision to use 
the MMAT enabled the use of one overarching criterion. The use of Morley's (2017) 
case study appraisal guidelines meant that while some criteria overlapped with MMAT, 
quality appraisal factors specific to the case studies and case series were captured. These 
tools enabled a more consistent critical appraisal, which was found to have high inter-
rater reliability.  
 The limited literature meant that this review explored studies focused on specific 
subtypes of FND, specifically either NEAD or mFND. While it is argued that these 
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different subtypes share common mechanisms (Paola et al., 2014) and researchers have 
identified similarities (Hopp et al., 2012), significant differences have been found 
between the presentations. Compared to patients with mFND, patients with NEAD tend 
to be younger, more likely to report childhood abuse and stressful life events and 
experience alterations in consciousness (Driver-Dunckley et al., 2011; Hopp et al., 
2012). The limited data in this review did not find differences in how FND subgroups 
responded to the intervention. However, it may be that different subtypes of FND 
respond in different ways to various interventions and would benefit from separate 
investigations on the effectiveness of different therapies.  
2.4.2 Addressing gaps in the literature  
The review has identified significant literature gaps concerning third-wave CBT 
interventions for people with FND, such as no qualitative studies and low-quality 
intervention studies that lack participant's qualitative experiences. These literature gaps 
can inform future work in the area. 
Research recommendations. Several recommendations can be made for 
intervention studies. First, future intervention studies using case series could include the 
use of multiple baselines pre-intervention. Baseline measures would make it possible to 
identify patterns that indicate threats to internal validity, such as maturation, 
instrumentation issues, and testing before the intervention. Moreover, to assess changes' 
longevity, follow-up measures are vital and could be administered at multiple follow-up 
points. 
 Standardised outcome measures could also be collected on a sessional basis if 
appropriate and be selected to capture theoretically related process measures that are 
model-specific. Model-specific measures may be more sensitive to picking up on 
change and provide a greater understanding of what intervention factors can impact 
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change processes. Additionally, research would benefit from capturing participants' 
direct experiences of the intervention and change experienced using qualitative methods 
such as the Change Interview (Elliott, 1999; Elliott et al., 2001). Again, this may 
provide a further understanding of how different intervention components work and 
greater insight into patient acceptability. Acceptability is essential in designing, 
evaluating and implementing healthcare interventions (Sekhon et al., 2017).  
An important part of assessing the intervention acceptability involves considering 
factors such as participants' attitudes towards the intervention, appropriateness, 
suitability, convenience, and perceived effectiveness of the intervention, which is best 
captured through qualitative accounts (Sekhon et al., 2017). Subsequently, qualitative 
research and mixed-method designs are essential in voicing the participant's 
perspectives that can provide a sociocultural context that informs how interventions are 
designed and delivered in different contexts in a way that generates patient acceptability 
across a range of socioeconomic and geographical groupings (Sekhon et al., 2017). 
Ayala and Elder (2011) recommend focus groups and interviews to assess intervention 
materials' acceptability in cultural appropriateness, context, presentation, and delivery. 
This approach can provide a deeper understanding of reactions to the intervention that 
increases willingness or act as a barrier to engagement and shape future work.  
 This review has also highlighted the need to provide more detailed reporting on 
uptake, drop-out, non-responder and deterioration rates at different intervention stages. 
Future research may also benefit from detailing participant information and 
characteristics to contextualise findings. For example, this information could provide 
greater insight into acceptability by supporting identifying factors contributing to drop-
out, non-response or deterioration rates. Participant information could include 
concurrent treatments (e.g. psychopharmacological or physiotherapy intervention) that 
could confound results—as well as the collection of information on physical and 
- 70 - 
 
psychological comorbidities that may impact therapeutic outcomes. It is also 
recommended that future intervention studies consider how to ensure fidelity to the 
model being used. Video-recorded sessions would ensure adherence to the model and 
evaluate the therapist's interactions and skills during sessions. 
 Feasibility studies implemented before conducting outcome-focused studies 
could enable a focus on how an intervention can be implemented and evaluated and 
provide the opportunity to test interventions in practice settings, consider real-world 
barriers and facilitators to implementation, and address cultural or linguistic relevance 
(Bowen et al., 2009; Kazdin, 2018). Without this preparatory work, outcome-focused 
intervention studies can be negatively impacted by quality issues (e.g. inadequate 
measures, treatment integrity, sample size), as well as issues around compliance, 
acceptability, recruitment issues, which could be predicted and remediated through 
feasibility studies (Eldridge et al., 2016).  
Practice recommendations. The evidence suggests that for some patients with 
FND, third-wave CBT interventions are effective. However, within the limited 
literature, it is unclear who may benefit and when best to offer the intervention. 
Preliminary evidence suggests lower effectiveness for those with greater chronicity of 
symptoms, comorbid mental and physical health difficulties, younger people, 
identifying as being from an ethnic background, and having fewer years of education. 
The limited evidence suggests a particular promise for MBT programmes for 
patients with NEAD and formulation-driven ACT approaches for patients with mFND. 
Further work is required in investigating whether it is beneficial to adopt time specified 
and manualised third-wave CBT for patients with FND that can offer higher feasibility. 
While third-wave CBT approaches share key commonalities, differences in their focus 
and delivery need to be considered within an individualised formulation. It may be that 
different subtypes of FND respond in different ways to various interventions.  
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This review indicates that real-world research within clinical settings is possible. 
Clinicians working with patients with FND are advised to consider how they can 
contribute to the evidence base. A broad range of methodological designs can be 
adopted. Perhaps the most methodological robust and feasible within an NHS context 
are SCEDs. Here, patients can serve as their controls and high-quality regular data 
collection before, during and after the intervention can explore the unique contributions 
of different parts of the intervention that may contribute to therapeutic change. 
Moreover, collecting patient’s qualitative experiences will help establish feasibility and 
acceptability and aid understanding of how the intervention works and for whom.   
Given the current low-quality evidence available for third-wave CBT for FND, it 
may be that other therapeutic modalities are more appropriate for treating FND. 
However, third-wave CBT interventions can still be drawn upon flexibly. They 
emphasise the importance of working with transdiagnostic processes, such as supporting 
an individual in moving from experiential avoidance towards acceptance of their 
experiences and providing useful skills to become more present-focused and better able 
to identify and manage emotions. Furthermore, an ACT perspective may have particular 
utility in a clinical setting that requires a multi-disciplinary approach. It can be used and 
translated across professional groups to provide a coherent and joined-up approach 
focused upon increasing personally meaningful activity without discussing the cause of 
symptoms. 
2.4.3 Future direction and conclusion 
Future direction. This review outlines the significant gaps within the literature 
and the need for further qualitative research focusing on patients’ experience and 
higher-quality research that can be shaped by feasibility research focused upon 
understanding research processes. Future research would benefit from considering how 
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to capture participants' direct experiences of the intervention and change, which can 
shed further light on the acceptability of third-wave CBT approaches and potential 
intervention factors that contribute to change. Finally, future research would benefit 
from further exploring the effectiveness or efficacy of various third-wave CBT, using 
different durations and delivery formats for different subpopulations of individuals with 
FND. Ultimately, to conclude the efficacy of third-wave CBT for FND, RCTs are 
needed.  
Conclusion. A small number of published studies have applied third-wave CBT in 
different formats across several FND presentations. There is limited detail provided on 
factors related to feasibility and acceptability, highlighting the need for feasibility 
studies and qualitative research to help develop higher-quality intervention studies that 
shape acceptable and effective interventions. There was some evidence that third-wave 
CBT may improve NEAD frequency and QoL, mood, and psychological flexibility. 
However, studies are of low quality, and there have not been RCTs of third-wave CBT 
for FND. Therefore, third-wave CBT is currently not well established for use in FND.  
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3 An evaluation of the impact and experiences of a two-phase 
psychological intervention for FND  
3.1 Introduction 
This study evaluates the impact and experiences of patients attending a Clinical 
Health Psychology Service treatment pathway for FND, consisting of two intervention 
phases: 1) assessment and formulation, and 2) an ACT group.  
The impact of this two-phase psychological intervention is explored using pre and 
post-standardised outcome measures for each intervention phase and for participants 
attending Phase 2, a Single Case Experimental Design (SCED), which included a daily 
survey. The daily survey aimed to track change and identify whether the intervention's 
specific components were linked to change. Finally, all participants took part in a 
Change Interview (Elliott, 1999; Elliott et al., 2001) that captured their qualitative 
experiences of the intervention, the therapeutic changes they perceived experiencing 
and how they made sense of this. This study is the first to use a SCED to explore an 
ACT group intervention for FND and collect interview accounts of patients’ 
experiences of a psychological intervention for FND.  
3.1.1 Research aims and hypotheses 
Evaluation of the impact and experiences of the two-phase psychological 
intervention is explored by looking at changes in standardised measures, SCED data, 
and participants' descriptions of their experiences. The study aims to bring these sources 
of data together to explore effectiveness. Specifically, reliable and clinically significant 
improvements in standardised measures and improved SCED data trends were 
evaluated. Several hypotheses are made for the changes expected in standardised 
measures and SCED specific measures following each intervention phase.  
- 74 - 
 
It was hypothesised that following assessment and formulation (Phase 1): 
H1: There will be reliable and clinically significant improvements in distress, 
symptom interference and QoL measures. 
H2: There will be reductions in participants’ threatening illness representations 
(controllability, treatability and coherence). 
It was hypothesised that following the ACT group (Phase 2): 
H3: There will be reliable and clinically significant improvements in distress, 
symptom interference and QoL measures following Phase 2. 
H4: There will be reliable and clinically significant improvements in emotion 
processing and psychological flexibility measures associated with improvements in 
distress, symptom interference, QoL measures, and greater use of ACT processes. 
H5: Daily FND experiences of FND symptom severity, interference and distress 
will improve as the ACT group progresses. 
3.2 Method 
3.2.1 Overview 
First, the design for the research is presented, followed by a description of the 
research procedure. This description provides context to the measures used to evaluate 
change. Following an overview of the measures used, their administration timepoints 
are outlined. This information is presented alongside participant information and an 
overview of the actual data collected. Data collection was interrupted by a pandemic, 
which resulted in the Change Interviews being a standalone measure for some 
participants. The design description is followed by a presentation of the ethical 
considerations, clinical and research inclusion and exclusion criteria, and finally, data 
analysis. 
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3.2.2 Design 
Rationale. The design of the study centres on a single-case series method. It had 
been intended that participants would be tracked across the two-phase intervention with 
standardised measures at specified time points and that a daily survey would be 
collected during Phase 2. The design was influenced by Hermeneutic Single-Case 
Design, as outlined by Elliott (2002). It included a Change Interview at the end of the 
intervention. Due to the disruption caused by the pandemic, the intervention and daily 
data collection stopped during the second group.   
Quantitative and SCED measures. Pre and post-standardised outcome measures 
were used for both intervention phases. A SCED collected a daily survey for those 
attending the ACT group (Phase 1). A SCED helps explore new treatments where the 
population studied is small or heterogeneous by exploring comparisons between the 
same person’s behaviour (or response to measures) at different times. The design was 
used to identify the ACT group's components associated with therapeutic changes 
(Morley, 2017). This SCED explored an established clinical intervention offered in a 
psychology service. Given the small sample and lack of control group for the ACT 
group, an alternative design of pre and post-evaluation for Phase 2 would have 
considerably reduced the ability to reach any conclusions about the ACT group's 
effectiveness and exploration of change mechanisms. 
Qualitative measure. Qualitative interview data was collected using a Change 
Interview template to capture any changes following each phase. The Change Interview 
summary and any reported changes are briefly summarised for each participant in the 
SCED. The Change Interview transcripts have also been analysed to provide a broader 
picture of participants' intervention, their perceived experiences of change, and how 
they made sense of this change. 
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3.2.3 Description of procedure and intervention 
The study procedure was shaped around a pre-existing clinical intervention 
offered to patients with FND. All participants were referred to the Clinical Health 
Psychology Service under the FND treatment pathway and attended initial assessment 
and formulation sessions with a Clinical Psychologist. The sessions are carried out on a 
one-to-one basis with a Clinical Psychologist and can take up to six one-hour sessions. 
The sessions aim to generate a shared understanding of how the patient’s FND 
symptoms may have developed and factors that may maintain or exacerbate symptoms. 
The assessment acts as a screening process for Phase 2 (the ACT group). Patients 
assessed as clinically suitable are invited to attend the seven-session ACT group.  
Before attending assessment and formulation sessions, patients were posted a set 
of routine, standardised outcome measures to complete with their appointment letter and 
asked to bring these measures completed to their first appointment with the clinician. 
Patients were also asked to repeat these measures at the end of Phase 1. At this stage, 
patients were given the option to consent to their routine clinical measures being 
accessed anonymously. Those offered the ACT group were also asked for their consent 
to participate in the SCED and Change Interview. 
Clinicians asked all patients taking part in the ACT group to complete 
standardised outcome measures at the start and the end of the group as part of routine 
clinical care. These measures were posted out with invites to the group, with 
instructions to bring completed to the first group session. Otherwise, clinicians asked 
patients to complete these measures at the start of the first group session and the final 
group session. In both groups, the researcher was briefly present at the start of the first 
session to introduce the research and answer any study questions.  
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Patients who took part in the SCED had the choice of completing the daily survey 
through a paper-based survey provided weekly by clinicians or through an online survey 
link sent via email or text by the researcher. Furthermore, four-week follow-up 
standardised outcome measures were posted to consenting participants at the end of the 
group by the psychology service together with a pre-paid and addressed envelope to 
post back to the department. The three participants who completed the first seven-week 
ACT group consented to complete a Change Interview one to two weeks after the final 
group session. 
The second ACT group recruited a further five participants to complete the SCED 
and Change Interview. However, the group ended abruptly due to the pandemic. 
Subsequently, these five participants completed a Change Interview focused upon their 
experiences of Phase 1 (assessment and formulation). The researcher held these 
interviews over the phone, which were recorded and then transcribed by the researcher. 
ACT group description. The ACT group consisted of seven weekly two-hour 
sessions, with fifteen-minute breaks, with a group of up to eight individuals and two 
facilitators. The group draws upon ACT techniques to increase psychological flexibility, 
such as exploring participants' overarching values and encouraging individuals to 
initiate actions that support their values (Dahl, 2015). The development of the openness 
and awareness aspects of psychological flexibility is facilitated by mindfulness and 
perspective-taking to assist committed action. Moreover, group facilitators are creative 
in using relational framing (i.e. purposefully creating new relationships between words 
and other stimuli). Relational framing help make the conditions in which new 
psychologically flexible behaviours might occur (Villatte et al., 2015).  
Each group session targeted areas of the ACT Triflex (‘Opening up’, ‘Being 
present’ and ‘Doing what matters’). Different sessions had a particular focus on one 
aspect of the tri-flex. ACT processes are not conceptualised to work sequentially, and 
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therefore, they can theoretically be introduced in any order (Blackledge & Barnes-
Holmes, 2009). The first group session introduced ACT with a focus on ‘Being 
present’. The next group session introduced ‘Doing what matters’ and explored values 
and the concept of choice point, alongside continued mindfulness exercises. The third 
group session introduced an understanding of emotions and body awareness, focusing 
on mindfulness and values-based action and building a compassionate relationship. The 
fourth session introduced ‘Opening up’, which included a discussion of emotional 
regulation and related techniques.  
The fifth session focused upon defusion and associated methods before moving 
back to ‘Doing what matters’ through exploring self-as-context and value-based actions. 
The final two sessions re-capped the group's content and provided time for evaluation 
and completion of routine, standardised outcome measures. The introduction of 
different processes within the various sessions aimed to enable a clearer understanding 
of participants’ responsivity to particular processes or techniques, which would 
otherwise have been obscured. Table 5 summarises each group session’s topic, skill 
focus, key aims and home practice. 




Group session topic, skill, key focus and home practice 
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Selection of measures. Measure selection included standard, target and process 
measures (collected at different time points and varying frequencies), as outlined in the 
Treatment Assessment Funnel (Morley, 1996) illustrated in Figure 4.  
Figure 4 
 
The Treatment Assessment Funnel (adapted from Morley, 1996) 
 
The measures selected are presented below in the grouping of standard, target and 
process measures. The majority of the measures were collected as part of routine 
clinical practice and covered eight broad domains, summarised in Table 6. Standardised 
outcome measures captured clinical distress, symptom interference, illness 
understanding, emotion processing and psychological flexibility. It was planned that 
Phase 1 data on these measures would provide baselines for the SCED. However, this 
was not possible due to data collection problems. The SCED specific daily target 
measures were collected across the ACT group and captured participants’ experiences 
of FND and use of ACT processes; this was created specifically for the research. In 




     









- 82 - 
 
terms of process measures, an ACT fidelity measure was used by facilitators to measure 
adherence to ACT concepts. The change interview was intended as a process measure 
for the SCED, but in the final study was used to capture participants’ experiences in 
both intervention phases.  
Table 6 
 
Measures used and rationale 
 Domain Measure Reason 
Standard 
measures 
Clinical distress PHQ-9 Measure of low mood 




WSAS Measure of symptom 
interference 
Health status EQ-5D-3L Measure of health status and 
QoL 
Illness understanding B-IPQ Measure of cognitive and 
emotional representations of 
illness 
Emotion processing EPS-25 Measure of emotional processing 
Psychological 
flexibility 




FNS experiences Daily survey of 
FND experiences 
Daily survey of symptoms, 
interference and distress 
FND impact WSAS Measure of symptom 
interference 
Behaviour change  Daily activities 
and positive 
changes 
Measure of participant’s daily 
engagement in ACT processes, 




Process measures Change interview Measure of participant’s 
experiences of group and change 
ACT fidelity 
measure 
The ACT fidelity 
measure 
Measure of ACT group 
adherence to the ACT model 
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Standard measures. Several standardised outcome measures were used to capture 
general wellbeing and functioning, illness perception, emotion processing, and 
psychological flexibility. Due to their length, these measures are not designed for 
repeated use over a short time frame. Standard measures were administered at the start 
and the end of each intervention phase. Below is a description of each standard measure 
used.  
Physical Health Questionnaire (PHQ-9; Kroenke et al., 2001): is a measure of 
depression based on the standard DSM-IV diagnostic criteria and used as a routine 
clinical measure. The 9-item self-report measure asks the person to report on the 
frequency that they have experienced nine symptoms of depression from 0 (‘not at all’) 
to 3 (‘nearly every day’) over the past two weeks. Higher scores indicate more severe 
symptoms. A score of 5 indicates mild symptoms, 10-15 indicates moderate symptoms, 
15-20 indicates moderately severe symptoms, and a score of 20 above indicates severe 
depression. A PHQ-9 score ≥10 has a sensitivity of 88% and a specificity of 88% for 
major depression (Kroenke et al., 2001). 
Generalised Anxiety Disorder-7 (GAD-7; Spitzer et al., 2006): is a measure of 
anxiety symptoms based on the standard DSM-IV diagnostic criteria and used as a 
routine clinical measure. The 7-item self-report measure asks the person to describe the 
frequency that they have experienced seven symptoms of anxiety from 0 (‘not at all’) to 
3 (‘nearly every day’) over the past two weeks. Higher scores indicate higher anxiety 
levels. A score of 10-15 indicates moderate anxiety, and a score of 15 and above 
indicates moderate to severe anxiety. The GAD-7 has excellent internal consistency, 
good test-retest reliability and strong criterion validity (Spitzer et al., 2006).  
Work and Social Adjustment Scale (WSAS; Mundt et al.,2002): is a measure of 
symptom interference ascribed to FND and used as a routine clinical measure. The 5-
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item self-report measure asks a person how their difficulties interfere with their ability 
to function across work, home management, social leisure activities, private leisure 
activities, and close relationships, from 0 (‘not at all’) to 8 (‘very severely’). Scores 
range from 0 to 40, with higher scores indicating more significant symptom 
interference. The WSAS has an internal scale consistency ranging from 0.70 to 0.94 and 
a test-retest correlation of 0.73 (Mundt et al., 2002).  
EuroQol-5D-3L (EQ-2D-3L; Brooks et al., 2013): is a routine clinical measure of 
health status that provides a simple, generic measure of health and quality of life for 
clinical and economic appraisal. EQ-5D is a preference-based measure of health status 
widely used in clinical trials, observational studies and other health surveys. The EQ-5D 
measures five dimensions; (1) mobility, (2) self-care, (3) usual activities, (4) pain/ 
discomfort, and (5) anxiety and depression. A person is asked to rate these dimensions 
for the day using three severity levels (‘no problems’, ‘moderate problems’, ‘severe 
problems’). Respondents also self-rate their health on a vertical, visual analogue scale. 
The endpoints are labelled ‘best imaginable health state’ and ‘worst imaginable health 
state’. This information provides a quantitative measure of health outcome as judged by 
the person. This measure offers two scores, one reflecting the participant's overall health 
status through responses on the five items and a second score reflecting their self-
reported health status. 
Brief Illness Perception Questionnaire (B-IPQ; Broadbent et al., 2006): is a 
measure of cognitive and emotional representations of illness ascribed to FND and was 
a routine clinical measure. The 9-item self-report measure asks a person to rate 
questions from 0 to 10 about their perceptions of different illness dimensions. 
Dimensions cover the illnesses' consequences, control, treatment control, timeline, 
illness concern, coherence, identity and emotional representation. A final open-ended 
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question asks the person to rate the importance of three self-generated causations for 
their illness. Scores range from 0 to 60, with higher scores indicating greater overall 
illness threat. The BIPQ has good psychometric properties, including concurrent, 
predictive and discriminant validity (Broadbent et al., 2006). 
Emotional Processing Scale- 25 (EPS-25; Baker et al., 2007, 2010): is a measure 
of emotion processing styles and shortfalls and was used as a routine clinical measure. 
The 25-item measure covers five subscales; suppression, signs of unprocessed 
emotions, unregulated emotion, avoidance and impoverished emotional experience. 
Different statements are rated over the past week, from 0 (‘completely agree’) to 9 
(‘completely disagree’). Two open questions also ask the person to recall the strongest 
positive or pleasant emotion and the strongest negative or unpleasant emotion they have 
experienced over the past week. Higher scores indicate more significant difficulties with 
emotion processing. The EPS-25 has been used in patients with NEAD (Novakova et 
al., 2015) and in patients with mixed FND (Williams et al., 2018). The measure was 
found to have an internal consistency of 0.92 in fifty patients with NEAD (Novakova et 
al., 2015). The measure has also been shown to have satisfactory, test-retest reliability 
and correlates well with the Toronto Alexithymia Scale (TAS-20) and the Courtauld 
Emotional Control Scale (Baker et al., 2007). 
Comprehensive assessment of Acceptance and Commitment Therapy processes 
(compACT; Francis et al., 2016): is a measure of psychological flexibility as 
conceptualised within the ACT model and was introduced as a research specific 
measure. The 23-item measure consists of three subscales capturing the dyadic 
processes; ‘openness to experience’, ‘valued action’ and ‘behavioural awareness’. Items 
are rated from 0 (‘strongly disagree’) to 6 (‘strongly agree’). Scores can range from 0 to 
60, with higher scores indicating greater psychological flexibility. In this study, the total 
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psychological flexibility score was derived by computing the sum of item responses and 
exploring each of the three subscales. The compACT has an internal consistency of 0.91 
and converges and diverges in theory-consistent ways with other measured variables 
(Francis et al., 2016). The three-factor structure, reliability and validity of the compACT 
have been demonstrated in an independent sample (Bayliss, 2018). 
Target measures. Target measures tend to be brief and taken frequently, focusing 
on the intervention's elements explored in the SCED. A daily survey was created in 
consultation with previous patients who had attended the ACT group for FND. The 
daily survey measured participants' FND symptom severity, interference and distress 
using a 10-point Likert scale (see Table 7). This measure was adapted from a chronic 
pain study case-series daily survey by Roche et al. (2017). Daily practice of ACT 
processes taught in the group was measured with the following options; ‘formal 
mindfulness’, ‘informal mindfulness’, ‘valued-based action’, ‘other’, or ‘none of the 
above’. Space was left for participants to provide details if they selected ‘other’, and 
participants had the option to provide additional information using an open text box. 
Participants were then asked whether they had made any positive changes using an open 
text box. The daily survey was designed and administered via free internet software 
(Online Surveys), piloted before administration.  






Process measures. A Change Interview was used to explore participants’ 
experiences of the intervention and change for both intervention phases. 
Change Interview (Elliott, 1999; Elliott et al., 2001): participants were 
interviewed after either Phase 1 or Phase 2 using an adapted semi-structured Change 
Interview (see Appendix H). This interview captures participants’ experiences of the 
intervention, changes experienced and provided opportunities to give feedback. The 
Change Interview also caught contextual issues to rule out any other alternative 
plausible explanations of change (Elliott, 2001).  
The 45 to 90-minute interview explored the changes a participant had noticed 
since attending the psychological intervention and whether they attributed these changes 
to helpful and unhelpful aspects of the intervention. Participants are asked to identify 
changes, including any changes for the worse, and prompted to consider changes in 
thoughts, feelings, actions, or ideas. Participants then rate these changes according to 
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how ‘expected’ they were, how ‘likely’ they would have occurred without therapy, and 
how ‘important’ the change was for them. Participants are also asked what they thought 
had caused the various changes, both outside and within the intervention. Finally, 
participants were asked to consider what had been helpful about the intervention and 
what was hindering, unhelpful, negative or disappointing for them. These areas of 
questioning helped to evaluate the credibility and validity of the quantitative data 
collected. 
ACT group adherence measure. An adherence measure was completed at the 
end of each ACT group session by facilitators, described below. 
The Acceptance and Commitment Therapy fidelity measure (O'Neill, 2018): 
measured the ACT fidelity within the group. The measure consists of 24-items 
structured around the therapist’s stance, with ACT consistent and inconsistent items. At 
the end of each group session, the two facilitators rated their delivery of the group using 
ratings ranging from 0 (‘this behaviour never occurred’) to 3 (‘therapist consistently 
enacts this behaviour’). The measure has moderate to excellent inter-rater reliability 
(ICC = 0.73) and high content validity (O'Neill, 2018). Higher scores indicate a 
therapist’s greater adherence to the ACT model. Ideally, this rating is provided by an 
observing ACT expert. However, given service constraints, this was not possible.  
Measurement time-points. It was initially planned that the various measures 
described would be implemented at the time points illustrated in Figure 5 for each 
participant. Unfortunately, disruptions in data collection meant this was not possible.  




Types of measure used and timepoints 
 
 
3.2.5 Recruitment and service context 
Clinical recruitment occurred between June 2019 and February 2020. Figure 6 
provides a flow chart of the patients with FND who attended the Clinical Health 
Psychology Service between the 1st June to the 27th February 2020. The recruitment 
process adopted a two-stage approach. Patients who completed the initial assessment 
and formulation (Phase 1) were asked whether they consented to their routine, 
standardised outcome measures being accessed for analysis. While six agreed, low 
completion of measures resulted in three complete data sets being collected for Phase 1. 
- 1 - 
Types of measure used and timepoints 
 Phase 1: Assessment and formulation phase 
• Session 1   
     
• Session 2  
    





            Phase 2: ACT group 
  
 
     
• Session 1     ACT-FM 
 
• Session 2     ACT-FM 
 
• Session 3     ACT-FM 
 
• Session 4     ACT-FM 
 
• Session 5     ACT-FM 
 
• Session 6     ACT-FM 
 









• Four-week follow-up measures 
 
 
Pre-measures (PHQ-9, GAD-7, 
EPS, B-IPQ, WSAS, EQ-5D 
CompACT)  
Post-measures (PHQ-9, 
GAD-7, EPS, B-IPQ, 




Post/ Pre-measures – repeated 
twice if time delay in starting the 
group (PHQ-9, GAD-7, EPS, B-
IPQ, WSAS, EQ-5D, CompACT)   
Post-measures (PHQ-9, GAD-7, 
EPS, B-IPQ, WSAS, compACT, 
daily measures)   
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The patients who provided standardised outcome measure data for Phase 1 were 
separate from the patients who completed the SCED in Phase 2.  
Participants for Phase 2 of the pathway were recruited from an ACT group that 
started in October 2019 and finished in December 2019. The Change Interviews were 
completed within two weeks of the group's end date. Nine patients were offered places 
in this group. However, three of these patients did not attend the ACT group from the 
start. Out of the six patients that started the group, only three completed the full course. 
The reasons for drop-out related to one participant feeling too young within the group 
and two experiencing significant stressors unrelated to the group. The three patients 
who finished the group completed the SCED and Change Interview.  
A second ACT group started in February 2020 and came to an abrupt end in 
March 2020 due to the pandemic. Six patients attended this group, and five consented to 
participate in the SCED and Change Interview. The premature end of the group stopped 
data collection. However, four of the five participants in this group completed the 
Change Interview related to their experiences of Phase 1 (assessment and formulation). 




Flowchart of patients who attended the Clinical Health Psychology Service between the 
1st June 2019 to the 27th February 2020 
 
Participants’ pathway information. All participants were recruited from the 
twelve patients identified as starting the ACT group in Figure 6. Table 8 summarises the 
data collected for each participant. Four participants completed Change Interviews 
related to their experiences of Phase 1. Three of these participants also completed pre 
and post- measures for Phase 1. Three participants completed the SCED for Phase 2, 
Referred to Psychology 
Service between 1st June 
2019 and 27th February 2020  
(n = 48) 
Responded 
to invite? 
Discharged due to 
non-response 
No 






(n = 1) 
Yes 






(n = 36) 
Dropped out 
(n = 2) 
Referred elsewhere 
(n = 3) 
Awaiting further medical 
information 
(n = 5 
No 






(n = 26) 
Referred elsewhere 
(n = 2) 
Discharged 
(n = 8) 
Invite sent for ACT 
group 
Yes 
(n = 16) 
No 
(n = 10) 
Responded 
to invite? 
Discharged due to 
non-response 
No 




DNA first group 
session 
Yes 
(n = 15) 
Yes 
(n = 12) 
No 
(n = 3) 
Invite sent for initial 
assessment 
- 92 - 
 
and a Change Interview focused on their ACT group experiences. These participants did 
not have available pre and post-data measures for assessment and formulation (Phase 1). 
Table 8 
 
The data provided by participants 
 
Note. N = Not collected, Y = Yes, collected, N/A = Not applicable 
Out of the four participants who attended Phase 1, three attended four sessions. 
One participant attended six sessions, as summarised below in Table 9. 
Table 9 
 
The number of assessment and formulation sessions attended by participants 
 
Note. A = Attended session 
Out of the three participants that completed the SCED for the ACT group, two 
missed one or more of the ACT group sessions, as summarised in Table 10. 




The number of ACT group sessions attended by participants 
 
Note. A = Attended session, M = Missed session 
 
3.2.6 The participants 
Participant demographics are summarised in Table 11. Minimal detail has been 





Note. * Participants were classified by decade into five age groups (i.e. 20s, 30s, 40s, 
50s and 60s) 
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3.2.7 Ethical considerations 
 The East of Scotland Research Ethics Service approved this study (see Appendix 
E). Several ethical issues were considered: 
Informed consent. Participants were informed about the research verbally and 
provided with a patient information sheet (see Appendix F and Appendix G). Written 
consent was collected at least 48-hours later, leaving time for reflection. Group-
attending participants also had the opportunity to meet the primary researcher in person 
to ask questions or raise any concerns. Informed consent was gathered by the clinicians 
and stored securely at the Clinical Health Psychology Service department. 
Right to withdraw. It was made clear to participants that they could withdraw from 
the study at any time and that this would not impact the treatment that they received. 
They could withdraw through contact with the clinicians or researcher. 
Confidentiality. The research was conducted following the Data Protection Act 
(1998). Participants were allocated a unique identifying code enabling data to be 
collected and stored confidentially. All details were stored on secure services, and any 
emails containing data was sent via a secure network. 
Incentive to participate. Participants attending the ACT group completed a daily 
survey, alongside a Change Interview at the end of the group, which might have been 
burdensome. Previous patients who had attended the ACT group were consulted for 
their opinion regarding this. They highlighted the importance of keeping measures as 
brief as possible. They also believed that a financial incentive for taking part in the 
research would not be appropriate. They described feeling that patients would be 
incentivised by having the opportunity to contribute to research that supports effective 
FND treatment. Thus, participants were only offered compensation for the costs of 
travelling to take part in the Change Interview, where relevant. 
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3.2.8 Inclusion and exclusion criteria 
Participants were attending the Clinical Health Psychology Service two-phase 
psychological intervention for FND. Inclusion criteria for patients attending the clinical 
service included an FND diagnosis and being eighteen years old or above. For this 
study's research component, participants had to be deemed to have the capacity and 
provide informed consent.  
As this study focused upon a clinical intervention, exclusion criteria were set by 
clinicians rather than by the researcher. For example, participants were not invited to the 
ACT group if they did not express an interest or willingness. Similarly, some 
participants were referred elsewhere when clinicians felt participants’ needs were best 
met in primary or secondary mental health care services. Furthermore, insufficient 
understanding of English or additional requirements that prevented the patient from 
benefitting from a group setting was an exclusion criterion for the ACT group. Research 
exclusion criteria were set for participants who took part in the SCED. Daily survey 
completion rates of below 50% meant data were excluded from the analysis. 
Participants missing more than two out of seven group sessions were also excluded 
from data analysis. No participants met these exclusion criteria.  
3.2.9 Data analysis 
Pre and post-intervention analysis. The Reliable Change Index (RCI; Kaplan, 
2014) and Clinically Significant Change (CSC) are both psychometric criteria. The RCI 
indicates whether a change in score is significantly greater than a difference recorded 
due to a random measurement error and, therefore, is likely to result from the 
intervention (Jacobson & Truax, 1992). The RCI is calculated using a function of the 
standard deviation and the reliability of the measure used. Changes were assessed to see 
- 96 - 
 
if they were reliable and of ‘clinical importance’ using the CSC, indicating meaningful 
improvement or deterioration using the measures’ clinical cut-offs (Evans et al., 1998). 
The RCI for all standardised outcome measures was calculated using the 
appropriate data if available (see Table 12). This data was not available for the EPS-25 
and B-IPQ. The B-IPQ has different norms depending on the clinical population it is 
used on, and to date, this information is not available for FND. For the other outcome 
measures, psychometrics from relevant validation studies and data from literature using 
the samples deemed similar to an FND sample were used, such as those with mixed 
mental health samples. The CSC was used where the clinical cut-off scores for measures 
were available. It was not available for the EPS and B-IPQ. The CSC made it possible 
to determine whether the magnitude of change from the start to the end of each 
intervention phase was reliable and clinically significant (Evans et al., 1998; Jacobson 





Note. Psychometric data is from the following sources; PHQ-9 (Kroenke et al., 2010), 
GAD-7 (Toussaint et al., 2020), WSAS (Zahra et al., 2014), and compACT (Francis et 
al., 2016). 
SCED analysis. The SCED data should be evaluated using multiple methods to 
increase interpretation confidence (Lane & Gast, 2014). Subsequently, the effectiveness 
and causality of the ACT group were assessed using the following methods: 
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1. Comparing standardised outcome measure scores across different time points of 
the treatment pathway, using the RCI and CSC criteria (Jacobson & Truax, 1992), as 
outlined above. 
2. FND Symptom severity, Interference, Distress and activity data across the 
intervention was displayed in graphs to allow for visual inspection (Morley, 2017). The 
effect of the intervention was also evaluated by examining changes in patterns from the 
start to the end of the ACT group (Morley, 2017). 
3. Hermeneutic Single-Case Efficacy Design (HSCED; Elliott, 2002) explores 
SCED data and guided the synthesis and interpretation of study data. Quantitative and 
qualitative data were combined to help decide whether changes could be attributed to 
the effects of the intervention. 
Quality standard for SCED. The ACT group followed a session plan to ensure 
standardisation. However, the facilitators exercised clinical flexibility, as participants 
were encouraged to ask questions and share their experiences. Two Clinical 
Psychologists delivered the ACT group, both with considerable experience in the area. 
The facilitators used an in-session checklist to ensure that the intervention was delivered 
consistently and completed the ACT-fidelity measure together immediately following 
each session. As shown in Table 13, the facilitators rated themselves as overwhelmingly 
ACT consistent and indicated minimal occasions where they were ACT inconsistent. 
The research supervisors also checked the visual analysis and qualitative data from the 
obtained results to ensure accuracy.  




ACT fidelity measure 
 
Note. Con = ACT consistent, inc = ACT inconsistent 
Thematic analysis. The qualitative data from the Change Interviews for 
participants who were part of the SCED is presented descriptively for each participant, 
alongside their quantitative measures. Here it was noted that data was rich enough to 
warrant further analysis. Subsequently, thematic analysis (Braun & Clarke, 2006) was 
chosen given the Change Interview's focus (see Appendix H) on participants’ 
experiences of the intervention, their perceived changes, and how they made sense of 
these changes.  
Thematic analysis is a qualitative research process used to organise, analyse and 
describe patterns within complex data sets (Boyatzis, 1998). It is often considered 
independent of theory and epistemology and can be adapted flexibly to a broad range of 
data (Braun & Clarke, 2006, 2013). Before data analysis, interviews were transcribed 
with the participant’s identifiable information removed. These transcripts were then 
printed out in their entirety to enable analysis. A mixed approach was adopted to study 
data, with both a deductive and inductive approach used to code the data.  
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During the initial stages of data analysis, a deductive approach was used to draw 
codes and themes directly from the data, where data was collected without any influence 
from the researcher’s theoretical interest in the topic area (Braun & Clarke, 2006). 
However, the interview data was rich enough to warrant an inductive analysis.  
Subsequently, these codes and themes were then considered in the broader theoretical 
literature in the latter stages of the analysis (Braun & Clarke, 2006).  
Braun and Clarke (2006) developed a six-stage systematic approach to thematic 
analysis. The first stage of this method requires the researcher to familiarise themselves 
with the data by transcribing and re-reading the text passages. The researcher 
transcribed all interviews and spent additional time familiarising themselves with the 
whole data set. The second stage of thematic analysis involves identifying codes within 
the data set. Here transcripts were printed in their entirety, and codes began to be 
recognised and scribed directly to the transcript. The researcher intentionally did not 
narrow the coding process's focus to ensure that the identified codes were data-driven. 
Stage three is concerned with the development of themes from the coded data. Here 
individual codes were clustered into preliminary broader themes and sub-themes (see 
Appendix I).  
During stage four, the themes were reviewed and refined based on the strength of 
data available for each theme and whether the themes ‘work’ as a complete data set. 
During this stage, the preliminary themes that had significant overlap were clustered to 
ensure that the themes were distinct from each other but communicated the participants’ 
experience in its entirety. Once a satisfactory thematic map was developed, stage five 
involved deciding the names and definition for each theme that was concise and 
encapsulated the essence of the data that contributed to that theme. The final step 
involved the production of the report summarising the themes developed from the initial 
data set. 
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Quality standard for thematic analysis. At each stage of the thematic analysis 
process, the data, codes, and themes were discussed with the research supervisors. This 
process provided a critical analysis of the analytic process. It ensured that the themes 
were sufficiently refined and suitable to give a clear and concise account of the data. 
This process enabled different perspectives on the codes and themes that emerged from 
the data and provided a critical approach to the analysis process. If there was 
disagreement regarding code or theme, the researcher and supervisor discussed until 
consensus was reached. An independent researcher was also asked to assess the 
identified themes. An agreement was made across the themes to combine the data from 
participants in both intervention phases, given the significant overlap in themes. 
Furthermore, at each stage of the data analysis, codes and themes were grounded within 
the transcripts' raw data. 
3.3 Results 
3.3.1 Overview 
Three analyses of the data sets are now presented. First, pre and post-standardised 
outcome data collected for participants attending either Phase 1 or Phase 2 are examined 
in relation to hypothesises 1 and 2. Next, the SCED for the three participants who 
attended the ACT group, alongside key details from the Change Interview, is presented 
in order to address hypotheses. Third, a thematic analysis of the Change Interview data 
for participants attending either Phase 1 or Phase 2 is presented. 
3.3.2 Changes across a two-phase psychological intervention for FND 
Changes in standardised measures following each intervention phase are presented 
for the following hypotheses: 
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- There will be reliable and clinically significant improvements in distress, 
symptom interference and QoL measures following both phases. 
- Following Phase 1, there will be reductions in participants’ threatening illness 
representations (controllability, treatability and coherence). 
The final two hypotheses will be addressed in ‘SCED analysis’ – Section 3.3.3.  
Phase 1 pre and post-measures 
Changes in distress measures. Out of the three participants who completed the 
outcome measures for Phase 1, only Participant 1 (P1) experienced reliable and 
clinically significant improvement in mood (measured by the PHQ-9) and anxiety 
(measured by the GAD-7). Participant 2 (P2) and Participant 3 (P3) experienced reliable 
and clinically significant worsening in their mood. P2 also experienced a reliable and 
clinically significant worsening in anxiety (see Table 14).  
Changes in symptom inference. Following Phase 1, two participants experienced 
post-intervention reliable and clinically significant worsening in symptom interference 
(P1 and P3) (measured by the WSAS) as recorded in Table 14. The third participant 
(P2) remained in the severe range.  
Changes in QoL. Following assessment and formulation (Phase 1), all three 
participants’ overall health rating remained similar across the two-time points. Self-
rated health status improved slightly for one participant (P1) and worsened for two 
participants (P2 and P3) (see Table 14).  
Changes in threatening illness beliefs. Two participants (P1 and P2) experienced 
improvements in overall illness threat. Exploring relevant items indicated improvements 
in treatment control (P1 and P2), personal control (P2) and illness coherence (P1), as 
illustrated in Figure 7. However, P3 experienced a worsening. 
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Phase 2 pre and post-measures 
Changes in distress measures. In Phase 2, only Participant 5 (P5) experienced 
reliable and clinically significant improvements in mood, anxiety, and post-intervention. 
No reliable and clinically significant change in mood or anxiety were observed in 
Participant 6 (P6) and Participant 7 (P7) (see Table 15). 
Changes in symptom inference. Following the ACT group (Phase 2), two 
participants experienced worsening in symptom interference (P5 and P7), which was 
reliable and clinically significant change P7 (measured by the WSAS). The third 
participant (P6) remained in the severe range post-intervention and at follow-up (see 
Table 15).  
Changes in QoL. Following the ACT group, all three participants’ overall health 
rating did not change. Participants’ self-rated health status improved slightly for P7 but 
worsened for the other two participants (P5 and P6) (see Table 15).  




Summary of scores for participants who completed pre and post-measures for the assessment and formulation 
 
Notes. *significant reliable change (RCI criterion at 0.05 level), ! clinically significant change, **significant reliable change in the non-
predicted direction (worsening); Sev = Severe range, V-hi = Very high, M/se = Moderate severe, Mod = Moderate, H-av = High 
average; PHQ-9 = higher scores indicate a worsening; GAD-7 = higher scores indicate a worsening; WSAS = higher scores indicate a 
worsening; EQ-5D-3L rating = higher scores indicate a worsening; EQ-5D-3L self-rating = higher percentage indicates an improvement; 
B-IPQ = higher scores indicate a worsening; EPS = higher scores indicate a worsening; compACT = higher scores indicate an 
improvement. 
 




Bar chart of participants’ pre and post-intervention illness perception domain scores on the 










































































































Summary of scores for participants who completed pre, post- and follow-up measures for the ACT group 
 
Notes. *significant reliable change (RCI criterion at 0.05 level), ! clinically significant change, **significant reliable change in the non-
predicted direction (worsening); Sev = Severe range, V-hi = Very high, M/se = Moderate severe, Mod = Moderate, H-av = High 
average; PHQ-9 = higher scores indicate a worsening; GAD-7 = higher scores indicate a worsening; WSAS = higher scores indicate a 
worsening; EQ-5D-3L rating = higher scores indicate a worsening; EQ-5D-3L self-rating = higher percentage indicates an improvement; 
B-IPQ = higher scores indicate a worsening; EPS = higher scores indicate a worsening; compACT = higher scores indicate an 
improvement.
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3.3.3 SCED analysis 
The SCED analysis is next presented on an individual basis for participants who 
attended the ACT group, and it considers the following hypotheses for each participant; 
- Participant’s experiences of FND symptom severity, interference and distress 
will improve as the ACT group progresses. 
- There will be reliable and clinically significant improvements in emotion 
processing and psychological flexibility following associated with 




Overview of the participant. P5 is a female in her twenties, experiencing severe 
right arm weakness and pain. She attributes these symptoms to an accident three years 
earlier that involves ongoing litigation. While attending the group, she reported living 
by herself and not working. P5 attended six out of the seven group ACT sessions. She 
missed session three that covered ‘understanding of emotions and body awareness’. Her 
adherence to completing the daily survey was approximately 50%, 22 out of the 43 
daily surveys were completed. Caution has been taken in interpreting her results, given 
this incomplete data set. 
Target measures. Figure 8 provides a visual plot of P5’s self-reported FND 
symptom severity, distress and interference across the group. While there is sparser data 
in weeks 4 and 5, the plots reveal a downward trend in all measures as the group 
progresses. The most visible change across time is in distress, which reduced across the 
intervention, as illustrated in the downward trend lines. Her distress was as high as 10 in 
the first week and dropped as much as eight points on the group's final week, with a 
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final score of 3. There are variations within the data, with the most extensive variation 
in symptom interference, which drops five points from day 24 to 25. The least variation 
in scores is on the symptom severity measure, which is as high as 9 in the first week and 
falls to 5 in the last week. Her responses suggest that she was distinguishing between 
her experiences of FND symptoms, distress and interference. 
Figure 8 
 
Visual display of P5’s FND symptom severity, distress and interference scores 
 
Standard measures. P5’s standardised outcome measures are now described. 
Follow-up measures were not obtained for P5. Thus, only pre and post-ACT group 
measures are presented. 
Emotional Processing Scale-25 (EPS-25): Pre-intervention P5 scored ‘High’ to 
‘Very High’ on the EPS total (score = 6.84, 95%) and across the subscales, indicating 
difficulties with emotional processing. Post-intervention, the EPS total score and 
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indicating that the intervention reduced emotional processing difficulties. The 
‘Suppression’ and ‘Controllability’ scale showed the greatest improvements.  
Comprehensive Measure of Acceptance and Commitment Therapy (compACT): 
P5’s score on the compACT revealed increases in psychological flexibility (pre = 34, 
post = 64). The greatest change was on ‘Valued Action’, which was the only subscale to 
show reliable clinical changes.  
Brief Illness Perception Questionnaire (BIP-Q): There were minimal changes pre 
to post-intervention (pre = 59, post = 57). These scores showed that her threatening 
illness beliefs remained stable. Pre and post-intervention, the most important factor she 
felt caused her FND symptoms remained the same with (1) car accident.  
Distress measures: Scores showed improvement on the PHQ-9 and GAD-7 that 
reduced from a ‘Moderate/ Severe’ range to a ‘Moderate range’ (PHQ-9 pre = 19, post 
= 12; GAD-7 pre = 19, post = 13), this indicated reliable but not clinically significant 
change. 
Adjustment measures: There was minimal change in symptom interference, 
measured by the WSAS, which was in the ‘Severe’ range pre and post-intervention (pre 
= 32, post = 29). 
Quality of life: There was minimal change in overall health status (pre = 11, post = 
10). However, P5 reported a 31% rise and subsequent improvement in her perceived 
health rating, rated at 64% post-intervention. 
Use of ACT processes. Over the forty-two days of the ACT group, P5 provided 
activity responses on twenty-one days. On nine of these occasions, she reported not 
using any ACT processes. She reported using informal mindfulness exercises on eleven 
occasions but no formal mindfulness or value-based practice. She described making 
three positive changes, including socialising with a friend, eating out and going for a 
walk. P5’s use of ACT processes is summarised visually by summing their occurrence 
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each week (see Figure 9). Due to the missing data, it is not possible to make 
comparisons between these weekly events.  
There was an option to leave further comments within the survey, which she did 
on nine occasions. Her remarks related to the difficult experiences that she had 
experienced that day. For example, on day one, she described the ‘distress of meeting 
other people with FND’. On four occasions, she described feeling exhausted and 
sleeping excessively, and she reported having a bad migraine on another day. She also 
noted her mood as ‘being up and down’ and experiencing ‘high pain and low mood’ on 
two different occasions. 
Figure 9 
 
Visual display of P5’s weekly use of ACT processes 
 
Change interview. P5 commented on several helpful aspects of the ACT group. 
She described no changes in her FND symptoms. Still, she felt that she managed her 
mood and stressful situations better following the group. She reported three important 
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ways of thinking, and feeling less alone (see Table 16). She attributed these changes to 
the various skills that she learnt, particularly ‘choice point’ that enabled her to ‘take a 
step back’ from her thinking and be more ‘positive’.  
She attributed feeling less alone to meeting others with FND and feeling 
‘understood’ and ‘encouraged’ by group members. She also described feeling better in 
herself, in part, due to a change of living circumstances that provided her with more 
physical help. P5 commented on several unhelpful aspects of the group. Unhelpful 
aspects included experiencing anxiety before the first group session and a lack of 
information on what to expect. She also spoke of the first group session being a shock, 
as she met others with the condition, which impacted her mood. She described feeling a 
sense of loss when the group came to an end. P5 made several suggestions on how the 
group could be improved, such as more information before the first group session 
through a leaflet or meeting people who had previously attended.  
Table 16 
 





Overview of the participant. P6 is a male in his forties, experiencing a range of 
symptoms associated with FND over the past three years. His symptoms included; 
motor sensory difficulties, muscle weakness and pain, comprehension and memory 
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difficulties and migraines. He was on long-term sick leave and living at home with his 
partner and children. Due to ill health, he missed two consecutive weeks of the group, 
session 3 (‘understanding emotions and body awareness’) and session 4 (‘opening up’). 
His adherence to completing the daily surveys was 60%, with thirty-one out of the 
forty-three collected. The missing data, particularly in week three and four, when he did 
not attend the group, makes interpretation of this data tentative. 
Target measures. Overall, there appear to be no changes in his FND symptom 
severity, distress and interference post-intervention (see Figure 10). When there is 
information recorded over consecutive days, there are notable variations in scores. Such 
variation is also evident in his scores within the final week of the intervention. The 
scores of nine in both week 3 and 4 indicated that he was experiencing high levels of 
FND difficulties during these times. His pattern of responses suggests he scored the 
same ratings for his FND symptom severity, interference and distress, except for the 
first week and a half of the group. 
Figure 10 
 
Visual display of P6’s FND symptom severity, distress and interference scores 
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Standard measures. P6’s standardised outcome measures are now described in 
turn. Follow-up measures were obtained for P6. Thus, pre and post standardised 
measures, and one-month follow-up measures are detailed. 
Emotional Processing Scale-15 (EPS-25): Pre-intervention P6 scored ‘Very High’ 
on the EPS total (score = 6.5, 95%) and across the subscales, indicating difficulties with 
emotional processing. Post-intervention, his EPS total score remained unchanged. 
However, his scores increased slightly on all subscales, other than Controllability. 
Similarly, at one-month follow-up, his scores increased somewhat (score = 8.4, 95%), 
indicating a worsening on this measure, although remaining in a ‘Very High’ range. 
Comprehensive Measure of Acceptance and Commitment Therapy (compACT): 
P6’s score on the compACT pre-intervention of 49 revealed no reliable clinical changes 
post-intervention with a score of 51. His score reduced to 43 at one-month follow-up, 
indicating a reduction in psychological flexibility. However, this was not a reliable 
change.  
Brief Illness Perception Questionnaire (B-IPQ): There were no changes post-
intervention on the B-IPQ total score of 62. Pre-intervention, he ranked the three most 
important factors that he believed caused his FND symptoms as; (1) long-term stress, 
(2) lack of ‘me’ time and space, and (3) family and work pressures. Post-intervention, 
the order but not content of his rankings changed; (1) extreme stress over time, (2) 
family issues, and (3) no ‘me’ time. At one-month follow-up, his score increased 
slightly (score = 64), and his rankings remained similar, with; (1) family, (2) stress, and 
(3) no me time. 
Distress measures: Scores revealed slight post-intervention improvements on the 
PHQ-9 and GAD-7, which remained in the ‘Severe’ range and did not represent a 
reliable and clinically significant change. Both these scores worsened slightly at one-
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month follow-up and remained in the ‘Severe’ range. (PHQ-9 pre = 24, post = 21, and 
f/u = 25; GAD-7 pre = 21, post = 18, and f/u = 21). 
Adjustment measures: There was minimal change in symptom interference, 
measured by the WSAS, which was in the ‘Severe’ range across measurement time 
points (WSAS pre = 33, post = 36, and f/u = 40). 
Quality of life: There was minimal change in overall health status (pre = 11, post = 
10). However, P6 reported a 19% worsening in their self-reported health rating, which 
fell from 26% to 7%. Follow-up was not obtained on this measure. 
Use of ACT processes. Over the 42 days of the ACT group, P6 provided activity 
responses on twenty-two days, illustrated in Figure 11. He reported using informal 
mindfulness on four occasions, formal mindfulness on seven occasions and used value-
based processes on three occasions. He also described using ‘other’ techniques on two 
occasions, both related to having ‘quiet time with no plans’.  
He reported making five positive changes between week 2 and 5, which involved 
spending time with family and friends, retail therapy, eating out, relaxing and reflecting. 
There was an option to leave further remarks within the survey, which he did on four 
occasions. His comments were themed around the day's difficult experiences, including 
bereavement, feeling ‘chronically fatigued’, feeling ‘not in control’, and a stressful 
event related to employment. 




Visual display of P6’s weekly use of ACT processes 
 
 
Change interview. P6 described several beneficial aspects of the ACT group. He 
described no changes in his FND symptoms but felt that the group had created several 
positive changes. The most important change that he reported was being able to ‘slow 
down’ and ‘put himself first’. He also described resting more, being able to ‘take a step 
back’, ‘ground’ himself and making a decision not to go back to work (see Table 17). 
He attributed these changes to several skills that he learnt, including mindfulness and 
breathing exercises, cognitive defusion techniques (such as ‘leaves on the stream’) and 
‘choice point’. He also spoke of the benefits of having ‘others to talk to’ and how 
gaining support helped him be ‘kinder’ on himself and feel that ‘it is not just me’.  
P6 commented on several unhelpful aspects of the group, such as a lack of 
information on what to expect, which caused him anxiety. He suggested an outline of 
the session structure would have helped manage his anxiety. He also indicated that the 
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group could be made longer. Finally, P6 spoke of struggling when the group came to an 
end and ‘feeling abandoned’ and unsure what to do next. 
Table 17 
 





Overview of the participant. P7 was a male in his thirties. He had experienced 
symptoms associated with FND for eight years. His symptoms included motor sensory 
difficulties, muscle weakness and pain and migraines (associated with dissociative 
episodes and memory issues). He was not working and lived with his partner. He 
missed no group sessions and missed only two of the forty-three daily surveys sent. 
Target measures. There appears to be a slight upward trend and worsening in his 
FND symptom severity, interference and distress as the group progresses (see Figure 
12). His experiences of FND difficulties, particularly distress, appear to increase 
immediately following the first group session then fluctuate until day 10. However, 
from here onwards, his experiences of distress and inference worsen. His FND 
symptoms are worse in week four and six, whilst he rated his distress as highest in week 
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five and six. His responses suggest that he was distinguishing between his experiences 
of FND symptoms, distress and interference. 
Figure 12 
 
Visual display of P7’s FND symptom severity, distress and interference scores 
 
Standard measures. P7’s standardised outcome measures now described in turn. 
Follow-up measures were not obtained. Thus, pre and post-measures are described. 
Emotional Processing Scale-25(EPS-25): Pre-intervention P6 scored ‘High/ Very 
High’ on the EPS total and across the subscales (score = 5.8, 90-95%). These scores 
indicated difficulties with emotional processing, which worsened into the ‘Very High’ 
range post-intervention (score = 7.56, 95%). The greatest worsening was on the 
‘Emotion Experience’ subscale. He rated highly for the items ‘feelings did not belong to 
me’ and ‘hard to work out if felt ill or emotional’ throughout. 
Comprehensive Measure of Acceptance and Commitment Therapy (compACT): 
P7’s score on the compACT revealed improvements in psychological flexibility (pre = 
37, post = 58). The only subscale demonstrating a reliable clinical improvement was 
‘Valued Action’.  
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Brief Illness Perception Questionnaire (BIP-Q): There was a slight increase in 
threatening illness beliefs (pre = 55.5, post = 58). Pre-intervention, he ranked the three 
most important factors that he believed caused his FND as (1) car accidents, (2) history 
of being bullied and (3) assault. Post-intervention, these factors stayed similar, but the 
order changed; (1) assault, (2) history of being bullied and (3) car accidents. 
Distress measures: His score on the PHQ-9 and GAD-7 was in the ‘Severe’ range 
both pre and post-intervention (PHQ-9 pre = 21, post = 20; GAD-7 pre = 17, post = 18).  
Adjustment measures: His score on the WSAS pre-intervention was in the 
‘Moderate’ range. This worsened post-intervention to a ‘Severe’ range, indicating a 
reliable and clinically significant worsening (pre = 19, post = 31). 
Quality of life: There was no change in overall health status (pre and post = 10). 
However, P7 reported a 27% rise in their perceived health rating, rated 67% post-
intervention. 
Use of ACT processes. Over the forty-two days of the ACT group, P6 responded 
on thirty-six of these days, summarised in Figure 13. He reported using informal 
mindfulness on eleven occasions, formal mindfulness on seventeen occasions and using 
value-based processes on sixteen occasions. Only in week two did he report two days 
when he did not use any form of practice. He also described using ‘other’ techniques on 
three occasions, which included listening to podcasts (n = 2) and playing a game on his 
phone. Throughout the intervention, he reported making twenty-three positive changes. 
These changes included going out despite experiencing pain, helping a family member, 
doing chores, waking up earlier than usual, identifying areas of improvement, focusing 
on formal mindfulness and physiotherapy. Other positive changes included using his 
walking stick, although noting that it made him ‘feel old’, to walking more than usual, 
going shopping (based on values), meeting up with family, and attending the 
psychological intervention session.  
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There was an option to leave further comments within the survey, which he did on 
eleven occasions. His comments related to the struggles he had experienced. He 
reported struggling to focus on mindfulness, find time, go out for a walk and not finding 
his phone game relaxing. Other comments described his difficult experiences of the day, 
including pain, depression and struggling with physiotherapy.  
Figure 13 
 
Visual display of P7’s weekly use of ACT processes 
 
Change Interview. P7 commented on several beneficial aspects of the ACT group 
(see Table 18). He described no changes in his FND symptoms. Still, he felt he was 
managing his mood and stressful situations better following the group. He reported 
extremely important changes in his ‘thought process’. These changes involved not 
getting ‘hooked into thoughts’ and experiencing less negative and more positive 
thoughts, and feeling better able to manage difficult situations. He attributed these 
changes to a range of ‘tools’, including several cognitive defusion techniques, and 
gaining a greater understanding of FND.  
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P7 also spoke of finding the routine of having the group helpful, alongside 
meeting others. He also described experiencing increased dissociation episodes due to 
the group and likened this to a medication side effect. He spoke of the group's unhelpful 
aspects, relating to a lack of information on what to expect and not always being 
comfortable when paired up for exercises. He felt that receiving more details would 
have been helpful and shorter but more regular breaks. He thought he was given too 
much information and could struggle to take this in. 
Table 18 
 




3.3.4 Change Interview analysis 
In this final section of this results chapter, Change Interview data will be presented 
to explore participant’s descriptions of intervention acceptability for each intervention 
phase, followed by a description of the themes that emerged from the thematic analysis 
summarising participants' experiences of the interventions and change. 
3.3.5 Acceptability of the intervention 
Phase 1, Assessment and formulation sessions: Four participants attended the 
assessment and formulation sessions (ranging from three to six appointments) and three 
ACT group sessions before the group was suspended due to the pandemic. All 
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participants described these sessions as a helpful, informative and positive experience. 
This was despite one participant describing initial apprehension due to past painful 
experiences of psychological intervention. Two participants initially believed either they 
had been misdiagnosed with FND or did not have the diagnosis. 
Three participants described experiencing positive changes due to the sessions 
(see Table 19). The participant who did not describe experiencing changes reported that 
they found the sessions helpful in providing clarification and confirmation in their 
understanding of FND by an expert. Unlike the other participants, this individual had 
known her diagnosis for many years. Participants attributed the changes they 
experienced to the skills and support they received from sessions. The three participants 
who reported experiencing changes also indicated experiencing challenges while 
attending sessions. Challenges included a deterioration in a health condition, ongoing 
employment issues and mental health difficulties. Furthermore, all participants 
experienced different levels of adjustment and distress related to a newly emerging 
pandemic, which placed significant restrictions on their day-to-day life and resulted in 
the abrupt end of the ACT group and uncertainty on when this would re-commence.  
All participants reflected upon how, within assessment and formulation, despite 
talking about painful topics, they found this necessary for moving forward and that 
sessions had helped address distressing issues. All participants spoke positively of their 
interactions with the psychologists, who were described as good at what they do, 
friendly, and non-judgemental. These interactions created a safe space where 
participants felt listened to, expressed their feelings, and asked questions. Only one 
participant reported worsening FND symptoms following the intervention related to 
increased seizure frequency. However, they attributed this to a deterioration in a 
comorbid health condition. While no participants reported any unhelpful experiences, 
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two participants commented on the individual sessions' environment being hindering, 
either due to the noise of building work or the uninviting appearance of corridors. 
Phase 2, ACT group: Three individuals completed the full ACT group and 
completed the Change Interview related to their experiences. Mirroring the high 
acceptability of Phase 1, all participants spoke of finding the group helpful and feeling 
better due to the group. All described a range of positive changes resulting from the 
group, summarised in Table 19, which participants attributed to having a safe space, 
gaining increased understanding and new skills. Participants spoke highly of the value 
of meeting other people with FND, which helped them to feel understood, less alone 
and more connected.  
Only one participant spoke of experiencing adverse effects at the end of the ACT 
group, related to increased ‘brain fog’ and dissociation. They attributed this to "thinking 
too hard" due to having new tools and likened this to medication's side effects. One 
participant described feeling upset following the initial session due to seeing others with 
FND. Another participant found it hard to think about their FND and how it impacts 
their life while also acknowledging that this was important. All three participants 
described finding the ending of the group difficult and daunting. As captured in the 
quotes below;  
“you have learnt but, it’s a bit, it’s still daunting. . . it’s kind of like here you go 
 we brought you some new things to do, but it’s… you’re on your own” (P5) 
“I have got all this support and input, and now I am done and left to get on with it 
 by myself…  that feels difficult. . . I am not sure what this Thursday will look 
 like” (P6) 
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3.3.6 Experiences of the intervention and change  
Participants reported positive changes in both intervention phases. The changes 
experienced by participants who attended different intervention phases overlapped in 
three super-ordinate themes: (1) safe space, (2) increased understanding, and (3) new 
ways of thinking. Figure 14 visually summarises these key themes and subthemes. 
There are clear links between these themes.  
All participants spoke of experiencing the sessions as a safe space that provided 
validation and affirmation, which seemed crucial in aiding understanding and new ways 
of thinking. Participants spoke of increased understanding, which included 
understanding FND, self-awareness, and new skills acquisition. Furthermore, all but one 
participant spoke of gaining new ways of thinking that resulted from changes in 
understanding. New ways of thinking included relating to thoughts, increased coping, 
greater acceptance and increased self-compassion. Given the differing focus of 
assessment and formulation (Phase 1) and the ACT group (Phase 2), some of the 
subthemes related more clearly or were exclusive to these different phases. These main 
themes are now described with supporting quotes to elaborate. 
 




Participant’s responses to Change Interview questions  
 
Notes. Ext event = influential external events during the intervention.  Ax/ formulation = assessment and formulation 




Thematic map of changes due to the two-phase psychological intervention 
 
 
Safe space. All seven participants spoke of experiences related to having a safe 
space, captured within the two subthemes validation and affirmation and being part 
of a group. 
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Validation and affirmation. Six participants spoke of experiencing validation of 
their FND experiences or affirmation of their understanding of FND, which is illustrated 
in the following quotes: 
“through the sessions, I have realised that, no, this is something that is really going 
on in my brain … I can’t control this, and at the moment it is controlling me. . .” 
(P1) 
“[psychologist] said things that I needed to hear. . .” (P4) 
 “I have had the FND for so long. . . knowing what I understand about my 
condition and then speaking to a clinical psychologist in relation to my condition, 
and that what I understood was actually correct helped. It makes you feel a bit 
better, especially when you have been talking to people who do not know what they 
are on about” (P2) 
The six participants described how this validation and affirmation led to feeling 
understood, contrasted with previous experiences of feeling misunderstood or not 
believed or even abandoned, both by professionals and family, as captured in the 
following excerpts: 
“I have been taken to A&E a few times, and the Doctors don’t have a clue what to 
do, they put you through scans that you don’t need and don’t know what you are 
saying. . . [family member] didn’t get it, she was saying well if you sit down, it will 
hurt more, and she wasn’t getting it, she didn’t understand how it felt” (P5) 
“it has been such a difficult path to finding out what is wrong with me… I feel like 
no one believed me for a long time…” (P6) 
“I have been made to feel very let down by Doctors in the past, and sometimes, erm 
I feel if I go to a doctor, everything is blamed on the FND, but you are allowed to 
have other illnesses, alongside FND” (P2) 
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 “trying to explain NEAD to your employer is embarrassing, it is degrading, 
because a lot of people just think, oh you are making this up, or oh you are just a 
little bit dramatic. . . patients suffering from FND symptoms do feel like they have 
just been abandoned and left to their own devices and that is tough… whereas if it 
was a cancer treatment, we know that there is a step by step pathway for cancer 
treatment, but then with FND sometimes there is not a clear pathway” (P1) 
One participant who attended individual sessions (Phase 1) described how the 
experience of validation and affirmation supported a process of de-stigmatisation of 
FND that helped them process their diagnosis: 
“The name dissociative seizures, I absolutely hate that term because of the stigma 
that it has with mental health. . . when I was first diagnosed, I thought oh God it is 
due to my mental health. . . [symptoms] are not a sign of weakness and not a sign of 
stress… I had previously been told that it was stress, but actually, there were 
multiple factors there in the background… for me, it was just a revelation and it 
helped me process my diagnosis” (P1) 
Having a safe space where people experienced validation and affirmation was 
described by four participants as enabling them to ask questions and express 
themselves. For example:  
“being able to ask questions, you know, every week I would go in, and sometimes I 
would feel really stupid asking a question, but actually it was really reassuring that 
other people have asked these questions as well, and other people have experienced 
that.  . . just to have that sounding board and having someone non-judgemental, oh 
it was just incredible you know… For all the times that she listened and explained. . 
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. for me it was just what I needed, a safe space, an opportunity to ask questions, an 
opportunity to learn, and an opportunity to express how it is affecting me” (P1) 
“It was really helpful because erm [psychologist] was really nice, she sat and 
listened . . . [psychologist] was good, very easy to speak too, she made you feel at 
ease” (P3) 
Social belonging. The three participants who attended the ACT group spoke of 
specific benefits related to being part of a group with others experiencing FND, such as 
creating supportive connections through their interactions with others, which lasted 
beyond the group itself, illustrated in the following quotes: 
“I have enjoyed the group, normally I would not go out and interact with people 
that I do not generally know. . . but with the regularity with coming to the group 
every week you kind of got to know them, so you opened up a little bit more, and at 
the end, those of us that were left have exchanged numbers and set up a WhatsApp 
group” (P7) 
“You do not feel so alone. . . meeting other people as well and being able to keep in 
touch with them helps” (P5) 
“been able to meet other people and have support… that connection has been 
important. . . it has helped me be kinder on myself and feel more supported. . .  we 
have a WhatsApp group, and we message regularly in that” (P6) 
These participants linked these supportive connections to receiving 
encouragement that supported them in creating change: 
“we are keeping each other’s spirits up. And you know, make sure everything is 
okay . . . we are constantly priming each other with other tools that we can use. . .” 
(P7) 
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“it has been nice having the WhatsApp group and having people who understand 
what you are experiencing encouraging you... as well being able to encourage 
others. . . we message ideas from the group and encourage each other…” (P6) 
“…there was a little task for each week that kind of pushed me to go out and into 
the supermarket because I thought right by the next time I go, I want to be able to 
tell everybody that I have done it, and that kind of push, erm, felt like what I needed 
really. . . having other people that maybe makes you a bit braver I think” (P5) 
Linked with a sense of social belonging, all three participants in the ACT group 
described feeling understood by peers and less alone: 
“they may not have the exact same thing as you. . . but they have an understanding 
of what you are going through, so it is easier to discuss with them” (P7) 
“When I told the group. . . because they have had the same pain, so they were like 
oh well why don’t you try this and try doing different things, and it was just having 
someone there who gets it. . . I think the biggest part that I have got from the 
session is meeting people with, erm, the same thing” (P5) 
“it can be difficult to explain to people what functional neurological symptoms 
mean to others, but we have all had a shared understanding of what it is, and it was 
good. . . the group has helped me feel like it is not just me” (P6) 
Increased understanding. Six participants spoke of experiencing increased 
understanding, linked to increased understanding of FND, greater self-awareness and 
learning new skills. 
Understanding of FND. Five participants described having a limited 
understanding of FND before the intervention. They found it helpful to gain an 
increased understanding, which is captured in the following quote: 
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“Before coming to the group, I had a limited idea of what FND was, what my 
condition was, and what it was doing to me. So, in the first lesson introduction of 
what is FND, it made me want to learn more about my condition, rather than walk 
away from it not knowing. . . by getting to grips with the condition, your anxieties 
move and start to dissipated” (P7) 
One participant described understanding FND better through a computer 
analogy: 
“I understand it a lot more. . . it did help you know, so many years with this disease 
and not knowing what it was. . . she explained your brain is like a computer. . . and 
things come to you, and it comes crashing… it is like the information in my brain is 
hard. . . so maybe my software is triggering the computer in my head” (P4) 
Another participant attending individual sessions described the ‘window of 
tolerance’ helpful in understanding FND: 
“she [psychologist] was good, and she was able to say you know people with 
different characteristic traits or different experiences are more likely [to have 
FND]… and I think the thing for me that was most significant for me was 
understanding the window of tolerance, and just having that kind of awareness of 
yourself is just, I mean, it was really, really helpful” (P1) 
This participant also described how through being able to understand their 
diagnosis, they were more able to talk to others about their diagnosis: 
“being able to educate my friends and family has made me feel like actually… do 
you know what I can trust these people to tell them, I can tell this is why what is 
going on and not to panic. . . understanding and being able to explain to people has 
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been a really big transformation for me because my friends and family have never 
heard of it” (P1) 
Greater self-awareness. Three out of the four participants who attended the 
assessment and formulation sessions spoke explicitly of gaining greater self-awareness, 
which included increased recognition of emotions and the role of life history. For 
example, one participant explained: 
“when [psychologist] explained it, it made it obvious that actually… in your 
subconscious, you can be stressed without realising that you are stressing and that 
is what I was struggling with” (P1) 
All four participants who attended Phase 1 spoke of experiencing a range of long-
term and acute stressors, for example: 
“it helped… because we have gone through a lot in the past twenty years my 
family, we have not seemed to have a break” (P2)  
“I have just been born into a challenging life after I got to a certain age, and that is 
just what I feel like it is one big challenge… sometimes I beat the challenge, and 
sometimes I don’t… we are not all winners” (P3) 
Two participants described their experiences of talking about their life history, 
including experiences of trauma and adversity as a painful experience, but helpful in 
creating awareness, illustrated below: 
“We talked about some of my history. . . how something that affects you as a child, 
could be symptomatic of what goes on in your subconscious now, I erm was 
abused. . . and nobody knew about it. . . I feel relieved that I was able to say it out 
loud” (P2) 
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 “I just did not want to associate any of this, my current circumstances with the 
past, so that was a tough realisation I guess. . . it gives me a focus for the future, so 
although it is negative, as it was difficult and painful, you know it is better than not 
having a realisation” (P1) 
New skills. All participants who experienced changes, in part, attributed this to the 
learning of new skills: 
“I have got some techniques to use, so now I am thinking right, I will try to go out 
with that meal with friends. I will try it because I have back up and from the things 
I have learnt” (P5) 
“By coming to the group, it keeps the routine going, but also giving us new tools to 
work with and help with putting those tools into practice” (P7)  
These new skills included mindfulness, breathing, defusion, choice point and the 
identification of values.  Participants spoke of finding different combinations of these 
skills helpful, for example: 
“Most helpful things is the techniques, so like the mindfulness, breathing and the 
choice point. . . so like giving you the ideas of how to help yourself, and more 
positive thinking” (P5) 
The most common skills spoken about was mindfulness and breathing 
techniques, where everyone who discussed these techniques described experiencing 
benefits, for example:  
“I guess that breathing and mindfulness has helped me. . . just giving myself time. . 
. those activities have helped me decide on not going back to work. . . practising the 
mindfulness exercises has given me a new perspective” (P6) 
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All three participants who attended the ACT group spoke of using cognitive 
defusion techniques, which contributed to changes in thought processes, illustrated 
below: 
“it is by giving us the tools to do the changes to the thought process, you know it 
was not expected at all. . . the thing that I tend to use a lot is the leaves on the 
streams. . . with leaves on the stream I find I am able to take control of my own 
thoughts” (P7) 
“with everything that is going on, I feel more able not to get caught up with it and 
hooked into the thoughts. . . so the leaves on the stream has helped me to get a little 
less caught up with all the stress” (P6) 
“I found it a bit childish. . . you know your brain is constantly active all the time 
and then to turn around to it and say thank you it seems a bit strange. . . but it 
helps” (P5) 
These three participants who attended the ACT group also described the benefits 
of using choice point and connecting with their values: 
“Working on the values of what is important to you. . . I still have not managed to 
get my independence back to going out on my own, but it is something that I have 
been working towards” (P7) 
 “choice point has been helpful… it has helped me think about what I can do next. . 
. it has helped me think about what really matters” (P6) 
“the choice point really stands out to me as something that was useful in being able 
to take a step back and think about what matters…” (P5) 
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New ways of thinking. Six participants spoke of experiencing new ways of 
thinking. These changes are captured within the four subthemes relating to thoughts, 
increased coping, acceptance and being kinder to self. 
Relating to thoughts. Five participants described how changes in managing their 
thoughts led to different perspectives, for example: 
“just like a different perspective. . . it has made me stop and think about it properly 
and what I am going to get out of it, as well as thinking more about the positive side 
of it” (P5) 
Another participant described feeling able to see the bigger picture and unhooking 
from difficult thoughts: 
“I find it has helped me think about things a bit differently… I guess to see a bigger 
picture and not just keep on doing the same old thing.  I feel more able not to get 
caught up with it and hooked into the thoughts. . .” (P6) 
While another participant described more easily dismissing thoughts: 
“One thing that changed for me is my thought process. . . now when I get a thought, 
I will quickly think it through and then just kind off, yeah thanks, I do not need to 
dwell on that one. . . dismissing the thoughts. . .  it is like there is a barrier and they 
are not getting in” (P7) 
Increased coping. Six participants also described experiencing increased coping, 
which was related but distinct to managing thoughts. For four participants, this 
increased coping included being better able to manage emotions, for example: 
“mood-wise, I think I am managing to manage it a bit better” (P5) 
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“instead of you know letting it all get on top of you, instead of smothering it, I let it 
[emotions] out” (P4) 
Two of these participants described being able to use grounding to manage their 
emotions better: 
“I struggled so much… she was dropping anchor with me, and I just felt much 
better” (P4) 
“panic. . . it will be a case of okay I will try to throw it out, even though I can feel 
my heart rate increasing, it is like I am not focusing on a specific thought and 
allowing myself to continue with what I do” (P7) 
Alongside feeling better able to manage emotions and using grounding, six 
participants spoke of being able to cope and manage stressful situations more 
effectively, illustrated below: 
“without the change in the thought process, I would not be able to cope with as 
much or manage situations as easily. . . the group helped more along the lines of 
anxiety and how to cope with stressful situations. . . I would not be able to cope 
with as much or manage situations as easily” (P7) 
“I am about to finish one of my jobs to see if that helps. . .” (P3) 
Three participants described being able to go more out more easily, for example: 
“It is getting better. I am finding it easier to go out” (P7) 
“I have been able to walk to the supermarket on my own. . . I pushed it, did it, felt 
proud of myself, and it has given me more of that, well, if I do push myself a bit, I 
could build up to more different things. . . I have been able to go out for a walk by 
myself, which I was not able to do before” (P5) 
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This change was particularly significant for one participant, who explained: 
“before sessions, I became quite recluse. . . I was frightened, I would have a 
seizure or that they would judge me, or that I was just faking it. . . I am a chatty 
person, and I am outgoing, and it was really hard to drop what I considered was 
my normal life” (P1) 
Another participant described going out following individual sessions despite their 
fear: 
“I am still scared… it is always weird and at the back of your mind… if I go 
shopping or anywhere by myself it is always there, am I going to have one” (P5) 
Acceptance. Another facet related to participants' descriptions of new ways of 
thinking was accepting both the diagnosis and emotions. Acceptance of diagnosis led to 
changes in work for two participants. Three participants who attended Phase 1 described 
struggling to accept their diagnosis: 
“I would not accept that I had FND... you know I have been fighting through the 
hospital for years” (P4) 
Another participant explained that they were still unsure of whether they had the 
diagnosis: 
“she [psychologist] is going to see if the neurologist can fit me it… to explain… It 
was one of his juniors, and they could not wait to get rid of me” (P3) 
For two participants, difficulties in accepting their diagnosis were linked to 
negative rumination related to the lack of control, uncertainty and unpredictability of 
their symptoms, for example: 
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“I would feel one day fine for a few days, and then it all comes crashing down 
again. . .  I did not want it, you know. . . I was always fighting, and I am still 
confused, why am I feeling this pain – is it this, is it that, and my head goes a little 
bit, so I question myself. . . I don’t know if it is me doing it, don’t know if I 
overthink because I do not want to be in pain” (P4) 
“emotionally it is quite a difficult to cope with... you know it is a frightening thing, 
and for a person that likes to be in control and come across as got together, it is a 
horrible thing to experience. . . I really like to be in control and have a plan, and I 
am very independent… not being able to drive, that is the hardest thing I think… 
because that was my coping mechanism driving” (P1) 
Three participants described how assessment and formulations sessions helped 
them to accept or be more open to an FND diagnosis: 
“Something had to switch inside me, erm, because I had to break that wall down 
before I could understand what was going on. . . when I first came in, I was in 
denial, and I think I went from denial into acceptance. . . I think the work has to 
come from me, which I think is what I have gathered from the sessions. . . I realised 
that I had to do the work, so I have to maybe give a change to my lifestyle or the 
way that I see the diagnosis” (P1) 
Similarly, one participant also spoke of sessions helping them accept their 
emotions: 
“I would not admit to my anxiety… but she got me to understand things” (P4) 
While another participant spoke of sessions helping them accept change: 
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“I do not like change a lot. . . I want everything back to the way it was, but I 
cannot… it is like keeping the memories alive, you got to let it go, but it is hard” 
(P3) 
Three participants described how increased acceptance was linked to stopping 
work, as illustrated below: 
“I push myself too much, and I know I got to stop… I know I have . . . It is tiring, it 
is time for me to resign now. . . I just cannot get it, you know why, it is just a four-
hour job, and I just cannot do it” (P4) 
“It feels like a huge shift for me in accepting that I can no longer work rather than 
fighting against it. . . I kept fighting to get back to what I was doing… but it was 
making me ill. I was going to work feeling in pain, and I was wiped out when I got 
home. . . this group has helped me to think about it and come to a decision… why 
would I go back to work and make myself unwell again?” (P6) 
Increased self-compassion. The final subtheme related to new ways of thinking 
was increased self-compassion. Five participants described being kinder to themselves 
by slowing down, having more time to themselves, and putting themselves first. 
Examples of different ways participants’ described increased self-compassion included: 
“You are rushing about, and you haven’t got a minute. . . now I think, no slow 
down and take your time. . . it does affect your health and that, yeah I was very 
surprised by that. . . she said no you need to take time out. . . take more time to 
relax and take care of me, which I have started doing. . . I found her very helpful. 
She started making me think on the one to ones, yeah bugger it, I do not care what 
they say now, it is my time, I need my time and that, so yeah, I have started doing 
that” (P3) 
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“you know, she taught me about how-to self-care. . . that works a hell of a lot” (P4) 
“one of the main changes I have made is slowing down and giving myself 
permission to slow down. . . rather than doing things. . . I am kinder to myself…” 
(P6) 
3.4 Discussion 
Overview. This study used multiple data sources to evaluate the impact of a 
two-phase psychological intervention for FND. This was explored in terms of changes 
in standardised and target measures and interviews of participant’s experiences of the 
intervention. First, the findings regarding the change in Phase 1 (assessment and 
formulation) are outlined and discussed, followed by a discussion of Phase 2 (ACT 
group) findings. Here, pre and post-data and SCED data are described in relation to the 
Change Interviews. These findings are then explored using Elliot’s (2002) hermeneutic 
single-case design (HSCED) and considered in the context of relevant literature and the 
limitations and strengths of the study. Next, the findings from the Thematic Analysis of 
the Change Interview data will be summarised, and findings related to similar literature. 
The limitations and strengths of this approach are also presented. Finally, the scoping 
review findings on third-wave CBT interventions for FND and the multiple data sources 
from the two-phase psychological interventions are considered together. This summary 
is followed by consideration of the overall implications of this thesis, including clinical 
and research implications. 
3.4.1 Phase 1 findings 
The impact of the assessment and formulation was explored through pre and post-
standardised outcomes measures for three participants, alongside four participants’ 
qualitative accounts of their experiences of this intervention and perceived therapeutic 
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change. Pre and post-change findings are now discussed regarding the two hypotheses 
made about the expected changes after assessment and formulation. Relevant Change 
Interview data is also considered.  
First, it was hypothesised that reliable and clinically significant improvement 
would be observed for standardised distress, symptom interference and QoL measures. 
However, results disconfirmed this, with one participant (P1) experiencing 
improvements in distress measures and two experiencing worsening (P2 and P3). Two 
participants (P1 and P3) also experienced significant clinical worsening for symptom 
interference, and two participants (P2 and P3) experienced a reduction in overall health 
status. 
Participants’ qualitative accounts perhaps help provide context for these findings. 
The two participants who experienced worsening in distress measures described 
exploring historical trauma, losses and judgment linked to their FND experiences within 
the context of feeling understood by the clinician. Literature on patients' psychological 
assessment and formulation experiences indicates that people can gain increased 
awareness and understanding of their difficulties, feel understood and accepted and gain 
a sense of relief. However, this process of increased awareness can have implications 
for a person's sense of identity, which can cause distress (Redhead et al.'s, 2015) and 
perhaps this contributed to the worsening distress measures for two participants. 
During assessment and formulation, the participants’ FND illness beliefs were 
explored, and information on FND and its treatment was provided. Accordingly, it was 
hypothesised that there would be reductions in threatening illness representations. Here, 
findings were mixed, with two participants (P1 and P3) experiencing an overall 
decrease in threatening illness perceptions—related to an increased understanding of 
FND and a belief that treatment could help. In contrast, another participant (P2) 
experienced increased threatening illness representation related to an increased 
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perception of the consequences and emotional impact of FND, alongside an increase in 
distress measures. This participant had their FND diagnosis significantly longer than 
other participants and was the only participant who experienced reliable and clinically 
significant emotion processing improvement. It may have been that improvements in 
emotion processing and perhaps reduced experiential avoidance came at the cost of 
increasing distress.  
Overall, for assessment and formulation, changes in standardised outcome 
measures were unexpected and included worsening overall health status, symptom 
interference and distress measures for two participants and increased threatening illness 
perceptions for one. However, participants reported positive experiences of the sessions 
and experiencing therapeutic changes attributable to the intervention. For example, 
some participants described receiving validation and affirmation and having the 
opportunity to ask questions and express themselves, which enabled an increased 
understanding and acceptance of FND, greater self-awareness, increased self-
compassion, and better stress management.  
3.4.2 Phase 2 findings 
The ACT group's impact was explored for three participants who completed pre 
and post-standardised outcomes measures, a daily survey and a qualitative Change 
Interview on the experiences and perceived therapeutic change. The pre and post-
change findings are presented, followed by SCED findings explored further through 
hermeneutic single-case efficacy design (HSCED; 2002), which explores these 
quantitative measures alongside the Change Interview. 
Pre and post-change findings. For the ACT group (Phase 2), it was also 
hypothesised that reliable and clinically significant improvement would be observed for 
distress, symptom interference and QoL measures following. Again, the findings were 
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unexpected. There was a lack of change for several standardised measures across 
participants. Only one participant (P5) experienced reliable and clinically significant 
improvements in distress measures. There was an unexpected reliable and clinically 
significant worsening in symptom interference for another participant (P7). This 
participant reported experiencing “a lot more brain fog” following the group, which 
they compared to the side effect of medication. 
The fourth hypothesis anticipated that there would be reliable and clinically 
significant improvements in emotion processing and psychological flexibility measures 
associated with improvements in distress, symptom interference, QoL measures, and 
greater use of ACT processes. This hypothesis held only partly true for one participant 
(P5), who experienced reliable and clinically significant improvements in emotion 
processing and distress measures and a reliable improvement in psychological 
flexibility. However, the other two participants experienced a worsening in emotion 
processing and no change in distress, and one participant (P7) experienced a reliable and 
clinically significant worsening in symptom interference but a reliable significant 
improvement in psychological flexibility. No associations were found between the use 
of ACT processes and other measures. The measure of psychological flexibility showed 
reliable improvement for two out of three participants (P5 and P7), linked only to the 
'valued action' subscale, reflecting the ACT group’s focus on increasing value-
orientated behaviour. 
SCED findings. The ACT group SCED collected a daily survey of participants’ 
FND symptom severity, interference and distress, and ACT processes. This allowed 
testing of the final hypothesis made – daily FND experiences of symptom severity, 
interference and distress would improve as the ACT group progresses. Again, this was 
disconfirmed. Although data completion levels were problematic, two participants 
completed approximately 50% of daily surveys, compared to a third participant’s almost 
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full data completion (P7). This participant also reported the most consistent use of ACT 
processes across the intervention.  A visual summary of their data revealed a slight 
worsening across FND experiences as the intervention progressed. There was no change 
in measures other than a reliable and clinically significant worsening in symptom 
inference and emotion processing and significant clinical improvement in psychological 
flexibility. 
For the two participants with approximately 50% adherence to the daily survey, 
one participant’s (P5) results showed a trend indicating improved FND experiences, 
particularly for distress. This finding was associated with reliable and clinically 
significant improvements in distress, psychological flexibility and emotion processing 
measures, but not increased ACT processes. The final participant’s (P6) daily survey 
revealed a lack of change in FND experiences, with symptom severity, interference and 
distress appearing unchanged and largely indistinguishable. This participant 
experienced no reliable or clinically significant changes in measures, although there was 
a trend of worsening in distress, symptom inference and psychological flexibility 
measures. They reported using more ACT processes than P5. In the next section, these 
unexpected findings from the SCED are explored further using Elliott's hermeneutic 
single-case efficacy design (HSCED; 2002). 
Elliott’s hermeneutic single-case design. Elliott's approach is now presented to 
evaluate the ACT group's findings and explore links between the intervention and 
outcomes. The method applies scientific rigour to examine factors within and outside of 
the intervention to explain observed changes and consider a lack of change or 
worsening through the standardised outcome measures and qualitative data. The starting 
point of the HSCED is to identify evidence behind the intervention being the primary 
cause of change (Elliott, 2002). This involves establishing clear links between the 
therapy process and outcomes by asking participants what caused changes and how 
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likely these would have occurred without the intervention (i.e. Change Interviews). 
Next, if possible, the intervention stages are mapped to outcomes to identify any early 
change in stable problems following the intervention's introduction. This is followed by 
an analysis of process measures and comparing them with target and standard outcome 
measures.  
Evaluating evidence that the intervention caused changes.  
Retrospective attribution. All three group participants reported multiple changes 
following the intervention during the Change Interview process that were rated as 
unlikely to have happened without the intervention. They all attributed these changes to 
being 'Very likely' due to the intervention and spontaneously attributed changes to 
specific intervention components. For example: 
Participant 5: "I have noticed a change because of different things really… like the 
 different things they taught us in the sessions... I have been using that 
 when out and about" 
Participant 6: "Breathing and mindfulness exercises have helped me slow down (...) 
 leaves on the stream has helped me get a little less caught up with all the 
 stress (...) has helped me think about things differently." 
Participant 7: "Gives new tools to work with and put these tools into practice and maybe 
 linking a couple of those tools together. So for me thanking the thoughts, 
 I never really got the gist of it or understood it fully, but if you kind of 
work it in with leaves on the stream, for example, every time you see the 
thought, you can say thank you, and put it on the leaf and allow it to go." 
All three participants also attributed the changes that they had experienced to 
gaining a sense of peer affiliation: 
Participant 5: " having other people that maybe makes you a bit braver." 
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Participant 6: "having others to talk to has helped. It has helped me be kinder on 
 myself and feel more supported." 
As well as an increased sense of routine: 
Participant 7: "normally, I would not go out and interact with people that I do not  know 
 well, but with the regularity of coming to the group each week (...) I felt 
 more relaxed around people (...) got that routine which is something that 
 I now kind of need." 
Overall, support for intervention effectiveness is found for each participant. 
Change Interview comments linked changes to the group’s specific components, 
meeting others and gaining a routine. 
Outcome to process mapping. Participants linked changes to specific intervention 
processes and events. However, the symptom interference outcome measure (WSAS) 
directly linked to FND experiences revealed no change. The psychological flexibility 
measure revealed clinically significant improvement for participant 5 and participant 7 
due to changes in the ‘Valued action’ subscale. There were also reliable but not 
clinically significant improvements in distress measures for participant 5. 
Process to outcome mapping. Data from the daily survey (FND symptom 
severity, interference and distress) was graphically displayed to map any changes 
following the introduction of different weekly ACT components. Participant 5 and 
participant 6 only had 50% adherence to the daily surveys weighted towards the 
intervention's front end, making it impossible to identify whether changes in FND 
experiences corresponded to specific intervention events and processes. Participant 7 
had almost full adherence to the daily survey, but there was no evidence of FND 
experience changes related to intervention events and processes found. 
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Early change in stable problems. Change can be attributed to the intervention 
when it coincides with a shift in long-standing difficulties compared to baseline. 
Unfortunately, multiple baseline measures were not available. Subsequently, it was not 
possible to assess for early change in stable problems. There was evidence that FND 
was chronic for all participants, with symptoms varying between 2 to 8 years. 
Event-shift sequences. It is assumed that important events should precede a stable 
shift in participants' target problems during the intervention. This pattern was not 
observed in participant 6 and participant 7. There was evidence of shifting patterns in 
participant 5's target measures. However, important missing data and high variability 
during the second half of the group made it impossible to link changes to specific 
intervention components. 
Evaluating non-treatment explanations for change 
Non-improvement or trivial change. Where possible, the RCI was calculated for 
measures to ensure a reliable and clinically significant change. Participant 5 experienced 
reliable and clinically significant improvement in distress and emotion processing 
measures. Participant 5 and participant 7 experienced a reliable improvement in 
psychological flexibility, and participant 7 also experienced QoL measure improvement.  
Overall, there is minimal evidence for reliable and clinically significant change 
other than psychological flexibility improvement for participant 5 and 7 and 
improvement on distress and emotion processing measures for participant 5. These 
findings were at odds with the participant’s Change Interview, which indicated 
important changes. 
Negative changes. The only reliable and clinically significant worsening following 
the ACT group was reported by participant 7 on symptom interference (WSAS 
measure), which was described in their Change Interview: 
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Participant 7: "more clouded, a lot more brain fog, so I will have moments where I 
 will dissociate, and it feels like my head’s all fuzzy". 
They attributed this worsening to a ‘side-effect’ of the group due to:  
"thinking too hard".  
Participant 7 also experienced a reliable worsening on the emotional processing 
scale post-intervention, which was perhaps impacted by the adverse ‘side effects’ they 
reported experiencing. Notably, participant 6’s emotional processing scale remained 
unchanged post-intervention but indicated a reliable worsening at one-month follow-up, 
which fitted with an overall worsening across measures for this participant. 
Relational artefacts. Relational artefacts were considered as a potential 
explanation for the changes reported in the Change Interview. First, data was analysed 
for evidence of the 'hello-goodbye' effect. This effect describes a tendency to emphasise 
distress at the start of the intervention to justify the need for treatment and is followed 
by an exaggeration of improvement at discharge, to show gratitude or justify the wish to 
end therapy (Elliott, 2002). Additionally, the interviews were explored for evidence of 
any participants failing to disclose any difficulties or disappointments with the 
intervention due to social desirability (Gale, 2000).  
Change Interviews were conducted by a researcher rather than clinicians, which 
enhanced validity. During the Change Interview, all participants commented on both 
positive and negative aspects of the intervention. There was no dynamic of wanting to 
please the researcher evident. Additionally, participants' answers about specific factors 
within the intervention were full of personal detail. Based on the detailed, differentiated 
nature of the qualitative data, it did not appear that participants reported changes during 
the Change Interview or within the outcomes that were inflated. 
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Expectancy artefacts. Another source of bias in attributing the change to 
interventions is participants' expectations or wishful thinking. However, none of the 
participants' comments indicated this being present. On the contrary, a couple of 
participants commented on their unfulfilled expectations or lack of expectations. For 
example, participant 7 said:  
"I am going through physio at the moment because, erm, my walking is not as 
 good (...) I kind of expected my walking to have improved slightly, but it has not 
 (...) before I was diagnosed with FND, I was diagnosed with psychogenic 
 amnesia, so I was hoping for improvement with my memory too." 
While participant 6 explained:  
"I did not really know what to expect from the group, so I did not have any 
 expectations of what would happen, erm, sounds strange but because I did not 
 know what it was for really." 
Overall, there is no evidence that expectancy artefacts could explain changes in 
participants. 
Self-correction. Several factors were considered to evaluate whether participants' 
self-help efforts, natural maturational process or spontaneous recovery caused changes. 
During the Change Interview, participants were asked what changes they noticed and 
how likely they would have occurred without treatment. Participants reported changes 
following the intervention and rated the changes as 'Very unlikely' or 'Somewhat 
unlikely' without the intervention, except for participant 5's change related to managing 
their anxiety, rated as 'Somewhat expected'. Unfortunately, with no baseline measure, it 
was impossible to identify pre-intervention trends that might suggest self-correction 
artefacts. 
Extra-therapy life events. Factors outside of the intervention, including changes in 
relationships, social activities, or work that may have contributed to or negatively 
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affected outcomes, were considered. Participant 5's improvements in measures could, in 
part, be attributed to extra-therapy life events related to moving into a less stressful 
home environment. Participant 6's lack of improvement and a slight worsening in some 
measures may have been partially attributed to significant life stresses, including 
bereavement and ill-health. 
Psychobiological causes. Improvement or worsening in study participants can be 
explained by biological changes, such as medication regime changes, hormonal 
processes, and health changes. Participant 6 missed two consecutive group sessions due 
to ill health. Participants 5 and 7 described experiencing significant difficulties with 
anxiety, while participant 7 also described re-occurring episodes of low mood. These 
factors may have impacted the improvements experienced by participant 5 or the lack of 
change for participant 6 and participant 7. 
Reactive effects of participating in research. Another common artefact involves 
changes attributed to the sole fact that an individual participated in the research, which 
can create either negative or positive effects on outcomes (Elliott, 2002). Moreover, an 
adverse impact on outcomes can emerge if the procedure is perceived as too 
bothersome. In contrast, positive effects on outcomes can occur through the sense of 
altruism felt by research participants ('being able to help others') and the rapport with 
the researcher. Participants were attending the group as part of routine care but had 
agreed to complete an additional daily survey. There was a low adherence rate for daily 
surveys for two participants. Participant 7 described frustration with the daily survey:  
 "I found the questions rather plain (...) I really did expect it to be maybe ten 
questions or, erm, I do not know more in-depth questioning (…) it felt like 
there was not much thought put into the questions."  
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Participant 7's adverse experience of the daily survey may have been a factor 
behind the slight worsening over time on this measure. It may have also contributed to 
the low adherence to the daily survey for participant 5 and participant 6. 
Summary and conclusions of HSCED critical analysis. The final step of the 
HSCED is a summary of positive and negative evidence to decide whether or not any 
changes were observed and whether this could be attributed to the intervention. HSCED 
standards require replication of positive evidence across two out of five direct evidence 
types (e.g. retrospective attribution, outcome-process mapping, process-outcome 
mapping, early changes in stable problems, and events-shift sequences). This evidence 
was only established for participant 5, who had an incomplete data set for the daily 
survey and reported important positive extra-therapy life events. However, the SCED 
analysis suggests that this alone could not have accounted for their observed changes 
and suggests that change for participant 5 resulted from the intervention. For participant 
6 and participant 7, other non-therapy explanations may have contributed to the lack of 
change and worsening for some standardised measures. Unfortunately, the lack of data 
collection across baseline measures and incomplete data hampers any further 
conclusions being drawn. 
Overall, therapeutic change was not captured by the pre and post-standardised 
outcome measures, which included some lack of change and worsening. This was 
unexpected and juxtaposed to participants’ descriptions of change directly linked to the 
intervention, such as feeling better able to manage distress, thought processes, feeling 
less alone, slowing down and putting themselves first. Notably, the lack of change and 
some worsening on standardised measures for the ACT group also contrasts with the 
limited literature on third-wave CBT interventions, which, while characterised by small 
samples and low quality, have found changes across various standardised outcome 
measures similar to those used in this work. For example, in the only SCED that 
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explored a six-week self-help ACT intervention for NEAD participants, Barrett-Naylor 
et al. (2018) found improvements in distress, symptom interference and psychological 
flexibility measures. The only other studies to explore an ACT intervention and FND 
are Graham et al. (2017, 2018). These studies used a single-case study and a concurrent 
single-case series to examine the impact of an ACT intervention on symptom 
interference, distress and psychological flexibility measures, and again improvements 
were found across measures for most patients.  
These unexpected findings will be explored further in ‘Limitations’ – Section 
3.4.5. Next, the limitations and strengths of the quantitative methods used are outlined. 
This will be followed by a deeper exploration of the qualitative findings and limitations 
and strengths of this approach before summarising the multiple sources and discussing 
the findings collectively.  
Limitations and strengths of the quantitative approach. There are several 
significant limitations to the pre and post-design and SCED. It was planned that pre and 
post-standardised measures collected for Phase 1 would be collected for the same 
participants in Phase 2. However, no participants contributed to both data sets. 
Consequently, it was impossible to track change across the intervention phases to 
explore how changes evolved. This was due to a lack of clinician adherence with the 
collection of routine clinical measures rather than due to participants not consenting.  
The lack of outcome data also meant that the anticipated baseline measures for the 
ACT group SCED were not available, reducing the level of control over confounding 
variables. It was expected that data from participants attending a second ACT group 
would have mitigated against this and would have provided data for participants who 
attended both phases.  
There was low adherence by participants in the SCED daily survey. Two out of 
three participants completed this measure at approximately a 50% level. Only one 
- 151 - 
 
participant completed one-month follow-up measures. The lack of data completion 
across the SCED participants limited the interpretation of the results and the 
conclusions drawn.  
The daily survey attempted to capture FND symptom severity, interference and 
distress as three distinct concepts, but one participant did not distinguish between these 
measurements, making it unclear what the daily survey was capturing. The daily survey 
was kept brief, and sessional measures were not used in order to reduce the 
burdensomeness. However, more frequent data would have been beneficial in providing 
more meaningful analysis.  
In hindsight, within the design, there was a lack of data regarding patient 
characteristics that may have impacted change. Formal recording of participant factors 
such as medication, other concurrent therapeutic inputs (e.g. physiotherapy and 
occupational therapy), and explicit checking of comorbidity and a rating of FND 
severity and acceptance of diagnosis would have provided useful contextual information 
to interpret the results.  
Despite these limitations, the study had some important strengths. For example, 
the use of SCED allowed detailed observation of individuals’ FND experiences and 
their use of ACT processes that could then be linked to various outcomes. The use of 
SCED exploring ACT for FND has only been carried out in one other study, which used 
a guided self-help format and recruited NEAD volunteers from a social media site 
(Barrett-Naylor et al., 2018). However, an advantage of the current study was the use of 
clinical populations within a clinical context. Also, changes in assessment and 
formulation were explored at the individual level rather than using group statistics, 
which provided a more meaningful exploration of this unexpectedly small data set.  
Change Interviews were carried out by an independent researcher, reducing bias 
and enabling group participants to voice their intervention and change experiences. 
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Published studies of third-wave CBT interventions for FND have overlooked this 
important source of data. In this research, the Change Interviews provided a richer 
understanding of SCED data not captured by standardised outcome measures. Finally, 
measurement of the fidelity in the ACT group was attempted. Although carried out by 
the facilitators, there were two clinicians, potentially increasing reliability.   
Summary of the pre and post-design and SCED findings. The quantitative 
results indicated some lack of change and worsening, which was hard to reconcile with 
the broader literature on third-wave CBT for FND. Several factors may have 
contributed to the limited findings, including the time and type of measurement used, a 
lack of diagnosis acceptance and a lack of intervention effectiveness. These findings' 
clinical and research implications will be explored in the ‘implications’ – Section 3.4.6. 
Next, the qualitative results are discussed. As has been touched upon, the Change 
Interview findings were at odds with the quantitative findings and provided a rich 
account of participants' experience of the intervention and change, which will now be 
discussed. 
3.4.3 Change Interview findings  
A thematic analysis of participants’ Change Interviews based on either their 
experiences of assessment and formulation sessions or the ACT group was carried out. 
This analysis revealed shared themes across each phase. All participants spoke of 
experiencing a safe space through validation and affirmation and the ACT group's social 
belonging. Several described how these experiences contrasted with previous 
experiences of feeling misunderstood or not believed by Health Care Professionals 
(HCPs) and family members. Participants’ descriptions of feeling misunderstood by 
HCPs mirrors qualitative research exploring the experiences of people with FND, where 
many patients felt most HCPs misunderstood their difficulties and lacked confidence in 
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the HCP’s ability to help (Nielsen et al., 2019). Some of the current participants 
described experiencing a corrective experience of validation and affirmation that 
enabled them to ask questions and express themselves, which helped them process their 
diagnosis. The importance of sharing and feeling understood in participants’ 
understanding of their FND diagnosis echoes previous work (Gerskowitch et al., 2015; 
Nielsen et al., 2019). 
Previous work has found patients with FND can experience marginalisation, 
which may contribute to the emotional burden of the diagnosis and be a source of 
significant distress (Nielsen et al., 2019) and a longing for social recognition (Lind et 
al., 2014). Participants who attended the ACT group spoke of specific benefits formed 
through the group's social belonging that led to feeling understood and less alone, 
alongside creating supportive connections and receiving encouragement. This 
experience mirrors that of patients diagnosed with a somatoform disorder who attended 
a mindfulness group and described experiencing positive feelings of social belonging 
and reduced loneliness (Lind et al., 2014).  
All participants described increased understanding of FND, themselves, and 
learning skills related to their thoughts and feelings. Several participants described 
having a limited understanding of FND before the intervention and benefitting from 
information that made it easier to talk to others about their diagnosis. Some participants 
also gained increased self-awareness of emotions and the role of their life history, 
including stressors and past traumas. These themes correspond with Lind et al.’s (2014) 
findings that a mindfulness group for patients with somatoform disorder improved 
patients’ ability to identify and express their needs and feelings of distress. This 
increased understanding aided a range of new ways of thinking. 
New ways of thinking involved effective management of thoughts, increased 
coping, greater acceptance and increased self-compassion. Participants described 
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changes in managing their thoughts that led to 'different perspectives’ through 
‘unhooking’ and ‘dismissing’ difficult thoughts. These changes supported increased 
coping. Some participants described gaining new mindfulness skills, breathing 
techniques, defusion, choice point, and value identification skills. Participants spoke of 
finding different combinations of these skills helpful in creating changes. Some 
participants described managing their emotions and stressful situations more effectively 
and subsequently going out more easily. Several participants also reported increased 
acceptance of emotions and of their diagnosis. This finding is important given that 
rejection of psychological explanations by patients with functional symptoms is widely 
reported in the literature and backed by evidence from qualitative studies (Nettleton et 
al., 2005; Rawlings & Reuber, 2016), illness belief questionnaires (Binzer et al., 1998), 
and anecdotal evidence from neurologists (Kanaan et al., 2011). Another theme across 
participants was increased self-compassion, reflected through participants’ descriptions 
of slowing down, having increased time to themselves and putting themselves first. This 
theme is interesting when considered in the context of recent work that has focused 
upon the role of self-compassion and adjustment in patients with NEAD, where self-
compassion was associated with adaptive coping strategies (Clegg et al., 2019). 
Limitations and strengths of the Change Interview findings. These qualitative 
findings represent the views of a small sample. Participants were restricted to patients 
who attended assessment and formulation and either part of or the full ACT group. 
Patients who declined the group or taking part in the research, dropped out of the 
service, or were referred elsewhere were excluded, making the sample biased and 
limiting generalisability. Four participants who attended the second ACT group had this 
intervention cut short due to the lockdown caused by the pandemic. Subsequently, these 
participants were asked to discuss their initial assessment and formulation sessions and 
their experiences of change at an unsettling and uncertain time, without a clear sense of 
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when treatment or 'everyday' life would resume. The researcher's identity as being 
independent of the department was highlighted. However, a psychologist involved in 
the intervention was part of the research team, which may have influenced how 
participants responded (i.e. demand characteristics).  
The qualitative analysis enabled the investigation of phenomenon and elicited data 
grounded in human experiences in an area in which there is a paucity of research 
(Sandelowski, 1995). The thematic analysis provided a structured but flexible approach 
to handling the data sets that allowed identifying similarities and differences between 
participants' accounts of experience (Braun & Clarke, 2006; Nowell et al., 2017). The 
flexibility of thematic analysis can also be perceived as a weakness. It can lead to 
inconsistencies and lack of coherence in data analysis (Holloway & Todres, 2003). 
However, inconsistencies were checked using an independent researcher to explore and 
compare themes, which revealed a shared consensus on the key themes. Of final 
consideration, while thematic analysis can be flexible, it is also a structured approach 
and could have resulted in an increased focus on the change, which was the focus of the 
structured Change Interview. Results may have looked very different had an open 
interview been used, which was focused more broadly on the intervention experiences.  
Next, the multiple data sources' findings are summarised before considering the 
implications of the thesis.  
3.5 Summary of findings 
A scoping review examined the extent and nature of third-wave CBT for FND. 
Preliminary factors related to the feasibility, acceptability and effectiveness of third-
wave CBT for FND were also explored. The review identified eight low-quality 
intervention studies using varying designs. These studies captured DBT, MBT and ACT 
- 156 - 
 
interventions delivered to people experiencing various FND presentations, although 
mainly NEAD. There was a lack of reporting on data that indicated intervention 
feasibility and acceptability. No specific intervention factors were found to relate to 
effectiveness, indicating that there may be particular feasibility in adopting manualised 
third-wave CBT that can be replicated across clinical contexts by facilitators with 
varying skills mixes. Intervention effectiveness was linked to improvements in FND 
symptoms and symptom interference, with the most robust evidence for reducing 
NEAD frequency. Some improvements were also found for standardised QoL, distress, 
and psychological flexibility measures. It is impossible to know whether changes were 
due to the intervention or other confounding factors due to the low-quality evidence. 
When exploring the experiences and impact of a two-phase psychological 
intervention for FND, an unexpected and complex change pattern was found within pre 
and post-standardised outcome measures, which included some lack of change and 
worsening. Following assessment and formulation, only one participant experienced 
improvements in distress measures. Two participants experienced a reliable and 
clinically significant worsening in distress and symptom interference measures. 
Following the ACT group, only one participant experienced an improvement in distress, 
emotion processing and psychological flexibility measures. Using Elliott's (2002) 
HSCED approach, changes attributable to the intervention were found for this 
participant. 
Participants’ qualitative accounts from the Change Interview revealed shared 
themes across each intervention phase, with both representing a safe space where 
participants experienced validation and affirmation that led to feeling understood, 
listened to, able to express their feelings and ask questions. Participants attending the 
ACT group also spoke highly of the value of meeting other people with FND and 
gaining a sense of social belonging that created supportive connections and 
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encouragement. Within this context of a safe space, participants were able to gain an 
increased understanding of their diagnosis, self-awareness and new skills. This helped 
create several new ways of thinking – such as managing thoughts, increased coping, 
greater acceptance and increased self-compassion. Despite talking about painful topics, 
sessions brought about positive change. In summary, the thematic analysis results 
revealed that the interventions created therapeutic changes, with both phases being 
described as acceptable by participants. 
3.5.1 Implications 
This work set out to explore the impact of third-wave CBT for FND using 
multiple methods, which will now be explored collectively to make sense of the overall 
findings. Several areas for reflection when reconciling these different data sources. 
Findings indicate that some people with FND experience positive therapeutic changes 
from third-wave CBT. However, it is unclear what patient and treatment characteristics 
contribute to this, which appears in part to be an artefact of the challenges in measuring 
change and providing psychological interventions for this complex and heterogeneous 
clinical group. These areas will now broadly be discussed before outlining clinical 
implications, overall limitations and strengths and research implications, including 
future research recommendations, before concluding.  
A key finding in this work was the lack of change and some worsening in the ACT 
group's standardised outcome measures. At first glance, this is not easily reconciled 
with the scoping review findings on third-wave CBT intervention for FND. This review 
found previous studies using third-wave CBT for FND were of small samples and low 
methodological quality but generally found changes across the various standardised 
outcome measures used in this work. However, these were published studies and may 
represent a publication bias – where only positive findings are published. Importantly, 
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the review identified that that are no RCTs on third-wave CBT for FND. However, 
higher-quality research using ACT interventions and related clinical samples has found 
limited effectiveness. For example, Pedersen et al. (2019) carried out a large RCT for an 
ACT group-based intervention for 180 patients with functional somatic syndromes 
randomly assigned to enhanced care with a brief ACT workshop or a nine three-hour 
session ACT group. The authors found no differences in post-intervention measures for 
the ACT group other than overall self-rated health improvement.  
The limited evidence for third-wave CBT approaches for FND makes it unclear 
whether a more protracted ACT intervention may have created change. Several studies 
using third-wave CBT for FND have found that the patients least likely to experience 
improvements, or in some cases worsening, had severe FND presentations and 
comorbid physical and mental health difficulties (Baslet et al., 2015; 2020; Bullock et 
al., 2015; Graham et al., 2018). The participants who experienced worsening in the 
current study also described comorbid mental health and physical health difficulties. 
Furthermore, the literature indicates that FND prognosis is poor – a systematic review 
found that 39% of patients with mFND had the same or worse symptoms at follow-up, 
and only 20% had complete remission (Gelauff et al., 2014). Given the relatively short 
seven-week ACT group evaluated in this work, it is perhaps unsurprising that it was not 
effective in creating change. This work indicates that for some people with FND, third-
wave CBT is not effective.  
More robust and high-quality evidence of effectiveness exists for alternative 
psychological approaches for FND. For example, Goldstein et al. (2020) recruited 368 
patients with NEAD into an RCT for either standard medical care or routine medical 
care plus CBT. They found improvements in QoL, symptom interference, distress and 
somatic symptom measures that remained at 12-month follow-up for the CBT group. 
The CBT intervention involved twelve one-hour sessions over four to five months, with 
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a booster session nine months' post-randomisation. In another trial, Sattel et al.'s (2012) 
twelve weekly session PIT for patients with multisomatoform disorder found the 
intervention improved physical QoL and somatisation measures better than enhanced 
medical care (three sessions). The current evidence base for third-wave CBT for FND is 
a long way off this level of robust research design, perhaps unsurprisingly given its 
more recent emergence. 
Another key finding of this work was that standardised measures following the 
two-phase intervention revealed a lack of change and worsening for some. These 
findings contrasted with participants’ interview accounts. Here participants described 
experiencing a range of positive therapeutic changes resulting from the intervention, 
with rich accounts full of idiosyncratic detail on how changes linked to the intervention. 
The unexpected changes for both intervention phases may have perhaps been an artefact 
of when and how the change was measured. For example, standardised outcome 
measures were collected immediately following each phase. However, it may have 
taken time for change to have become apparent and meaningfully captured.  
Although there is a broad consensus that therapy's goal is to create change (Miller, 
Duncan, & Hubble, 2005), what this looks like and how this is measured is often 
arbitrary (Wampold, 2001). While the standardised outcome measures selected were 
psychometrically sound, such measures are 'arbitrary metrics' (Blanton & Jaccard, 2006) 
and perhaps may not have translated into participants’ real-world functioning (Kazdin, 
2001). In contrast, the Change Interview was more flexible and rooted in the 
participants’ experience and highlighted that each participant was unique and 
experienced their own distinctive set of changes. The concept of reliable and clinically 
significant change can also be problematic as a participant must fall within the 'clinical' 
population to achieve clinical significance. However, several current participants fell 
into a subclinical range for some of the standardised measures. Additionally, some 
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individuals may never return to within the non-clinical population cut-off due to the 
chronicity of their difficulties, despite making meaningful change for themselves 
(Hansen et al., 2002), which may have also contributed to the lack of change found for 
some in this work. 
Across the two-phase psychological intervention, participants’ intervention 
descriptions suggest high acceptability. However, when exploring the Clinical Health 
Psychology Services overall FND referral numbers between June 19th 2019, to 
February 27th 2020, forty-eight patients were referred, but seventeen dropped out or did 
not respond – no other service referral numbers are available to draw comparisons. 
Additionally, three did not attend the first appointment for the ACT group out of the 
fifteen patients offered the ACT group within this data. While in the group used for the 
SCED, three participants attended the final group session out of the nine invited. These 
high drop-out rates indicate a lack of acceptability for the two-phase psychological 
intervention for some. Although it is important to remember that this data is collected in 
a clinical setting from a recently established treatment pathway that contrasts with large 
scale well-funded trials set up to perhaps be more efficient than clinical settings at 
engaging and retaining participants.  
Patients in this work were predominantly referred from the hospital neurology 
department and are typically at an early stage of receiving an FND diagnosis and 
making sense of this, likely impacting the patient's readiness to engage in the 
psychological intervention. Literature indicates that rejection of psychological 
explanations of FND can be related to perceived incompatibility between physical 
problems and psychological mechanisms (Neilson et al., 2019). A mind-body dualistic 
way of thinking is embodied in society in general (Wade & Halligan, 2017). This mind-
body dualism may be reinforced in patients with FND by being given overly simplistic 
psychological explanations (e.g. symptoms caused by stress) and explanations that fail 
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to take precipitating physical events into account when they are an essential part of a 
patient’s narrative. Indeed, this underlined the experiences of feeling stigmatised and 
ultimately de-stigmatisation by one participant in the current study. 
Moreover, the stigma associated with mental health can contribute to participants’ 
dissatisfaction with psychological explanations of FND (Neilson et al., 2019). Several 
participants referred to the negative attitudes held by some HCPs towards FND and felt 
that they had to prove their experiences' legitimacy. Negative attitudes towards FND 
have been reported in clinician surveys (Ahern et al., 2009; Evans & Evans, 2010). One 
of the few qualitative studies on patients with somatoform disorder experiences of a 
mindfulness intervention highlighted the importance of patients feeling acknowledged 
as legitimately ill (Lind, Delmar & Nielsen, 2014). 
Literature indicates that an important variable in predicting post-intervention 
improvement for patients with FND is their acceptance of a psychological formulation 
for their symptoms (O'Connell et al., 2019). A participant's lack of acceptance of a 
psychological understanding of their diagnosis may have contributed to some 
participants’ lack of engagement in using ACT processes and subsequent lack of change 
and, for some, deciding to drop out or not engage in the service all. In O'Connell et al.'s 
(2019) sample of 98 patients with mFND, the authors found that only 49% of their 
sample accepted a psychological formulation before the commencement of therapy. The 
authors found that patients' acceptance of a psychological account of symptoms 
predicted post-measure improvements – those that did not accept a psychological 
framework were less likely to use therapeutic tools.  
The high drop-out rates in this work reflect the challenges in providing 
psychological therapy for FND. Many patients do not perceive psychological 
interventions as an acceptable treatment for their physical symptoms and can feel that 
their symptoms are not being taken seriously (Carson et al., 2012; Nettleton, 2006; Reid 
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et al., 2001; Stone et al., 2002). Indeed, referral to psychology can be perceived as 
tantamount to saying that the individual’s very real physical symptoms are all in their 
head. Nevertheless, psychological intervention is often considered the most important 
treatment option for FND (Howlett et al., 2007; Reuber, Howlett, & Kemp, 2005). 
The patients represented in this work accepted a psychological intervention 
enough to engage with the Clinical Health Psychology Service and then experienced 
some benefits that kept them engaged in the intervention. Thus, current findings only 
represent a small subsection of the FND population. Furthermore, those referred to the 
ACT group were pre-selected based on clinicians' perceptions of suitability, further 
reducing the findings' generalisability. This process highlights the need to be cautious in 
generalising FND intervention study’s findings to broader FND populations and 
suggests that future psychological studies on FND will have limited feasibility and 
acceptability when considered in the context of the broader FND population. 
Arguably, the commissioning and service structure of separate physical and 
mental health service reinforces unhelpful messages on the nature of FND that can 
make it hard for some to reconcile that their very physical symptoms may have a 
psychological explanation (Nettleton et al., 2005; Rawlings & Reuber, 2016). In the 
current service evaluated, patients with pre-existing mental health and trauma-specific 
issues as their primary concern are referred to mental health services. However, the 
literature indicates that it is not meaningful to separate mental health problems from 
FND symptoms, given that FND symptoms can be a physical manifestation of the same 
underlying difficulties as those found in mental health difficulties. These underlying 
difficulties include a range of cognitive-emotional processes (Brown, 2004; Edwards et 
al., 2018; Novakova et al., 2015) and difficulties recognising or acknowledging affect 
(Novakova et al., 2015). Subsequently, there is limited validity in having an FND 
treatment pathway separate from a mental health pathway.  
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The problematic separation between mental and physical health services has 
started to be tackled in recent years through the growing acknowledgement and support 
for a multidisciplinary approach to treating FND. A multidisciplinary approach shares 
knowledge from a physical, psychological and social perspective that supports a patient 
through providing physical therapy (physiotherapy and occupational therapy), 
pharmacotherapy, individual and family therapy and psychoeducation (Carson et al., 
2012; Kozlowska, 2017; Kozlowska et al., 2012, 2013). Multiple studies assessing 
multidisciplinary inpatient and outpatient rehabilitation treatments that vary from three 
to fourteen weeks indicate that most patients experience significant improvements in 
physical function and quality of life (Demartini et al., 2014; Jordbru et al., 2014; 
McCormack et al., 2014; Petrochilos et al., 2020). However, this structured 
multidisciplinary team (MDT) approach is not consistently available in the UK and is 
not supported by national guidelines (NICE, 2017). 
Clinical implications. The current findings indicate that whilst some patients 
value the sessions provided by Clinical Health Psychology Services; a third-wave CBT 
intervention is neither acceptable nor effective for all. Findings suggest that acceptable 
and effective interventions for some people with FND will need to provide a joined-up 
multidisciplinary approach that is personalised and formulation-driven. The present 
Clinical Health Psychology Service two-phase psychological intervention may be an 
acceptable and feasible first-line approach for some people with FND within current 
service commissioning limits. Offering assessment and formulation sessions can help 
tackle the unhelpful mind-body dualism by providing a psychologically informed 
understanding of symptoms, but only if patients are ready to consider this perspective. 
In this work, participants described having space for their stories to be listened to, 
which increased understanding and acceptance of their diagnosis. This process 
emphasises the importance of listening to patients’ stories and the need for an integrated 
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biopsychosocial explanatory model to help patients make sense of their illness 
experience.  
Following assessment and formulation, the ACT group could be seen as part of a 
stepped-care treatment pathway, followed by individualised, one-to-one input using a 
range of evidence-based therapeutic approaches when required. The ACT group is an 
initial intervention that could provide high feasibility, given the group format and brief 
nature. The current findings suggest that the group format provides additional value for 
some patients, although some will not find it acceptable. Moreover, ACT can offer a 
shared understanding and language-focused upon increasing value-based activity that 
can be translated across different disciplines. Providing a choice of the ACT group or 
other individualised therapeutic approaches can help patients feel empowered and that 
their concerns are heard, which are important factors contributing to improved patient 
outcomes (Mauksch, 2000; Williams, Frankel, Campbell, & Deci, 2000).  
The study findings also highlight the power of group-based interventions for FND, 
which can offer a social affiliation that leads to patients building supportive 
connections, receiving encouragement, feeling more understood and less alone. 
Literature and the current findings highlight several group factors that can support 
change, such as hope, advice, kindness and socialising (Yalom & Leszcz, 2008). 
Bullock et al. (2010) suggest coping skills may be more readily accepted and learnt by 
patients with FND after interacting with and observing others experiencing symptoms 
similar to their own. Consequently, it may also be beneficial for clinicians to consider 
ways to provide a structured, supportive space for patients with FND to meet others 
with the diagnosis. 
Limitations and strengths. Using several methods allowed for a rounded 
understanding of the feasibility, acceptability and effectiveness of third-wave CBT for 
FND. Although, this posed the challenge of interpreting findings that looked different 
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from each other. A potential limitation of this work was that participants had a mix of 
different FND presentations. Research on different subcategories of FND indicates that 
patient’s with NEAD and mFND may have varying treatment needs, which may have 
conflated results and made findings less pertinent. 
This thesis included a thorough review of the literature that identified significant 
gaps and highlighted the need for further research and the importance of the questions 
explored in this work, which is the first to explore an ACT group for FND and 
participants’ experiences of a psychological intervention. Unfortunately, the scoping 
review was carried out retrospectively following data collection disruptions, and 
although the review provided useful insights into conducting SCEDs in clinical practice, 
this did not shape the SCED presented. Despite this, the SCED was robustly designed, 
with the full potential unfortunately not realised due to the second ACT group's abrupt 
ending.  
Data collection was also hampered by SCED participants’ low adherence to the 
daily survey. Although the researcher attended the first group to discuss the research, it 
appears additional time spent on getting participants to understand and invest in this 
survey was necessary. However, a strength of this work was that participants’ burden 
was prioritised in designing measures, which were finalised in consultation with past 
patients of the service. This decision reflected the clinical context that offered high 
ecological validity, albeit at the expense of more stringent controls and meaningful data 
collection. A final key strength of this work was the value placed on participants’ 
experiences. Using a semi-structured Change Interview provided rich qualitative 
information on participants’ experiences of the intervention and change.  
Research implications. This work demonstrates that research within clinical 
settings can be feasibly carried out and contribute to the evidence base for FND. 
Findings highlight that some people with FND benefit from third-wave CBT. However, 
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despite the focus on understanding the impact of third-wave CBT, it remains unclear 
which patients with FND may benefit from this approach and the best time to offer the 
intervention. Unlike other therapeutic approaches for FND, the literature on third-wave 
CBT is limited and low quality, highlighting the need for more robust research in the 
area. Subsequently, different recommendations for future research are next outlined.  
The SCED for the ACT group explored change at the individual level and did not 
require a large sample size. According to Morley (2017, p. 159), there is a ‘tremendous 
potential in replicating single-case series’ in developing interventions that can create an 
understanding of third-wave CBT interventions. Indeed, SCEDs can explore the unique 
contributions of different intervention parts that may contribute to therapeutic change. 
Through repeated replication, SCEDs can build evidence for the effectiveness of third-
wave CBT for FND that may generate enough evidence to warrant larger scale RCTs. 
Currently, RCTs have only been carried out for third-wave therapies in broader clinical 
populations and other therapeutic modalities within an FND population. 
Through tracking change across the full two-phase psychological intervention, it 
was hoped that it would be possible to compare the differences in change for each phase 
for a participant and between phases. Using a SCED or non-randomised trial to explore 
different third-wave CBT approaches, deliveries (e.g. group-based versus individual 
work) and other therapies can help in understanding the differences and similarities in 
patient change and experiences. It is recommended that intervention studies use frequent 
high-quality time points of measurement before, during and after the intervention, rather 
than pre and post-measures of change. Such timepoints provide higher quality data and 
understanding of the intervention but need to be weighed up with the measures’ 
burdensomeness. Follow-up measures at multiple time points can also assess change 
longevity.  
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Recording potential confounding variables, such as concurrent treatments (e.g. 
medication, physiotherapy), can increase the validity of findings. Importantly, future 
research needs to explore how change is defined and measured for FND. It is 
recommended that idiosyncratic measures of change are used, such as the Change 
Interview and process measures directly targeted by the intervention. Moreover, it is 
recommended that treatment fidelity measures monitor the accuracy and consistency of 
the intervention delivered, ideally through an independent rater. 
Future research is needed to understand factors that contribute to third-wave CBT 
effectiveness. It is currently unclear what role various factors, such as the chronicity and 
severity of FND symptoms, comorbid difficulties and acceptance of the diagnosis, play 
in intervention feasibility, acceptability and effectiveness. Exploring these factors 
requires researchers to collect a range of patient demographics and characteristics. 
Similarly, research also needs to provide detailed reporting on the uptake, drop-out, 
non-response and deterioration rates at different intervention stages. Analysing such 
variables to see if patterns emerge in patient change or experience will help identify 
patients that are more or less likely to benefit from third-wave CBT interventions or 
other therapeutic approaches.  
Further research is needed to understand the outcomes for patients who do not 
attend services or drop-out at different time points of the intervention (e.g. before the 
group, after the first session). The limited evidence suggests patients with greater 
chronicity of FND symptoms, comorbid mental and physical health difficulties, who are 
younger, identify as being from an ethnic background and have fewer years of education 
may be less likely to find third-wave CBT interventions acceptable and effective. 
Qualitative research and mixed-method designs are essential in capturing these 
participants’ perspectives. Understanding these patients’ experiences and perceptions 
can help better understand what could be an acceptable and effective intervention for 
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the individual. While feasibility research implemented before conducting intervention 
studies can also help consider real-world barriers and facilitators to intervention 
implementation and address cultural or linguistic relevance (Bowen et al., 2009; 
Kazdin, 2018).  
Future work needs to continue to develop an understanding of this diverse clinical 
population’s needs that can shape therapeutic interventions. Literature indicates a range 
of psychological and psychiatric factors associated with FND. It also suggests 
subgroups of patients with varying treatment needs (Brown & Reuber, 2016a). 
Differences in patient subgroups need to be considered in shaping therapeutic 
interventions that are feasible, acceptable and effective for the individual. It may be that 
different subtypes of FND respond in different ways to various interventions. Future 
research can consider how therapeutic interventions drawing upon different therapeutic 
modalities in varying formats and duration can be effectively tailored for different 
subgroups of patients with FND in a feasible and acceptable manner. It will be 
important to explore how such psychological therapies can also be offered in 
conjunction with other health treatments, such as physiotherapy and occupational 
therapy, to start bridging the gap between mental and physical health in treating FND. 
3.5.2 Conclusion 
This work used multiple methods to explore the impact of third-wave CBT for 
FND. A scoping review revealed that literature in the area is limited, diverse, and low 
quality and lacks information on feasibility and acceptability. There was some promise 
for third-wave CBT effectiveness with improvements found for QoL, distress and 
psychological flexibility measures. However, higher-quality research is required to 
explore the acceptability and effectiveness of such approaches, alongside the need for 
greater exploration of participants' perceptions and experiences of interventions. 
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This work also explored the experiences and impact of a two-phase psychological 
intervention for patients with FND within a Clinical Health Psychology Service and 
included a SCED of a seven-week ACT group. Participants reported overwhelmingly 
positive experiences of the intervention and identified a variety of therapeutic changes 
attributable to the intervention. However, this contrasted with the broader service’s high 
drop-out rates, reflecting the challenges of providing psychological intervention for 
people with FND, particularly within existing service structures set up for either mental 
or physical health.  
Furthermore, across both intervention phases, standardised measures revealed 
limited change, and in some cases worsening, despite participants indicating that 
important changes resulted from the intervention. Whilst there were idiosyncratic 
explanations of the unexpected changes, the findings raise questions about both how we 
expect change to occur over the course of psychological intervention and how we 
measure that. Participants' descriptions of change included new ways of thinking, 
improved coping, greater acceptance of the diagnosis and increased self-compassion. 
These changes appeared to be facilitated through offering a safe space, validation and 
affirmation that enabled participants to ask questions and express themselves. Some 
participants appeared to experience the intervention as a corrective experience from past 
difficult experiences, such as misdiagnoses, stigma and dysfunctional health care 
professional encounters, which contributed to feeling misunderstood. This process 
highlights the need for clinicians to be curious and listening to patients' narratives and 
understanding their experiences when communicating the diagnosis, which is the first 
step in the treatment of FND. This is important given a patient's understanding, and 
acceptance of the diagnosis can significantly impact future treatment (Espay, Aybek, et 
al., 2018). 
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Given the adverse experiences that patients with FND can have before entering a 
psychology service, future work will be necessary to consider ways to enhance a 
patient's journey through the health care system. Findings highlight the need for 
integrated biopsychosocial explanations to help patients make sense of their illness, 
which requires the ongoing move away from a mind-body dualism that embodies health 
care services structures. Future work is needed in supporting these structural and 
cultural shifts. Perhaps this may best be carried out by helping patients with FND have 
their voice heard and ideas used in shaping treatment pathways and interventions 
through both clinical and research settings. 
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Appendix A 
Full details of the search strategy, including MESH terms  
1. [(bodily stress adj2 (syndrome* or disorder*)).tw,kw. 
2. [complex physical symptoms.tw,kw.] 
3. Conversion Disorder/ 
4. [conversion disorder*.tw,kw.] 
5. Dissociative Disorders/ 
6. [(dissociative adj2 (disorder* or convulsion* or seizure*)).tw,kw.] 
7. [FND.tw,kw.] 
8. [(functional adj2 (tic* or tremor* or stroke* or movement* or motor* or 
somatic* syndrome* or neurological* or disorder* or symptom* or 
seizure*)).tw,kw.] 
9. [((functional or psychogenic) adj2 (paresis* or weakness* or twitching* or 
sensory disturbance*)).tw,kw.] 
10. Gait Disorders, Neurologic/ 
11. [gait disorder*.tw,kw.] 
12. [hysteric*.tw,kw.] 
13. [(medically unexplained adj2 (physical* or disorder* or syndrome* or 
symptom*)).tw,kw.] 
14. medically unexplained symptoms/ 
15. [medically unexplained symptoms.tw,kw.] 
16. [((movement or motor) adj (disorder* or symptoms*)).tw,kw.] 
17. [NEAD.tw,kw.] 
18. [((nonepileptic or non-epileptic) adj (attack* or seizure* or event*)).tw,kw.] 
19. medically unexplained symptoms/ 
20. [medically unexplained symptoms.tw,kw.] 
21. [((movement or motor) adj (disorder* or symptoms*)).tw,kw.] 
22. [NEAD.tw,kw.] 
23. [((nonepileptic or non-epileptic) adj (attack* or seizure* or event*)).tw,kw.] 
24. [nonorganic.tw,kw.] 
25. Psychophysiologic Disorders/ 
26. [pseudoseizure*.tw,kw.] 
27. [psychosomatic*.tw,kw.] 
28. [persistent physical symptom*.tw,kw.] 
29. [pseudoepilep*.tw,kw.] 
30. [(psychogenic adj2 (seizure* or disorder*)).tw,kw.] 
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31. Somatoform Disorders/ 
32. [somatoform*.tw,kw.] 
33. [somati#ation*.tw,kw.] 
34. [(unexplained adj2 (tremor* or weakness* or twitching*)).tw,kw.] 
35. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 
or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 
or 31 or 32 or 33 or 34 
36. "Acceptance and Commitment Therapy"/ 
37. ["acceptance and commitment therapy".kw,tw.] 
38. ((behavioural or behavior) adj activation).tw,kw. 
39. (cognitive behavio* analysis system of psychotherapy or CBASP).tw,kw 
40. (compassion focused therapy or compassion focussed therapy or compassionate 
mind or self-compassion).tw,kw. 
41. [defusion.tw,kw.] 
42. (dialectical behavioural therapy or DBT).tw,kw. 
43. [emotion* processing.tw,kw.] 
44. metacognitive therapy.tw,kw 
45. Mindfulness/ 
46. [mindfulness.tw,kw.] 
47. (mindfulness-based cognitive therapy or MBCT).tw,kw. 
48. [(thirdwave or third-wave).tw,kw.] 
49. 36 or 37 or 38 or 39 or 40 or 41 or 42 or 43 or 44 or 45 or 46 or 47 or 48 
50. 35 and 49 
51. limit 45 to english language 
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Appendix C 
Quality ratings and Fleiss’s kappa calculatioN 
 
Note. S1 – Barrett-Naylor et al. (2018), S2 – Baslet et al. (2015), S3 – Baslet et al. 
(2020), S4 – Baslet & Hill (2011), S5 – Bullock et al. (2015), S6 – 
Grahamet al. (2018), S7 – Graham et al. (2017), S8 – Rancourt & Darkes 
(2018). Colour coding key: N = no/ not present, Y = yes/ present, P = 
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Rating table  
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Appendix D 
Measures used in scoping review studies and their references 
• Acceptance and Action Questionnaire-II (AAQ-11, Bond et al., 2011) 
• Alcohol Use Disorders Identification Test-Consumption (AUDIT-C, Bush et al., 
1998) 
• Beck Depression Inventory-II (BDI-II, Beck, Steer & Brown, 1996) 
• Comprehensive assessment of Acceptance and Commitment Therapy 
(CompACT, Francis et al. (2016)) 
• Clinical Outcomes in Routine Evaluation-10 (CORE-10, Barkham et al., 2013) 
• Depression, Anxiety and Stress Scale (DASS, Lovibond & Lovibond, 1995) 
• Dissociative Experience Scale (DES, Vanijzendoorn & Schuengel. 1996) 
• Patient Health Questionnaire-15 (PHQ-15, Spitzer et al. 2002) 
• PTSD Checklist-Civilian Version (PCL-C, Blanchard et al., 1996) 
• Quality of Life in Epilepsy-10 (QOLIE-10, Cramer, Perrine, Devinsky, & 
Meador, 1996) 
• Work and Social Adjustment Scale (WSAS, Mundt, Marks, Shear & Griest, 2002) 
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Appendix F 
Phase 1 participant information sheet 
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Appendix G 
Phase 2 participant information sheet 
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Appendix I 
Preliminary thematic map 
 
 
